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1. CELL CYCLE 
The cell cycle is the cellular life cycle which is essential for all the organisms. On the one hand, 
unicellular organisms generate a new organism through this process. On the other hand, 
pluricellular organisms require thousands of consecutive cell divisions to develop and maintain 
their status quo 
1
.  
The cell cycle is defined as the series of events that take place in a cell leading to DNA 
replication and segregation of replicated chromosomes into two separate cells 
2
. This process 
occurs in four consecutive cell cycle phases. The duplication of genetic material takes place in 
S phase or synthesis phase, a process known as DNA replication 
3
. It is a fundamental stage 
that has to be properly and accurately completed once per cell cycle to avoid loss of 
information and the acquisition of genomic instability, a hallmark of cancer 
4,5
. Once 
duplicated, the genetic material must be divided into two identical daughter cells, each 
bearing a diploid complement of chromosomes. This division occurs in M phase or mitosis, 
which includes different stages. During prophase, the chromosomes condense, nuclear 
envelope breaks down and mitotic spindle starts to form. Then, the mitotic spindle begins to 
capture and organize the chromosomes in a process known as prometaphase.  During 
metaphase, microtubules are attached to kinetochore and the chromosomes are aligned in 
the midline of the cell. The separation of duplicated chromosomes indicates the beginning of 
anaphase, in which each sister chromatid is moved towards one of the spindle poles. Finally, 
the DNA is decondensed and the new nuclear envelope is formed around daughter 
chromosomes in a phase named telophase. Then, cell is divided by a process known as 
cytokinesis, forming two daughter cells genetically identical between themselves and ending 
the M phase of cell cycle 
1
.   
For proper DNA duplication and cell division, two additional phases are required to provide an 
additional time for growth and control cell cycle: G1 (gap 1) and G2 (gap 2) phases. G1 phase 
precedes S phase and is necessary for the cell to supervise the environment and its own size, 
and when cells receive extracellular signals that determine cell cycle entry, they bypass the 
restriction point, making the decisive step towards DNA replication. G2 phase precedes M 
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phase and is necessary for cell to ensure that DNA replication has occurred accurately, and 
that DNA damage is repaired prior to mitotic entry 
1,3
.  
Cell cycle is a proliferative state and the switching between proliferative state and quiescent 
state is often reversible to achieve tissue homeostasis. The quiescent state, termed G0 phase, 
represents a resting state where cells are not preparing to divide. Reduced levels of mitogens, 
contact inhibition and various stress conditions are known to promote quiescence before cells 
pass through the restriction point in G1 phase, but the transitions between these states are 
still poorly understood 
1,6
. Recently, it has been postulated that the irreversible APC/C
Cdh1
 
activation (explained in section 1.2.2) marks the point of no return for cell-cycle entry 
7
.  
Each cell cycle is a complex process that requires the ordered and correct progression though 
different phases, which is tightly regulated by cyclin-CDK (cyclin-dependent kinases) 
complexes, different and specific for each phase 
3
, and E3 ubiquitin ligases, which mediate the 
timely and precise ubiquitin-proteasome-dependent degradation of cyclins 
2,8
.  
Proper cell cycle is also controlled by several checkpoints, defined as quality-control pathways 
that sense defects in the process and induce cell-cycle arrest till the previous phase is 
completed 
2,9
. 
1.1. CELL CYCLE REGULATION BY CYCLIN- CDKS 
The transition from one cell phase to another occurs in an ordered manner and is controlled 
by cyclin-CDK complexes 
3
. CDKs are a family of serine/threonine protein kinases that are 
activated at specific points of the cell cycle by the association with cyclins, the regulatory 
subunits which control kinase activity and substrate specificity 
3,10
. The number of CDKs and 
cyclins has increased during evolution, with 20 CDK and 29 cyclin proteins existing in mammals 
11,12
. CDK and cyclin families function in a variety of cellular processes apart from cell cycle 
regulation, such as transcription, RNA processing, translation, metabolism and neurogenesis, 
among others 
10,11,13
.  
In the classical model for mammalian cell cycle, just some specific CDK-cyclin complexes are 
responsible for cell cycle progression, in an orderly and sequentially manner 
14
. Four CDKs 
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(CDK1, CDK2, CDK4 and CDK6) and four classes of cyclins (A- B- D- and E-type cyclins) are 
responsible for driving cell cycle progression 
3,14
. When mitogenic signals are sensed by D-type 
cyclins (D1, D2 and D3 isoforms), they bind to CDK4 or CDK6 and form complexes that are 
essential for the entry in G1 phase, a stage where cells are preparing to initiate DNA synthesis 
in the next cell cycle phase. To do so, the expression of E-type cyclin is allowed, by a partial 
inactivation of pocket proteins (pRB, p107 and p130), and it binds and activates CDK2 to 
regulate progression from G1 into S phase. The availability of E-type cyclins (E1 and E2 
isoforms) is tightly controlled and limited to early stages of DNA replication; during late states 
of DNA duplication, CDK2 is activated by A-type cyclins (A1 and A2 isoforms) to drive the 
transition from S phase to G2. Finally, CDK1 is activated by A-type cyclins at the end of G2 to 
facilitate the mitotic onset. After prophase, A-type cyclins are degraded, and CDK1 is activated 
by B-type cyclins (B1, B2 and B3 isoforms), responsible for triggering mitosis (Figure 1) 
3,14–16
. 
 
Figure 1. Cell cycle regulation by cyclin-CDKs. The classical model of cyclin-CDK complexes responsible 
for cell cycle progression. Adapted from “The cell cycle: a review of regulation, deregulation and 
therapeutic targets in cancer” 
3
. Cyc: cyclins.  
This “classical” model, in which each cell cycle phase is driven by specific CDKs, has been 
recently challenged by the generation of knockout mice for several CDKs 
10,14,16,17
. Those 
studies revealed that CDK2, CDK4 and CDK6 are not essential for cell cycle of most cell types, 
except in highly specialized cell types: for instance, CDK2 is essential for meiotic division of 
germ cells 
18,19
, CDK4 is essential for proliferation pancreatic β-cells and pituitary lactotrophs 
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Cyc D CDK6 
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20,21
 and CDK6 is essential for haematopoietic cells 
22
. Only CDK1 is essential, since its 
elimination causes cell cycle arrest, preventing the development beyond the two-cell stage 
23
. 
Thus, under certain conditions, CDK1 can be used as a substitute for the other CDKs. 
1.1.1. REGULATION OF CYCLIN-CDKS 
Due to the importance of cyclin-CDK complexes for correct and ordered cell cycle progression, 
these complexes are tightly regulated by several mechanisms explained below. 
Regulation of cyclin protein levels 
First, as previously mentioned, CDKs need to bind with cyclins, their activating proteins, in 
order to become functional. The interaction of CDKs with cyclins promotes a conformational 
change in the CDK subunit necessary to expose the catalytic site and the substrate binding 
interface 
10,12
. Each of the cell cycle phases are characterized by the expression of a distinct 
type of cyclin, while CDK protein levels remain stable during cell cycle. Oscillations in cyclin 
protein level during cell cycle represent the primary mechanism by which CDK activity is 
regulated, through the synthesis and degradation of cyclins 
24
.  
E2F transcription factors are downstream effectors of the pRb pathway and allow the 
expression of many genes required for the entry into S phase and cell cycle progression. In the 
last decades, eight members of the E2F family have been identified, and they have been 
classified into “activators” (E2F1-3) and “repressors” (E2F4-8), although these opposite roles 
are context-dependent  
25–27
. These transcription factors are important regulators that control 
S-phase entry and mitotic entry, and are also involved in processes such DNA replication, DNA 
repair, apoptosis, differentiation and development 
28
. 
E2F family is regulated by their association with pocket family proteins (pRb, p107 and p130), 
which interact and repress the function of E2F proteins in absence of appropriate extracellular 
signals. Therefore, growth factor stimulation induces pRb phosphorylation, allowing E2F 
release and activating their transcriptional activity 
24,28
.  
In this sense, during G1 and in response to mitogenic signals, the activation of D-type cyclin-
CDK4/6 induces the phosphorylation and inactivation of the pocket proteins (pRb, p107 and 
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p130). These proteins form complexes with E2F transcription factors. Thus, phosphorylation of 
pocket proteins by D-type cyclin-CDK4/CDK6 allows the release and activation of E2F1-3 to 
their promoters, inducing the transcription of some substrates required for entry and 
progression into S phase, such as E-type cyclin, A-type cyclin, Emi1 (early mitotic inhibitor 1), 
nucleotide synthesis and replication enzymes 
24,26,28
. Importantly, A-type cyclin expression is 
delayed relative to E-type cyclin, due to partial (in the case of E-type cyclin) or complete (in the 
case of A-type cyclin) inactivation of the pocket proteins. 
Once in S phase, the activity of E2F decreases by A-type cyclin-CDK2-mediated 
phosphorylation and inactivation of E2F proteins, due to E2F7-8-mediated repression of E2F1-
3-induced genes till the end of mitosis 
26,29
.  
Apart from their synthesis, cyclin levels are also controlled by the ubiquitin-proteasome 
system. Two different E3 ubiquitin ligase complexes target cyclins and other cell cycle 
regulators: the SCF (Skp1/Cul1/F-box-protein) complex and the APC/C (anaphase-promoting 
complex/cyclosome) complex 
24,29–31
. D-type and E-type cyclins are degraded by SCF complex, 
while A-type and B-type cyclins are degraded by APC/C complex. These complexes and their 
mediated-degradation of cell cycle components are explained in section 1.2 
31
.  
Regulation by phosphorylation and dephosphorylation 
In addition to cyclin availability, CDK activity is also regulated by 
phosphorylation/dephosphorylation on conserved threonine and tyrosine residues 
3
.  
On the one hand, CDK1, CDK2 and CDK4 require a phosphorylation of threonine 161, 160 and 
172, respectively, to stabilize the activated form of the kinase. Cyclin binding to CDKs changes 
the T-loop from a closed conformation to an open conformation where threonine becomes 
accessible for phosphorylation 
3,12,32
. These sites are phosphorylated by a cyclin-CDK complex, 
the CAK (CDK-activating kinase). The kinase is composed of three subunits: CDK7, cyclin H and 
MAT1. The phosphorylation made by CAK is stimulated by the association of the kinase with its 
corresponding cyclin. CKI (CDK inhibitory subunit) blocks CAK’s phosphorylation of CDKs by 
inducing conformational changes in which the activation segment is not accessible to CAK or 
the binding to the substrates is not allowed 
3,33
. 
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On the other hand, Myt1 and Wee1 kinases inhibit cyclin-CDK kinase activity by 
phosphorylating adjacent threonine and/or tyrosine residues (Threonine 14 and/or Tyrosine 
15) in the CDK subunit, preventing cell cycle progression. Removal of these phosphates by 
phosphatases of the Cdc25 family is required for CDK activation and further progression 
though cell cycle 
3,12,15
. Cdc25 phosphatases are found in all eukaryotic organisms except in 
plants. In mammalian cells, three isoforms (A, B and C) have been described, with catalytic 
domains quite conserved, but that differ on their activity, expression, intracellular localization 
and mechanisms of regulation 
34,35
. 
Due to the importance of phosphorylation and dephosphorylation of these residues for 
regulating CDK activity and cell cycle progression, Wee1 and Cdc25 are tightly regulated by 
several kinases, such as cell cycle checkpoint kinases 
36
. In response to DNA damage, when 
Chk1 and Chk2 (checkpoint kinases 1 and 2) are activated, Cdc25 is inactivated 
36–38
, while 
Wee1 is activated by phosphorylation 
39,40
. 
Regulation by CDK inhibitory proteins 
The fully active cyclin-CDK complex can be turned off by CKIs, which can bind to CDK alone or 
to the CDK-cyclin complex and inactivate its activity. Two families of CDK inhibitors have been 
described, based on their structure and CDK specificity: the INK4 family and Cip/Kip family. The 
INK4 family includes p16
 INK4a
, p15
INK4b
, p18
 INK4c
 and p19
 INK4d
, that specifically bind to CDK4 and 
CDK6, preventing their association with D-type cyclin by allosteric competition. The Cip/Kip 
family includes p21
WAF1/Cip1
, p27
Kip1
 and p57
Kip2
, that bind to both cyclin and CDK subunits and 
disable their activity 
3,41–43
. 
Both CDK inhibitory families have multiple roles in addition to regulate cell cycle. Cip/Kip 
proteins play important roles in apoptosis, transcriptional regulation, cell fate determination, 
cell migration and cytoskeletal dynamics 
42
. INK proteins are involved in senescence, 
apoptosis, DNA repair and oncogenesis 
44
.  
p21
WAF1/Cip1
, in particular, has various effector functions involved in gene transcription, 
differentiation, DNA repair, apoptosis, senescence and aging 
45,46
. Its main transcriptional 
regulator is p53 transcription factor, which mediates the DNA-damage induced G1 and G2 
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arrest 
47,48
. p21
WAF1/Cip1
 has also additional CDK-independent roles for regulating cell cycle. For 
example, it associates with E2F1
49
 and other transcriptional factors 
45
 and suppresses their 
transcriptional activity. 
All the mechanisms mentioned above are required to ensure a proper coordination of cyclin-
CDK complexes and to safeguard a correct completion of cell cycle (Figure 2). 
 
Figure 2. Regulatory mechanisms of cyclin-CDK complexes. Summary of the mechanisms involved in the 
regulation of cyclin-CDK activity explained previously. Activating phosphorylation is indicated in green, 
while inactivating phosphorylations are indicated in red. Active cyclin-CDK complexes are indicated in 
blue. 
1.2. CELL CYCLE REGULATION BY UBIQUITIN PROTEASOME SYSTEM 
The ubiquitin proteasome system (UPS) regulates various cellular processes including cell cycle 
progression by promoting the degradation of many key cell cycle regulators. Ubiquitylation 
consist on the covalent attachment of small ubiquitin polypeptide of 76 amino acids to a 
target protein 
8
.  
The different ubiquitin signals that are linked to proteins determine their fate. A single protein 
can be modified on one or more lysine residues with a single ubiquitin (monoubiquitylation) or 
with several ubiquitin molecules (polyubiquitylation). The lysine residue of ubiquitin where 
polyubiquitylation occurs is also important: for example, polyubiquitylation at Lys-48 (best 
characterized) and Lys-29 is a signal for proteasome-mediated degradation, while 
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polyubiquitylation at other lysine residues may act as signals for DNA repair and translation, 
among others. On the other hand, monoubiquitylation has other functions, as endocytosis, 
histone regulation and virus budding 
50–52
.  
Importantly, ubiquitylation is a reversible process due to deubiquitylating enzymes (DUBs), 
thiol proteases that catalyse the breaking of the peptide bond between the ubiquitin and 
proteins, and from residual peptides, and disassemble multi-ubiquitin chains.  Their function is 
to ensure that highly ubiquitylated proteins preferentially remain associated with proteasome 
and prevent the accumulation of residual multi-ubiquitin chains at proteasomes 
50
.  
Ubiquitylation occurs in three consecutive steps, involving three types of enzymes. First, the 
ubiquitin is covalently linked and activated by an E1 ubiquitin activating enzyme. Second, the 
ubiquitin is relocated to an E2 ubiquitin conjugating enzyme. Finally, the ubiquitin is 
transferred by an E3 ubiquitin ligase from the E2 enzyme to a specific lysine of the target 
protein 
8,51
.  
The E3 enzyme is the one that determines specificity for substrate recognition 
50
. These 
enzymes can be subdivided into two major classes, HECT (homologous to E6-AP carboxyl 
terminus) family E3 ligases and RING (really interesting new gene) family E3 ligases. The HECT 
ligases form a transient covalent linkage with ubiquitin during the ubiquitylation process, while 
RING ligases only mediate the transference of ubiquitin from E2 enzyme to the substrate.  
The RING family can be divided into single and multi-subunit E3 ligases. Single-subunit E3 
contains both RING and substrate adaptor domains on the same polypeptide, while multi-
subunit E3 includes a RING finger protein and a substrate adaptor protein in a complex 
8,50
. 
One of the best described multi-subunit RING E3 ligases is the CRL (cullin RING ligase) 
superfamily, which includes the SCF and the APC/C E3 ligases 
8
. 
1.2.1. SCF COMPLEX 
The SCF complex is a multi-subunit RING E3 ligase and consists of three constant subunits: the 
cullin subunit Cul1, that functions as a scaffold, and interacts simultaneously with the adaptor 
subunit Skp1 (S-phase-kinase-associated protein-1) and the RING-finger protein Rbx1, which 
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interacts with the E2 ubiquitin conjugating enzyme (UBC/E2). Skp1 also binds to one variable 
component, known as an F-box protein, which binds through its F-box motif to Skp1 and is 
responsible for substrate recognition (Figure 3).  
 
Figure 3. Structure of SCF ubiquitin ligase. The SCF E3 ligase is a member of the CRL superfamily. Cul1 is 
the scaffold protein of SCF and it binds, on one end, to Rbx1, a RING finger protein, which recruits the E2 
ubiquitin conjugating enzyme (UBC, in purple). On their other end, it binds to the substrate specific unit, 
through an F box protein (in light red). Adapted from “The ubiquitin-proteasome system” 
8
. 
The mammalian F-box proteins are classified according to the structural class of their 
substrate-binding domains. One class is FBXW (“FBX” for F-box and “W” for WD-40 repeat 
domain) and seems to recognize specific Ser/Thr phosphorylation consensus sequences. The 
second class is FBXL (“L” for leucine-rich repeat) and seems to involve substrate 
phosphorylation for their interaction. And the third and last class is FBX0, which does not have 
WD-40 repeats or leucine-rich repeat and has different protein-protein interaction domains 
31,53
.  
Three F-box proteins, Skp2 (FBXL1), Fbw7 (FBXW7) and β-TrCP (β-transducin repeat-containing 
protein, also named FBXW1/11), are involved in cell-cycle control 
31,53
. The SCF
Skp2
 complex 
targets p27
Kip1
 
54
, p21
WAF1/Cip1
 
55
 and p57
Kip2 56
 CKIs and p130 pocket protein for degradation. So, 
it executes the transition to S phase by degrading these CDK inhibitors and maintains CDK1 
and CDK2 activities. It has also been reported that this complex targets D-type and free E-type 
cyclins, E2F1, ORC1 and Cdt1, among other proteins 
57
. The SCF
Fbw7
 complex targets E-type 
cyclin, JUN and Myc for degradation 
31,57
. The SCF
β-TrCP
 complex targets crucial cell-cycle 
regulators such as Wee1 
58
 and Cdc25 
59
, and it also induces the degradation of Emi1 (APC/C 
inhibitor) 
60
, allowing the correct degradation of A-type and B-type cyclins at the onset of 
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mitosis 
31,53,57
. Finally, SCF
β-TrCP
-mediated Claspin degradation is important for recovery after a 
replication stress or DNA damage 
61
.  
SCF complex is active from late G1 to early mitotic entry, although it is thought to primary act 
at the G1-S transition 
31,50,53
. 
1.2.2. APC/C COMPLEX 
The APC/C complex is a multi-subunit RING E3 ligase, structurally similar to SCF complex, but 
more sophisticated due to its large complex. It is a ubiquitin ligase of 1.5 megadaltons, forming 
a complex of 15 different proteins in vertebrates, including the scaffold Cul1-related protein 
(Apc2), the RBX1-related RING-finger protein (Apc11), which interacts with the E2/UBC 
enzyme, and at least 12 other components with unknown role. The variable component, 
known as co-factor or activator, confers specificity to APC/C complex, in the same way that F-
box proteins do in the SCF complex. In mitotically cycling cells, APC/C is activated by its 
association with Cdc20 (cell division cycle 20) and Cdh1 (Cdc20-homologue 1, also known as 
Fzr1). There are other APC/C activators that function during meiosis and in non-dividing cells 
31,62
. In humans, there are two E2 enzymes identified, UBCH10 and UBE2S, as a crucial 
regulators of cell division and identified as potential signallers for APC/C-mediated 
degradation (Figure 4) 
62,63
. 
 
Figure 4. Structure of APC ubiquitin ligase. The APC E3 ligase is a member of the CRL superfamily. Apc2 is 
the scaffold protein of APC/C and it binds, on one end, to Apc11, a RING-finger protein, which recruits 
the E2 ubiquitin conjugating enzyme (UBC, in purple). On their other end, it binds to the substrate 
specific unit, through several proteins (in blue) and the co-factor protein (in light red). Adapted from 
“The ubiquitin-proteasome system” 
8
. 
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Some motifs are important for substrate recognition by the APC/C E3 ligase. Chd1 and Cdc20 
recognize short destruction motifs or degron on target substrates. The classical APC/C degron 
is the destruction box or D-box, a nine-residue motif with the consensus sequence 
RxxLxxI/VxN. Another APC/C degron, the KEN motif is a seven-residue motif with the 
consensus sequence KENxxxN/D 
63,64
. Efficient ubiquitylation of substrates that harbour D and 
KEN motifs is dependent on both degrons. However, the substrates that contain only one of 
them, give some specificity on APC/C E3 ligase, since APC/C
Cdc20
 preferentially recognizes the 
D-box, while APC/C
Cdh1
 recognizes both degrons. Some substrates lack both degrons, indicating 
that a class of non-canonical APC/C recognition motifs contributes to APC/C-dependent 
substrate ubiquitylation that does not involve the co-activators in substrate recognition 
31,64,65
.   
Regulation of APC/C 
The APC/C E3 ligase is active from mitosis till the end of G1 phase. Although Cdc20 protein 
levels begin to accumulate in S phase, APC/C
Cdc20
 becomes active in anaphase and drives 
mitotic exit by inactivating CDK1, while APC/C
Cdh1
 ensures a G1 maintenance by a low activity 
of cyclin-CDK complexes 
66
. 
APC/C is activated in early mitosis by phosphorylation mediated by protein kinases CDK and 
PLK1 (polo-like kinase 1) 
67,68
. A second mechanism to control APC/C activity is the reversible 
phosphorylation of co-activators: whereas the phosphorylation of APC/C is required to allow 
the activity of APC/C
Cdc20
, CDK-mediated phosphorylation of Cdh1 prevents its binding to 
APC/C and activation 
69,70
. Direct phosphorylation of substrates is a third mechanism of control 
APC/C activity, since it hinders or reduces the APC/C ubiquitylation and subsequent 
degradation of some substrates, such as Cdc6 
71
 or securin
72
. 
Another level of APC/C regulation is the presence of pseudo-substrate-based inhibitors. The 
major APC/C inhibitor protein, Emi1 (also known as FBXO5), was initially discovered in 
preventing premature APC/C activation in early mitosis 
73
, but some years later it was 
recognized as a repressor of APC/C
Cdh1
 activity during G2 
74
. Emi1 levels are regulated during 
the cell cycle. Its transcription increases at the end of G1 phase induced by E2F transcription 
factors and rapidly stabilises APC/C
Cdh1
 targets such as cyclin A 
75
. Emi1 switches from being a 
substrate in G1 with low Emi1 levels to acting as an inhibitor of APC/C
Cdh1
 during S and G2 
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phases with high Emi1 levels 
76,77
. Emi1 degradation is produced in prophase, after it is 
phosphorylated by PLK1, generating a phospho-degron that is recognized by SCF
β-TrCP
 ubiquitin 
ligase 
60,78
. To avoid Emi1 degradation, its binding partner, the Evi5 oncoprotein blocks PLK1-
dependent phosphorylation, avoiding its ubiquitination by SCF
β-TrCP 79
. 
Another mechanism of control is the spindle assembly checkpoint (SAC), that inhibits 
APC/C
Cdc20
 activity until all the kinetochores have been attached to spindle microtubules, to 
avoid securin and cyclin B1 degradation, both inhibitors of separase, required for a proper 
segregation of sister chromatids during mitosis 
64,80
. 
Finally, the linkage between APC/C activity and ubiquitin-conjugating enzyme E2 provides 
another mechanism of regulation. UBCH10, an E2 for human APC/C, is a target of APC/C
Cdh1
 
activity, and its degradation inactivates APC/C at the end of G1 phase, once the high affinity 
substrates as cyclins have been ubiquitylated 
64,81
. 
Functions of APC/C during mitosis and G1 phases 
APC/C is inactive during G2. The increase in CDK1 and PLK1 activities at the beginning of 
mitosis produces the phosphorylation events required for APC/C interaction with Cdc20
67,68
. 
As a result, APC/C
Cdc20
 is activated and induces A-type cyclin degradation in prometaphase 
82–
84
. Once metaphase is completed, APC/C
Cdc20
 promotes securin degradation 
85,86
. Securin is a 
chaperone that binds and inhibits separase, an enzyme capable of cleaving cohesins to liberate 
sister chromatids at the anaphase onset 
87
.  APC/C
Cdc20
 also promotes B-type cyclin proteolysis 
82
, reducing CDK1 activity at the metaphase to anaphase transition 
8,88
, so the levels of 
dephosphorylated Cdh1 increase. This situation allows the formation of APC/C
Cdh1
, which 
negatively regulates APC/C
Cdc20
 by targeting Cdc20 for degradation 
8
. In late mitosis, besides 
securin and mitotic cyclins’ proteolysis, APC/C
Cdh1
 targets Aurora kinases 
89
 and PLK1 
90
 for 
ubiquitylation and degradation, which are important proteins for the correct chromatid 
separation and cytokinesis.   
During G1, APC/C
Cdh1
 is maintained active and is essential for the maintenance of G1 phase. 
APC/C
Cdh1
 keeps low CDK1/2 activity during G1 phase through A-type and B-type cyclins 
degradation 
91
, and through other regulators degradation, such as Skp2 
92,93
. Repressing Skp2, 
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stabilizes p21
WAF1/Cip1
 and p27
Kip
, which inhibit any residual cyclin-CDK complexes 
88
. In late G1 
phase, the E2F transcription factors stimulates the transcription of A-type cyclin 
94
 and Emi1 
75
, 
which inhibits APC/C
Cdh1
, causing an increase in Skp2 levels, and a decrease in CDK inhibitors 
p21
WAF1/Cip1
 and p27
Kip
. As a result, A-type cyclin levels increase activating CDK, and further 
supress APC/C
Cdh1
 activity by phosphorylating Cdh1. 
The activity of APC/C
Cdh1
 in G1 phase is also crucial for the formation of pre-replicative 
complexes (pre-RC) on origins of replication, where DNA polymerases initiate DNA synthesis in 
S phase 
8,31,95–98
. The pre-RC assembly, known as origin licensing, involves the loading of 
MCM2-7 (minichromosome maintenance protein) complex in the replication origins, that 
requires the ORC (origin-recognition complex) and two essential factors Cdc6 (cell division 
cycle 6) and Cdt1 (Cdc10-dependent transcript 1). To ensure that DNA replication occurs only 
once per cell cycle, the assembly of pre-RC or origin licensing can occur only in a window of 
time with low CDK activity, during G1, and origin firing or activation can only occur after APC/C 
inactivation and high CDK activity, during S phase. To promote the assembly of pre-RC, 
APC/C
Cdh1
 promotes the degradation of geminin 
99
, releasing Cdt1 from its inhibition 
100,101
 and 
thus starting the pre-RC assembly. Furthermore, low CDK activity prevents Cdc6 
phosphorylation and its consequent degradation or export from nuclei, allowing the formation 
of pre-RC 
71,96,102–104
. The limitation of origin licensing to G1 phase and origin firing to S phase 
due to APC/C
Cdh1
 activation is essential to prevent re-replication 
105
. The factors involved in 
DNA replication and its regulation are further explained in section 2. 
Besides its roles in cell cycle regulation, APC/C is also involved in other cell-cycle independent 
cellular functions 
97,98,106,107
. 
Interplay between SCF and APC during cell cycle 
The previously explained regulation and functions of SCF and APC/C E3 ubiquitin ligases during 
cell cycle are summarized in Figure 5. 
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Figure 5. Interplay between SCF and APC/C during cell cycle. Summary of the regulation and functions 
of SCF and APC/C during cell cycle. Positive regulations are represented with arrows, while negative 
regulations are represented with bar-head lines, which include degradation-mediated inhibition or other 
types of inhibition.  The main functions regulated by APC/C ubiquitin ligase during cell cycle are 
represented in boxes. The green ones correspond to positive regulations and the red ones to negative 
regulations. Green and orange colours correspond to APC/C and SCF activation states. The inactivated or 
degraded proteins are represented in grey, whereas the activated ones are represented in black. 
APC/C
Cdh1
 and DNA damage response
 
The first indications of a role of APC/C
Cdh1
 in the DNA damage response stem from 
observations in DT40 chicken cells, in which the loss of Cdh1 locus fails to maintain DNA 
damage-induced G2 arrest 
108
. These data suggested for first time that APC/C
Cdh1
 has a 
function in G2 phase of cell cycle, although it is restricted to DNA damage conditions. Under 
normal conditions, the APC/C
Cdh1
 is inactive in G2 phase and early mitosis, through multiple 
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mechanisms previously described. The activation of APC/C
Cdh1
 in G2 in DNA-damaged cells was 
described by the identification of Cdc14B phosphatase that specifically dephosphorylates and 
activates APC/C
Cdh1
 upon DNA damage, after its translocation from the nucleolus to the 
nucleus 
109,110
. Moreover, it was reported that p21
WAF1/Cip1
-dependent down-regulation of Emi1 
in cells arrested in G2 by DNA damage response contributes to APC/C
Cdh1
 activation 
110–112
. 
In the recent years, the mechanism by how APC/C
Cdh1
 is able to control DNA damage 
checkpoint response is being elucidated. Many regulators of DNA damage repair and genomic 
stability such CtIP 
113,114
, Claspin 
109,115
, UPS1 
116
 and Rad17 
117
 have been characterized as Cdh1 
substrates. Furthermore, G9a and GLP
118
 have also been identified as APC/C
Cdh1
 substrates, 
involving APC/C
Cdh1
 in the regulation of senescence 
62,107
. 
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2. DNA REPLICATION 
The discovery of double-helix structure in 1953 
119
, where two polynucleotide strands 
specifically paired  by complementary bases, suggested how the genetic information could be 
copied. Some years later, Meselson and Stahl proved that replication is semiconservative in an 
historical experiment using density labelling 
120
, and the first enzyme capable of synthesizing 
DNA was first described 
121
. Since then, the proteins required for DNA replication, their 
regulation mechanisms and the coordination of DNA replication with cell cycle progression has 
been extensively studied 
122
.  
DNA replication consists in the duplication of the genetic material in order to obtain two 
copies of the same information, to finally transmit it to two daughter cells. DNA replication is a 
daunting process that occurs since the moment that a fertilized egg first begins to duplicate 
DNA to harvest a pluricellular organism, which will continue to replicate its DNA to maintain all 
tissue and organs. It is estimated that the human body synthesizes approximately 2 x 10
6
 
meters of DNA in a lifetime, a distance that corresponds to 130000 times the distance 
between the Earth and the Sun 
123
.  So, DNA replication is an essential process that needs to 
be highly regulated in order to ensure the accurate duplication of the genetic material to avoid 
loss of information and genomic instability 
4,124
.   
Apart from copying DNA sequences, during replication, chromatin is disrupted ahead of the 
replication fork and must be restored behind the fork on the two newly synthesised strands. 
Moreover, the epigenetic marks that modulate genome accessibility also have to be 
maintained after DNA replication 
125–130
.  
The replication occurs in three consecutive phases (initiation, elongation and termination) that 
result in whole genetic material duplication. In eukaryotic cells, around 40-50 different 
proteins are included into the replisome 
131
. In Saccharomyces cerevisiae, 42 individual 
proteins are sufficient to fully reconstitute DNA replication in vitro 
132
. 
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2.1. DNA REPLICATION INITIATION 
As previously explained, the replication origins are determined in two non-overlapping 
consecutive steps: a first step during G1 where pre-RCs are formed in a process known as 
origin licensing, and a second step during S phase where some of those pre-loaded origins are 
fired to duplicate the DNA. This two-stage mechanism is crucial to prevent re-replication 
105,133–135
.  
The origin licensing requires first the recognition of origins. The main origin binding factor is 
the ORC, a conserved heterohexameric protein (ORC1-6) first identified in yeast 
136
, which 
varies in its sequence specificity among different species 
137
. Specifically, in metazoan, ORC 
binds to DNA without apparent sequence specificity 
138
, but with certain characteristic 
elements, as nucleosome-free regions 
139
 or G-rich regions 
140
.  
Once ORC, which has ATPase activity, is recruited to replication start sites, another ATPase is 
bound to ORC, Cdc6, forming a complex required for initiation function 
141
. In addition to ORC-
Cdc6 complex, Cdt1 is required for the assembly of pre-RC, binding to MCM2-7 and facilitating 
their interaction with ORC-Cdc6 complex bound at the origin 
122,142–145
. The loading of the 
replicative helicase MCM2-7 into a stable heat-to-head double heterohexamer that surrounds 
double-stranded DNA is the defining step in origin licensing 
146–148
. Two rounds of sequential 
single MCM2-7 helicase recruitment and loading at origins are required for forming a double 
hexamer 
122,144,149
, resulting in the formation of pre-RCs. CDK1/2 inhibits MCM loading by 
phosphorylating ORC, restricting the formation of pre-RCs in G1 phase 
132
. Subsequent events 
in initiation of replication do not require either ORC, Cdc6 or Cdt1, and an in vitro study 
suggest that these factors may dissociate from the DNA after MCM2-7 loading 
122,149
. 
Importantly, only a fraction of all licensed origins is activated in a cell, at different times 
throughout S phase, whereas other called dormant origins are only used to complete genome 
replication in conditions where S phase is affected 
137,150–153
.  
The second step is the origin firing, which requires high levels of CDK activity, and for this 
reason this process is restricted to S phase. The activation of origins is achieved by several 
phosphorylation events on subunits of the MCM complex mainly by the sequential action of 
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DDK (Dbf4-dependent kinase, also known as Cdc7-Dbf4 complex) and CDK protein kinases, 
required for the recruitment of Cdc45 (cell cycle division 45) and GINS  (go ichi ni san) for the 
formation of CMG complex onto chromatin
154
, establishing the pre-initiation complex (pre-IC) 
155
. On their own, MCM2-7 hexamers possess little or no helicase activity, while the CMG 
complex possesses robust helicase activity 
156
.  
The formation of pre-IC is a process well studied in yeast, although is conserved fairly well in 
metazoan despite some discrepancies 
157
. In budding yeast, first Sld3-Sld7-Cdc45 associates 
with the pre-RC formed at replication origins in a DDK-dependent manner 
158,159
. DDK 
phosphorylates the MCM2-7 complex, which enhances the association with Sld3-Sld7-Cdc45 
and origins 
160,161
. Secondly, CDK-mediated phosphorylation of Sld2 and Sld3 
162
  allows the 
association of Sld2-Dpb11-Polε-GINS with the origins, that are bind to Sld3 and Cdc45, to 
finally form an active CMG helicase 
163,164
.  
In fission yeast, the orthologs of Dpb11, Sld2 and Sld3 are well conserved, and, although DDK 
is needed for the association of Sld3 with origins, DDK is not as necessary in fission yeast as in 
budding yeast 
157
. 
Interestingly, the process of CMG complex formation seems to be quite similar also in 
metazoan. Although the replication machinery is well conserved in eukaryotic organisms, the 
regulatory components have diverged during evolution (Figure 6) 
157
. Although TopBP1 
(topoisomerase-binding protein 1), RecQ4 and Treslin are the functional homologues of 
Dpb11, Sld2 and Sld3, respectively, and are required for the initiation of replication, their 
requirement for pre-IC association with chromatin vary slightly. TopBP1 is a larger and more 
complex protein that contains eight BRCT repeats and it is required for the loading of Cdc45 
165–167
. RecQ4 has been proposed as a functional homolog of Sld2, but this issue remains 
controversial since this protein is quite different from Sld2 
168,169
. Although RecQ4 is 
dispensable for Cdc45 recruitment and formation of CMG complex, it has a role on DNA 
polymerase α binding and DNA unwinding 
170,171
 and it is required for initiation of DNA 
replication 
172
. Treslin was identified for its association with TopBP1 in Xenopus egg extracts in 
a CDK2-dependent manner, and required for DNA replication 
173,174
. Other proteins are 
required for the formation on pre-IC: GEMC1 (geminin coiled-coil containing protein 1), which 
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promotes initiation of DNA replication by mediating TopBP1 and CDK2-dependent recruitment 
of Cdc45 into origins 
175,176
; DUE-B (DNA unwinding element), which is able to interact with 
both Cdc45 and TopBP1 
177
; and Mcm10, which is another protein required for initiation of 
replication 
178–183
 that interacts with RecQ4 
171,184
 and several replication factors 
185
.  
Furthermore, Claspin, a protein present in the replisome that have a role in replication 
checkpoint activation, may play a new role in regulating the origin firing through its interaction 
with Cdc7 
186
, which is also referred to as DDK
187
. 
 
Figure 6. Replication origins are licensed after the loading of MCM2-7 helicase complexes. This process 
is conserved in all eukaryotes and requires the action of ORC, Cdc6 and Cdt1, recruited in G1 to form the 
pre-RC. In S phase, sequential phosphorylations of DDK and CDK (labelled with light grey and dark grey, 
respectively) allow the recruitment of Cdc45, GINS and additional factors to form the pre-IC. In yeast, 
Sld2, Sld3 and Dpb11 are the main factors leading to Cdc45 and GINS recruitment and origin firing. In 
higher eukaryotes, TopBP1, RecQ4 and Treslin are the functional homologs for the Cdc45 and GINS 
recruitment, and also other factors are required, such as GEMC1, DUE-B and Mcm10, to initiate 
replication. Helicase activation induces the recruitment of other proteins (labelled in grey, explained in 
detail in next section) at each replication fork, inducing origin firing. Adapted from “GEMC1 is a novel 
TopBP1-interacting protein involved in chromosomal DNA replication” 
176
 and “DNA replication origin 
activation in space and time” 
135
. 
 
 
INTRODUCTION 
  
 
44 
 
2.2. DNA REPLICATION ELONGATION 
Once the pre-RC is assembled, CMG helicase complex starts to unwind the DNA in the 
formation of two bidirectional replication forks together with replisome components (Figure 
7). The initiation of DNA synthesis requires also RPA (replication protein A) and DNA 
polymerase alfa (α) 
122,188,189
. RPA is a heterotrimeric protein that consists of 70kDa, 32kDa and 
14kDa subunits, which have been termed RPA1 (RPA70), RPA2 (RPA32) and RPA3 (RPA14), 
respectively. RPA is a single-stranded DNA (ssDNA)-binding protein that binds to ssDNA with 
high affinity to protect it from nucleases degradation or to avoid the formation of spontaneous 
duplex DNA 
190–192
. After the DNA unwinding by CMG helicase, the ssDNA regions produced are 
rapidly coated by RPA. Apart from protecting this ssDNA, its function is to recruit the DNA 
polymerase α - primase to the replication origins since RNA priming is required to initiate 
leading and lagging strand synthesis 
131,190
. During elongation, RPA is thought to play a role in 
stimulating DNA polymerases delta (δ) and epsilon (ε) by its PCNA interaction 
131,190
.  
The major eukaryotic replicases, DNA polymerases α, δ and ε, catalyse the formation of 
phosphodiester linkages of an incoming dNTP by the 3’-OH end of a growing chain. Thus, the 
synthesis of DNA occurs in a 5’-to-3’ direction. Due to the structure of DNA, forming 
antiparallel double helix, when replication origins are activated, two replication forks proceed 
from each origin, one in each direction. In each replication fork, one chain is the leading 
strand, which is replicated continuously by DNA polymerase ε; while the other is the lagging 
strand, which is repeatedly primed and synthetized by DNA polymerase α and δ, respectively, 
as discontinuous fragments known as Okazaki fragments 
189,193
. This model, which has been 
supported by several studies and widely accepted 
194,195
, has been recently challenged by some 
studies that suggest an alternate arrangement of polymerases at the fork, concluding that 
DNA polymerase δ synthetize both strands 
196,197
 and that primers are elongated across the 
origin by DNA polymerase δ until the ends are coupled to DNA polymerase ε at the advancing 
replication forks 
198
.  
Many models of DNA replication postulate that the DNA synthesis of leading- and lagging-
strands is coordinated. Due to the several additional steps that require more time occurring 
during lagging synthesis, it has been proposed that lagging-strand polymerase copies DNA 
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faster than leading-strand polymerase 
199
. However, a recent study indicates that the average 
rate of both polymerases is similar, and that replication is kinetically discontinuous and 
disrupted by distinct pauses and rate-switches. During these pauses, helicase slows DNA 
unwinding to prevent the uncoupling of helicase and polymerases activities, suggesting that 
replication is more dynamic than previously thought 
200
.  
The efficient elongation of leading and laggings strands requires other factors. The clamp 
loader RFC (replication factor C) assembles the sliding clamp PCNA (proliferating cell nuclear 
antigen), conferring high processivity to DNA polymerases, and allowing the switch from DNA 
polymerase α to DNA polymerase δ 
122,201
. The DNA unwinding during DNA elongation 
generates supercoils in front of the fork, which are removed by either type I or type II 
topoisomerases, being the type I the essential one; and the intertwining of daughter strands, 
known as pre-catenanes (behind the fork) that can only be removed by type II topoisomerases 
122
.  
During maturation of Okazaki fragments, PCNA recruits FEN1 (flap endonuclease 1), which 
catalyses cleavage of the flap structure, removing the initiator RNA to make a nick 
201,202
. To 
complete the maturation process of Okazaki fragments, the nick is sealed by DNA ligase I, 
which is also recruited by its interaction with PCNA 
122,201
.  
 
Figure 7. Replication fork structure. Parental strands (in black) and nascent DNA strands (in grey) are 
represented. The RNA primer synthetized by DNA polymerase α-primase is represented in red. The 
proteins that compose the replisome are shown. The lagging strand is shown forming a loop so that 
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polymerases α and ε move in the same direction, in a complex composed by CMG and And1. CMG 
complex: MCM, Cdc45 and GINS. Pol: DNA polymerase.  
In order to prevent excessive unwinding, the activities of polymerases and helicase at the 
replication fork are coupled by the action of the replication pausing complex, which travels 
with the replisome and is composed by Tim1, Tipin, Claspin and And1 proteins. These proteins 
interact with several replisome components, including CMG helicase complex and 
polymerases 
203–207
. These proteins are part of a larger replisome progression complex, which 
contains FACT, Mcm10 and type I topoisomerase 
122,208
.  
Moreover, during replication fork progress, a physical link between sister chromatids resulted 
from duplication is required to maintain them together for its correct segregation in mitosis. 
This link is mediated by cohesin complex, a ring-shaped multiprotein that consist of four 
proteins: SMC1 (structural maintenance chromosomes protein 1), SMC3 (structural 
maintenance chromosomes protein 3), Rad21 and SA1/2. This complex is not only relevant for 
proper segregation but also for homologous recombination (HR)-mediated repair 
209,210
. 
2.3. DNA REPLICATION TERMINATION 
Replication termination is a process that occurs along the entire S phase, when two replication 
forks from neighbouring origins converge and the duplication of the DNA fragment among 
both origins is tidily completed. The termination includes five processes (Figure 8). The first 
process involves the relaxation of supercoils ahead of the fork mainly by type I 
topoisomerases. The second process is the encounter of converging forks, sliding on opposite 
strands of DNA (leading strand of each fork). Third, replisomes dissociate from DNA in a 
process known as disassembly, which requires SCF
Dia2
/CRL2
LRR1
-mediated ubiquitylation and 
removal from chromatin by p97/VCP/Cdc48 segregase 
211
. Fourth, synthesis of DNA is 
completed through gap filling between the end of leading strand and the last Okazaki 
fragment of the opposing fork. Finally, copying the last turn of parental strand generates a 
new catenanes, that must be resolved before chromosome segregation 
122,212
.  
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Figure 8. DNA replication termination. The different steps by which replication is terminated in 
eukaryotic model is represented. Adapted from “Mechanisms of DNA replication termination”
212
. 
2.4. DNA REPLICATION ORGANIZATION 
As mentioned previously, during replications, cells maintain their proper organization into 
chromatin (Figure 9) and some evidence suggest that the spatial organization of the genome is 
relevant 
213
.  
The first level of organization in DNA replication process is the formation of pre-RCs at all 
potential replication origins in a cell. From all the MCM2-7 complexes loaded in excess onto 
DNA, just 10% are being used in an unperturbed S phase. The rest normally remain dormant 
and are passively replicated by oncoming forks, but occasionally fire as backups to resolve 
problems that impede fork progression 
150,214
.  
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The second level is the replicon, which consist in 50-120kb in metazoan cells and includes 
several pre-RC, of which only one is activated to replicate the stretch of DNA conforming the 
replicon.  
The third level is the replication domain, which consist in 400kb to 1Mb in mammalian cells 
and contains several replicons in replication clusters. The replication domains adopt a 
structure in which replicons are separated into loops by cohesin rings. The active origins 
included into a replication domain fire synchronously at defined points during S phase. Early 
replication is observed in transcriptionally active gene-rich domains mainly located at the 
centre of the nucleus in contrast to late replication, which is observed in origin-poor regions 
enriched of repressive epigenetic marks and are located within lamina-associated domains 
(nuclear periphery) 
126,135,214,215
.  
 
 
Figure 9. Genome organization. Pre-RCs are assembled on both active and dormant origins, but only a 
subset is fired in S phase. A replicon corresponds to a DNA fragment that is replicated by a single origin 
(active origin in green, dormant origins in grey). Adjacent replicons that fire simultaneously formed a 
replication domain. Each domain can replicate at different times during S phase. Adapted from 
“Chromatin replication and epigenome maintenance” 
126
. 
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3. REPLICATION STRESS 
The definition of replication stress is constantly evolving. First, it was used to define the 
aberrant events in cells undergoing rapid proliferation 
216
. Later on, it was described as “the 
vulnerability to genotoxic insults and other stochastic events that impede the proper 
replication and segregation of their genomes to daughter cells” 
217
. In recent years, replication 
stress has been referred to as DNA replication conflicts that generate stretches of ssDNA that 
is protected by RPA 
218
. And finally, it has been described as “the slowing or stalling of 
replication fork progression and/or DNA synthesis” 
219–221
.  
Cells respond to replication stress by activating several mechanisms that coordinate fork 
stabilization and repair with cell cycle arrest to prevent cell division with unreplicated or 
damaged DNA. In this sense, cells try to overcome the cause of replication stress to promote 
replication resumption and cell cycle progression 
219,222–225
. 
In most cases, the replication stress leads to a transient pausing or stalling of the replisome 
until the stress is overcome by the checkpoint activation. Sometimes, the stalling can be more 
persistent and the failure to stabilize the stalled forks can lead to its collapse, which means 
that forks have lost their ability to replicate DNA. Fork collapse has been described as a 
process which includes replisome dissociation and the formation of double-strand breaks 
(DSB) at stalled forks 
226,227
. 
3.1. DNA REPLICATION STRESS CAUSES 
DNA replication is constantly challenged and arrested by DNA lesions induced by endogenous 
or exogenous agents. The hindrances can be chromosomal fragile sites, secondary DNA 
structures, existing DNA damage lesions, proteins tightly bound to DNA, collisions between 
replication and transcription machineries, insufficient nucleotides for DNA replication or 
oncogene activation. 
 
 
INTRODUCTION 
  
 
50 
 
Chromosomal fragile sites 
Common fragile sites (CFSs) are specific regions prone to exhibit gaps and breaks on 
metaphase following partial inhibition of DNA synthesis. Due to their genomic elements, CFSs 
are regions in risk for the DNA replication machinery. For example, AT-rich regions found at 
some CFSs can form secondary structures that stall replication forks 
228
. Moreover, some CFSs 
are located at longest genes in which collisions with replication and transcriptions are 
produced during S phase 
229
.  Furthermore, some CFSs have low fork density and are prone to 
breakability because replication forks have to cover long distances 
230
. 
Obstruction of replication fork barriers 
A wide variety of hindrances can impede fork progression, either by altering the helicase 
activity or the ability of DNA polymerases to incorporate nucleotides, resulting in a fork 
slowdown and stalling. These impediments are referred to as replication fork barriers  (RFB) 
and include DNA sequences prone to form secondary DNA structures, DNA lesions and DNA-
protein complexes 
223
.  
In DNA, there are some DNA sequences that are intrinsically challenging for the replication 
machinery, which includes repetitive sequences and DNA regions that potentially form 
secondary structures, such as G quadruplexes, hairpins or cruciforms, that are natural barriers 
for replication fork progression 
219,221,231
. To resolve or remove these obstacles, some DNA 
helicases are involved, such as WRN (Werner syndrome) helicase, BLM (Bloom’s syndrome) 
protein and PIF1. Also, topoisomerases are required to remove DNA supercoils generated by 
the normal unwinding of DNA to replicate the region and to alleviate torsional stress 
221,225
.  
Another barrier for replication fork progression is the presence of damaged DNA, which is not 
recognized as valid template by replicative DNA polymerases. There are a variety of 
endogenous or exogenous sources of DNA damage, such as products of cellular metabolism 
(for example, reactive aldehydes), ultraviolet light and chemical mutagens. To deal with DNA 
lesions, DNA repair pathways and translesion DNA synthesis (TLS) are activated to avoid 
replication inhibition 
219,225
. TLS polymerases are able to tolerate DNA template lesions, that 
DNA replicative polymerases do not, to resume replication 
232
.  
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Proteins tightly bound to DNA can obstruct fork progression, generating replication stress. 
Although is a process described in yeast, it is not clear if these regions represent a challenge 
for the replisome in mammalians 
221
. 
Replication-transcription conflicts 
The transcription machinery is a natural barrier to replication fork progression, since they 
share the same DNA template and collisions between them are an important source of 
replication stress. Therefore, cells have evolved mechanisms to limit both processes in space 
and time to avoid collisions: most transcription occurs in G1 while replication occurs in S phase 
233
.  
On the one hand, some studies suggested that replication stress appears before replication 
and transcription machineries’ collision, which is likely due to topological stress generated 
between them. For this reason, topoisomerases are essential to prevent genomic instability 
221,234
. 
On the other hand, the collision between both machineries forms a DNA-RNA hybrid, called R-
loop. The generation of R-loops is limited by the THO complex, that targets the nascent RNA to 
the RNA processing machinery and to the nuclear pore 
224,235
. Several factors are involved in 
the resolution of R-loop, including RNase H enzymes and RNA helicases such as senataxin, 
which remove the R-loop by degrading the RNA strand or undoing the hybrid, respectively 
224,225
. 
Down-regulation of limiting factors of replication 
Faithful DNA replication requires numerous factors, and their down-regulation can result in 
the slowing or stalling of replication fork. The pool of nucleotides (dNTPs), components of 
replisome, histones and histone chaperones are some of these replication factors 
236–238
. 
An excess of replication origin firing provokes the exhaustion of essential factors for DNA 
replication, including RPA. Certainly, the level of RPA, which protects any form of ssDNA from 
breakage, becomes limiting when additional origins become active, leading to fork collapse 
227,239
. 
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The balance of dNTP pools, due to the coordination of their synthesis and degradation, 
determines the accuracy during S phase. Small perturbations in the dNTP pools substantially 
affect fork progression 
240–243
. A decrease in the levels of dNTPs by oncogene expression has 
been proposed to induce oncogene transformation, since exogenously supplied nucleosides 
rescue this phenotype 
242
. Remarkably, a decrease in the pool of dNTPs can be induced by 
hydroxyurea (HU, also called hydroxycarbamide), which inhibits the ribonucleotide reductase 
enzyme causing replication inhibition due to lack of substrate 
244
. HU is an antineoplastic 
agent, which was used as treatment for several types of solid tumours and for infectious 
disease. Although newer and more efficient agents have replaced HU, it is still used for the 
treatment of head and neck cancers and chronic myeloid leukaemia 
231,245–247
. 
Oncogene expression 
Overexpression or constitutive activation of oncogenes, such as HRas 
248
, Myc 
249
 and cyclin E 
250
, is another source of replication stress. Oncogenes shorten the length of G1, which can 
disrupt replication dynamics altering origin licensing and induce more conflicts between 
replication and transcription machineries 
251,252
. Fewer licensed origins means a reduction in 
dormant origins, required when replication forks stall. Increased replication initiation can 
disrupt the temporal patter of origin firing and may deplete the dNTP pools in a cell 
242
, leading 
a persistent replication stress 
253
.  
3.2. CELL-CYCLE CHECKPOINTS 
As previously mentioned, cells have developed several mechanisms called checkpoints to 
ensure the fidelity of division and monitor successful completion of cell cycle events, which 
must occur in the proper order. When a cell cycle event has not been successfully completed, 
checkpoints sense the defects in the process and delay cell cycle progression until the previous 
step is correctly completed 
2,9,254
. 
The checkpoint pathways acts as a signal transduction cascade, that includes three groups of 
proteins: 1) sensor proteins that recognize damaged DNA or abnormalities and initiates a 
biochemical cascade; 2) transducer proteins, which are usually protein kinases that amplify 
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the signal from sensor by phosphorylating downstream target proteins; and 3) effector 
proteins, which include the most downstream targets and are regulated to avoid cell cycle 
progression 
4,254
.  
The checkpoint pathways operate during the entire cell cycle and interrupt cell cycle 
progression at any point during the four phases. The sensor proteins are shared by the various 
checkpoints, similarly as the transducing proteins; the effector proteins, which inhibit phase 
transition, are the proteins that give each checkpoint its identity 
254
. In this sense, checkpoints 
can be classified according to the cell cycle phase in which they are activated or upon the 
transition that is being inhibited: G1/S checkpoint, S-phase checkpoint, G2/M checkpoint and 
mitotic or spindle checkpoint 
254–256
. 
In this thesis, we focused on the mechanisms activated in S phase, which is the most 
vulnerable phase for the acquisition of DNA damage. As explained previously, several causes 
can induce fork stalling during S phase, which provokes the accumulation of ssDNA. This 
results in DNA replication checkpoint activation in order to ensure the fidelity of the copied 
DNA to avoid genomic instability and loss of information 
222
. If this stalling persist, replication 
forks are prone to collapse, and cells accumulate DSBs. When this happens, the DNA damage 
checkpoint is activated. The roles of these checkpoints are maintenance of fork stability and 
coordination of cell cycle delay and repair of DNA lesions with resumption of DNA replication 
222,225,254,257
.  
Three members of PIKKs (phosphoinositide 3-kinase-related kinases), DNA-PK (DNA-
dependent protein kinase), ATM (ataxia-telangiectasia mutated) and ATR (ATM and Rad3-
related), are the main sensors of DNA damage and replication stress. DNA-PK and ATM kinases 
are primarily activated by DSBs being ATM the main kinase involved in checkpoint response 
and DNA-PK in regulating DNA repair by the non-homologous end-joining (NHEJ) pathway, 
while ATR kinase is activated by ssDNA or replication fork arrest 
9,254,256,258–261
.  
Although both mechanisms are required to preserve genome integrity, ATR is essential for cell 
survival, since its deletion results in embryonic lethality 
262,263
. However, a recent work has 
described that, in contrast to ATM depletion, which is not lethal 
264,265
, point mutations in ATM 
that inactivate its kinase activity also result in embryonic lethality in mice 
266
.  
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Although the three members of PIKK family are large kinases with significant sequence 
homology and they target an overlapping set of substrates 
259,267
, they are activated by 
different signals and specialized in their responses so they present a low level of functional 
redundancy between them 
268
.  All three PIKK family members phosphorylate preferentially 
serine/threonine residues followed by a glutamine (S/T-Q) 
269
. They share some common 
substrates, such as the phosphorylation of the histone variant H2AX on the Ser139 and 
phosphorylation of distinct sets of RPA32. The foci formed by phosphorylated H2AX (ɣH2AX) 
has been commonly used as a DSB marker 
257,270,271
, although recent evidences indicates that 
only a small variable fraction of ɣH2AX foci in fact represents DSBs, when colocalizing with 
53BP1 foci 
272
. Another PIKK target is RPA, the heterotrimeric protein that accumulates on long 
stretches of ssDNA at stalled and collapsed forks. In response to replication stress, DNA-PK and 
ATR phosphorylate the RPA32 subunit 
273,274
, while in response to DSBs are the kinases ATM 
and DNA-PK the ones that phosphorylate RPA32 
275,276
. 
3.2.1. DNA REPLICATION CHECKPOINT 
The slowing or stalling of replication fork progression may expose significant amounts of 
ssDNA, generated by the uncoupling of helicase and polymerases activities or due to the 
uncoupling of leading and lagging strands synthesis 
124,200,232,277–279
. This ssDNA becomes 
coated by RPA acting as a platform for the recruitment of many proteins important to induce 
the DNA replication checkpoint (Figure 10) 
267,280–282
. One protein required for ATR recruitment 
to stressed replication fork is ATRIP (ATR-interacting protein) 
283
, although it is not enough for 
ATR activation 
218
. ATRIP deacetylation by Sirtuine-2 is required for ATRIP-ATR binding to RPA 
284
. Furthermore, ATR kinase activation depends on conformational changes mediated by the 
binding of ATR to activator proteins 
282
. In vertebrates, two ATR activators have been 
identified: TopBP1, which interacts with both ATR and ATRIP 
285,286
, and ETAA1 (Ewing tumour-
associated antigen 1), which is recruited through direct interactions with RPA 
287–290
. TopBP1 
recruitment depends on Rad9-Hus1-Rad1 (9-1-1) checkpoint clamp complex 
291,292
, which is 
loaded onto DNA  by the RPA-recruited Rad17-RFC clamp loader 
293,294
. After TopBP1 
recruitment on 9-1-1 clamp complex, which is partially dependent on MRN (Mre11-Rad50-
Nbs1) complex 
295,296
  and on RHINO (Rad9-Hus1-Rad1-interacting nuclear orphan) 
297,298
, 
TopBP1 interacts with ATR-ATRIP to stimulate ATR activation 
299
. 
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Figure 10. A model for replication checkpoint activation. ssDNA produced by the uncoupling of helicase 
and polymerases activity is coated by RPA, which acts as a platform for the recruitment of several 
proteins important to attract ATR, such as its regulatory unit ATRIP and regulatory factors, such as Rad17, 
TopBB1, the 9-1-1 complex to the replication fork. All these proteins stimulate ATR activity, and with the 
help of mediator proteins such as Claspin, the activation of Chk1 and the entire checkpoint pathway.  
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Once activated,  when ATR is autophosphorylated in Thr1989 
300
, ATR phosphorylates a large 
number of substrates. The main effector protein of ATR is Chk1. Chk1 is phosphorylated by 
ATR on Ser317 and Ser345 
301,302
, inducing a conformational change on Chk1 that allows its 
autophosphorylation on Ser296 
303
 to further activate this effector kinase. The ATR-mediated 
phosphorylation of Chk1 involves several mediator proteins, such as Claspin 
304
, Tim/Tipin 
305
 
or PARP1 
306
.  
Claspin is phosphorylated in response to replication stress by CK1 ɣ1 (casein kinase 1 ɣ1) 
307
 
allowing the association of Claspin with Chk1 
308–310
. Activation of Chk1 is enhanced under 
those conditions, since ATR shows a higher affinity for the Chk1-Claspin complex, than for 
Chk1 alone 
311
. 
It should be noted that ATR or its main downstream effector Chk1 have effect on unperturbed 
cells during S phase, where they regulates origin firing 
312–314
, although Chk1 is not strongly 
phosphorylated by ATR. The basal level of activity may be enough to their roles in normal 
conditions. 
Functions of DNA replication checkpoint 
As mentioned previously, DNA replication checkpoint is activated in response to an 
accumulation of ssDNA. When this happens, ATR is activated to control checkpoint activation, 
to promote a reversible cell cycle arrest to prevent mitotic entry with unreplicated DNA, to 
inhibit late origin firing and to maintain fork stability to recover replication when the stress is 
overcome. Additionally, this checkpoint regulates fork restart or DNA repair mechanisms to 
safeguard genomic integrity. The mechanisms involved in the most important functions of 
DNA replication checkpoint are explained below. 
- Cell cycle arrest. One important function of ATR/Chk1 pathway is to arrest cell cycle when 
replication fork progression is compromised. Once Chk1 is activated, it phosphorylates and 
activates Wee1 kinases 
39,40
, which phosphorylate CDKs and inhibit their activity, and 
phosphorylates and inactivates Cdc25 phosphatases 
37,40
, which are required to remove 
inhibitory phosphorylations of CDKs 
34
, leading to cell cycle arrest. Chk1 controls Cdc25 
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phosphatases by the binding of Cdc25C to 14-3-3 proteins that sequester the phosphatase in 
the cytoplasm or the induction of Cdc25A and Cdc25B proteasome-mediated degradation 
35
. 
- Regulation of origin firing. Inhibition of origin firing is another mechanism used by 
replication checkpoint to prevent cell cycle progression and to arrest cells in S phase. During 
an unperturbed S phase, ATR and Chk1 are negative regulators of origin firing, preventing 
excessive activation of origins 
312,315
. ATR has also a crucial role on blocking origin firing in 
response to replication stress 
316–318
 to prevent RPA exhaustion that leads to fork breakage 
227,239
. As mentioned previously, origin firing requires the loading of Cdc45 and GINS to the 
MCM2-7 complex, which is dependent of DDK and CDK kinases. As explained in the previous 
point, Chk1 phosphorylates Wee1 and Cdc25 that leads to inhibition of CDK2 
40
. Another 
mechanisms by which ATR-Chk1 blocks origin firing is ATR-mediated phosphorylation and 
stabilization of the histone MLL (methyltransferase myeloid/lymphoid) 
319
 that metylates 
histone H3 Lys4, and Chk1-mediated phosphorylation of Treslin 
320
, both preventing the 
loading of Cdc45 at replication origins. In addition, ATR regulates Rif1 (Rap1-interacting 
factor), which dephosphorylates MCM2-7 complex through directing protein phosphatase 1 to 
counteract DDK activity to restrain replication initiation 
135,321
.  
Although replication checkpoint suppresses origin firing under replication stress conditions, it 
allows dormant origin firing locally as a backup to complete replication in these regions  
322
. 
The reason why local dormant origins are activated whereas global origin firing is inhibited by 
replication checkpoint is unknown 
153
. A recent study suggests that regulation of origin firing 
by ATR depends on the level of replication stress: during low levels of replication stress, FANCI 
binds to unfired origin and directs DDK-dependent phosphorylation of MCM2-7 complex 
promoting dormant origin firing, while moderate-high levels of replication stress result in a 
more sustained ATR activation, leading to FANCI phosphorylation and reduced origin firing 
323
. 
- Maintaining replication fork stability. Replication fork stabilization has been described as an 
important function of the replication checkpoint and it is defined as the maintenance of the 
ability of stalled forks to restart DNA synthesis after removal or bypass the block of DNA 
replication 
282
. Once replication forks lose the ability to restart, forks collapse, which usually 
involves the formation of DSBs.  
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It is known that ATR is essential for stabilization of stressed replication forks 
324
. On the one 
hand, studies of chromatin immunoprecipitation performed in yeast show that replisome is 
disassembled in the absence of checkpoint kinases after HU, indicating a possible role for ATR 
in replisome stabilization 
325–327
. On the other hand, ATR signalling promotes the association of 
FAND2 with the MCM2-7 complex, restraining replisome function and preventing the 
accumulation of ssDNA upon HU exposure 
328
.  Moreover, cohesins are thought to participate 
in fork protection and stability maintenance 
329,330
. A recent study in yeast showed that the 
ATR-mediated ubiquitination of cohesins induces their mobilization to nascent DNA to stabilize 
stalled replication forks 
331
.   
Another mechanism of fork stabilization in response to genotoxic stresses that is rapidly 
emerging is replication fork reversal 
332
. This model was first observed in 1976 as a fork 
remodelling process 
333
. It is defined as the conversion of a replication fork, a three-way 
junction, into a four-way junction by the annealing of the two newly synthetized strands and 
the re-annealing of the parental strands forming a “chicken foot” structure 
334
. During the last 
years, it has been demonstrated that fork reversal is a very common event in response to 
various types of DNA replication stress, from which replication can be restarted 
332
. SMARCAL1 
is a translocase of SWI/SNF protein family, which is required for reversed fork formation 
335,336
. 
ATR-mediated phosphorylation of SMARCAL1 limits its fork remodelling activity and prevents 
aberrant fork cleavage by SKX4 and CtIP nucleases 
337,338
. But it has to be considered that other 
authors show that SMARCAL1 depletion leads to the activation of an alternative mechanism 
involving Mus81-dependent fork cleavage 
339
. On the other hand, Chk1 mediates the 
protection of replication forks by preventing fork collapse due to the inhibition of different 
nucleases 
340
, such as Mus81 
341
 and Mre11 
342
. 
- Regulation of DNA repair mechanisms. Replication checkpoint activates, if needed, DNA 
repair pathways to guarantee genomic stability. The repair mechanisms induced by replication 
stress are one-ended DSBs. Since DSBs can also be sensed by DNA damage checkpoint 
(explained in section 3.2.2), there is a crosstalk between both pathways at this point 
222,247
. 
ATR is described to be more implicated in HR repair than non-homologous end joining (NHEJ) 
repair of DSBs 
343
. For example, ATR regulates BRCA1 (breast cancer type 1) 
344,345
, a protein 
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directly involved in HR-mediated repair 
346
. Furthermore, it is described that Chk1 interacts 
and phosphorylates RAD51, stimulating HR pathway 
347
. 
Apart from HR, ATR might play an important role on Fanconi anaemia (FA) pathway, involved 
in the repair of DNA interstrand crosslinks. ATR-mediated phosphorylation of FANCI 
348
, which 
leads to FANCD2 mono-ubiquitination by the core complex 
349
, activates the FA pathway 
350
. 
Moreover, ATR phosphorylates FANCM, which allows its recruitment to the site of interstrand 
crosslinks and is also required for an efficient activation of ATR 
348,351
. 
- Regulation of replication fork restart. In addition to the replication checkpoint-mediated 
fork stabilization to prevent fork collapse, the replication checkpoint also regulates the 
pathways that promote fork restart 
282
. Several pathways are involved in fork restart: 1) 
repriming by PrimPol ahead of stalled polymerase 
352–354
, 2) bypass the damage with a TLS 
polymerase 
355
 or 3) template switching, using the undamaged sister chromatid as template 
for replication, 4) fork reversal 
334
, and 5) cleavage of the reversed or stalled fork by 
endonucleases to facilitate HR-mediated mechanisms of fork restart 
356–358
.  
ATR phosphorylates Rev1 (reversionless1) and polymerase η, two of the translesion 
polymerases 
359–362
. Moreover, ATR/Chk1-dependent recruitment of polymerase η and Rad18 
into chromatin 
363
, being the last one an important ubiquitin ligase that promotes PCNA mono-
ubiquitination, which is an important step for TLS 
364
, suggest a role of replication checkpoint 
in promoting TLS.  
In addition, ATR phosphorylates RPA 
365,366
, PALB2 
367
 and XRCC3 
368
, while Chk1 
phosphorylates RAD51 
347
 and BRCA2 (breast cancer type 2) 
369
, all of which promotes RAD51 
recruitment to stalled or collapsed forks 
357,370
. Furthermore, ATR phosphorylates BLM 
371
 and 
WRM 
372
, which promotes replication restart and prevents the formation of DSBs at stalled 
forks. All these substrates promote RAD51-dependent replication fork restart through diverse 
mechanisms, including template switching, fork reversal and HR 
282
.  
A detailed description of replication fork restart will be further explained in section 3.3. 
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3.2.2. DNA DAMAGE CHECKPOINT 
When the DNA damaged is sensed, a DNA damage response (DDR) is activated (Figure 11) to 
detect the lesions, signal its presence and promote their repair in coordination with the 
inhibition of cell cycle progression to avoid mitotic entry with damaged DNA, which is 
promoted by DNA damage checkpoint 
373
.  
The DNA damage can be produced by physical or chemical sources, such as ionizing radiation 
(IR), ultraviolet (UV) light, alkylating agents (methyl methanesulfonate), crosslinking agents 
(mitomycin C, cisplatin, psoralen) or topoisomerase inhibitors (camptothecin, etoposide). To 
counteract DNA damage, repair mechanisms specific for different type of lesions have 
evolved: 1) mismatch repair (MMR) when mispaired bases are replaced with the correct bases, 
2) base excision repair (BER) to recognize and repair small chemical alterations of DNA bases, 
3) nucleotide excision repair (NER) to correct pyrimidine dimers, 3) interstrand crosslink (ICL) 
repair to deal with ICL with the assistance of FA proteins, 4) single-strand break (SSB) repair to 
repair SSB, and 5) NHEJ or HR to process DSBs 
373,374
. In this thesis, we will focus on DSBs, since 
they can be generated by replication stress in S phase, as a result of collapsed forks 
219,222,224,225,257
.  
DSBs can be sensed by MRN mediator complex 
375–377
: Mre11, which has endonuclease and 3’-
5’-exonuclease activities, forms a complex with Rad50, a member of SMC family with ATPase 
activity that associates with DNA ends of DSBs, and Nbs1, which regulates the activities of 
Mre11 and Rad50 and contains additional protein-protein interaction domains important for 
MRN function 
374,377,378
. Nbs1 associates with ATM, promoting its recruitment to DSBs and 
activation 
374,379
, with the help of 53BP1 (p53-binding protein 1) and BRCA1 
376,380
. ATM protein 
is predominantly nuclear, where it exists as a catalytically inactive noncovalent homodimer. 
DNA damage turns it into an active monomer by ATM autophosphorylation at Ser1981 in the 
FAT domain 
381,382
. Additional ATM autophosphorylations, as well as Tip60-mediated 
acetylation at Lys3016, were identified for an optimal ATM-mediated response 
376,378,382–386
. 
Moreover, dephosphorylation events, by PP2A44 and PP5 phosphatases, might also contribute 
to ATM activation 
376
. 
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Once activated, ATM phosphorylates a large number of substrates, involved in cell-cycle 
checkpoints and DNA repair 
378,387
. The main transducer protein of ATM is Chk2, which is 
phosphorylated on Thr68 by ATM 
254,388
. As explained before, and together with other PIKKs, 
ATM also phosphorylates H2AX histone variant on Ser139 
270,389,390
, which acts as a signal 
amplifier: ɣH2AX is recognized by MDC1 (mediator of DNA damage checkpoint 1) protein, 
which in turn is stabilized on chromatin and phosphorylated by ATM, leading to further 
recruitment of ATM and additional ɣH2AX formation along chromatin, amplifying DDR 
signalling 
269,391
. ATM-mediated phosphorylation of MDC1 allows RNF8 retention on damaged 
chromatin
392,393
, stimulating ubiquitylation of linker histone H1
394
. Ubiquitylated H2 is 
recognized by another ubiquitin ligase, RNF168, that ubiquitylates H2A-type histones to 
promote recruitment of 53BP1 to repair toward NHEJ 
30,394
. The signal amplification of ATM is 
important for correct DNA damage checkpoint activation, but also for BRCA1 phosphorylation 
on multiple residues and recruitment at sites of damage  
269,374,395
.  
In HR repair pathway, DSBs are resected to generate 3’-ssDNA. This resection is promoted by 
MRN complex and CtIP (CtBP-interacting protein), and a further resection is carried out by 
Exo1 (exonuclease 1), BLM and DNA2 
396–401
. The ssDNA generated by the resection is coated 
by RPA, which activates ATR via ATRIP, activating the checkpoint response 
267
. Finally, RPA is 
exchanged for RAD51 to promote strand invasion, HR repair and resolution of intermediates. 
HR is restricted to S and G2 phases because it uses sister-chromatid sequences as the template 
to mediate repair 
373
, and although it is typically viewed as an error-free pathway, it often 
requires error-prone polymerases 
402
.  
During NHEJ, the Ku70/80 heterodimers recognize and bind to DSB ends to protect them from 
degradation. This complex also recruits and activates DNA-PK and the endonuclease Artemis, 
which removes the excess of ssDNA to generate a proper substrate by DNA ligase IV, with the 
help of additional factors involved in this pathway. NHEJ is considered an error-prone repair 
pathway since it involves direct ligation with little (less than 10pb) or no homology between 
joined ends. During cell cycle, this repair pathway occurs predominantly in G1 phase, but also 
in G2 phase 
403–406
. 
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Figure 11. A model for DDR activation and signal amplification in response to DSB. MRN complex are 
recruited at DSBs. Post-translational modifications (autophosphorylation and acetylation) induce ATM 
activation. Once activated ATM phosphorylates several substrates, which leads to a further recruitment 
and activation of ATM, amplifying DDR signalling. Phosphorylation is indicated in brown circles, 
acetylation is indicated in yellow circles and ubiquitylation is indicated in red circles. 
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Several factors regulate the DNA 3’ end resection, since it is the earliest divergent step 
between both pathways: BRCA1, in complex with MRN, promotes DNA end resection, while 
53BP1 plays an important role restricting this process 
407,408
. It is thought that in NHEJ-
mediated DSB repair, 53BP1 is phosphorylated by ATM, which allows the interaction with its 
downstream targets such as Rif1. Rif1 suppresses 53BP1 repositioning, protecting DSBs from 
resection and allowing NHEJ. When 53BP1 is dephosphorylated by phosphatases, it causes Rif1 
release from chromatin, which results in a reposition of 53BP1 allowing nucleases to access 
DNA damage sites and promoting resection for HR 
403,409
. A recent study suggests a role of 
APC/C
Cdh1
 in choosing the repair pathways in S/G2 phases. They demonstrate that the 
activation of APC/C
Cdh1
 leads to USP1 destruction and the recruitment of BRCA1, which expels 
Rif1 and reinforces end resection promoting HR repair 
410
. 
Functions of DNA damage checkpoint 
As it has been mentioned, different types of repair pathways that act into DSB repair are 
sensed by specific complexes that result in the activation of ATM, ATR and DNA-PK. The signal 
is transduced downstream by a kinase cascade. ATM activation results in the activation of 
Chk2, while ATR results in the activation of Chk1.  
These kinases stabilize effector proteins like Cdc25 by phosphorylation, inhibiting CDK activity 
as an early response to DNA damage 
9,34,411
. p53 transcriptional factor is a target of both 
sensor kinases (ATM/ATR) and effector kinases (Chk2/Chk1) 
412–414
. Moreover, MDM2, the 
ubiquitin ligase responsible for p53 degradation, is targeted after DNA damage by both 
ATM/ATR as well as Chk2/Chk1, contributing to stabilization and accumulation of p53 
414,415
. 
The key transcriptional target of p53 is p21
WAF1/Cip1
 
416,417
, an inhibitor of CDK activity which 
causes cell cycle arrest 
9,412
. Moreover, it has been reported that p21
WAF1/Cip1
 down-regulates 
Emi1 in G2 arrested cells after DNA damage, activating APC/C and degrading A-type and B-
type cyclins 
109,111,112
.  Participation of p21
WAF1/Cip1
 in DNA repair process was first suggested by 
its interaction with PCNA, resulting in the competition and displacement of other PCNA-
interacting proteins, such as TLS polymerases, which leads to DNA replication inhibition and 
regulation of the repair processes 
418–424
.  
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Apart from inducing cell cycle arrest, target genes of the activated cascade in response to DNA 
damage coordinate DNA repair. Moreover, in response to persistent damage, cells are 
withdrawn from the cell cycle by p53-mediated apoptosis or senescence in order to avoid cell 
division with damaged or unreplicated DNA 
425
. While cellular senescence response arrests cell 
cycle permanently, cell death response facilitates the destruction of the damaged cell. Since 
senescent cells secrete pro-inflammatory cytokines, which represent a threat for the 
organism, cell death seems to be the safest response 
411
.  
3.3. REPLICATION RESTART OR REPAIR PATHWAYS 
In response to replication stress, replication checkpoint tries to maintain the stability of 
replication forks to resume DNA duplication once the block is released 
222,426
. Restart from the 
same replication fork guarantees replication of the whole genome. If the same fork cannot be 
restarted, activation of dormant origins preserves genomic integrity 
137,150–153
, since dormant 
origins are located in the same replicon and their activation does not alter the replication 
timing program 
126,427,428
. However, when dormant origin firing allows resumption of 
replication after replication fork collapse 
370
, it might contribute to the acquisition of genomic 
instability 
226
. 
It has to be noted that the presence of DNA damage in the leading- or lagging-strand 
templates has different consequences for the replication fork. If unwinding by helicase is not 
impaired, damage in the lagging-strand does not hamper replication fork progression, because 
replication is constantly initiated on this strand generating new Okazaki fragments. On the 
other hand, damage in the leading-strand template is more problematic and the mechanisms 
described below are triggered to prevent genomic instability at this stalled fork 
232,278
. 
As mentioned previously, multiple processes have been suggested to promote fork restart: 
repriming, lesion bypass by translesion synthesis or template switching, fork reversal or the 
break-induced replication (BIR) after the cleavage of endonucleases 
219,282
. All these 
mechanisms (Figure 12) are further explained below. 
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Figure 12. Mechanisms involved in fork restart. The mechanisms used to restart replication after fork 
stalling, or the presence of DNA lesion, are represented. 
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case, the replisome may skip the damaged DNA, leaving an unreplicated ssDNA gap behind 
that must be repaired after replication. The replisome is able to reinitiate DNA synthesis 
downstream of the lesion in the leading strand by a de novo repriming event and the 
continuance of unwinding of the template strands 
429–432
. 
Repriming in mammalian cells is performed by PrimPol, the second human archaeon-
eukaryotic primase family identified 
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. This enzyme has RNA/DNA primase activities and 
polymerase and TLS activities 
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. The human PrimPol ensures resumption of DNA synthesis 
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repriming activity plays a central role in replication reinitiation downstream of DNA lesions in 
vitro that cannot be bypassed by its TLS activity 
436
. 
A plausible pathway for repriming after leading-strand template damage could be as follows: 
polymerase ε would stall whereas CMG would continue to unwind the parental strands and 
polymerase α/primase and polymerase δ would continue with replication of lagging-strand. 
Probably, polymerase ε might move away from the lesion with the progressing CMG complex 
437
, while PrimPol could reprime downstream of the damage on the leading-strand template 
232
. Then, polymerase δ could extend from the new primer until catching up with the 
progressing CMG-polymerase ε complex, dissociating by collision with the slower CMG 
complex 
232,437
. 
Direct bypass of damage 
DNA lesions represent a threat for replicative DNA polymerases, the ones that are part of the 
replisome and synthetize the bulk of undamaged DNA templates. These polymerases are 
highly accurate but do not tolerate DNA template lesions. Otherwise, the TLS polymerases 
have a larger catalytic site to bypass DNA lesions 
438,439
. There are many TLS polymerases in 
mammalian cells, being the important ones polymerase ζ, polymerase η, polymerase κ, 
polymerase ι and Rev1. All these TLS polymerases are error-prone polymerases that lack 
proofreading activity and have lower nucleotide selectivity than the replicative polymerases. 
Otherwise, several studies suggest that correct selection of the TLS polymerase to accurately 
bypass the DNA lesion is crucial to prevent elevated mutagenesis 
439–443
. 
As mentioned previously, the recruitment of TLS polymerases to stalled replication forks is 
promoted by Rad18-mediated PCNA mono-ubiquitination 
364,444,445
. However, several studies 
suggest that PCNA ubiquitination is important for efficient recruitment and synthesis of TLS 
polymerases in normal cells, but it is not essential, since TLS can occur in the absence of PCNA 
mono-ubiquitination 
446–449
. 
Many models suggest that replicative polymerases switch at the stalled fork for TLS 
polymerases to bypass the lesion. However, recent studies suggest that replicative polymerase 
α is able to replicate and bypass lesion directly in the replisome, without the recruitment and 
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activation of error-prone polymerases 
450,451
. In eukaryotic cells it is unlikely that polymerase ε 
would be able to bypass damaged DNA, similarly of polymerase α, which would release at the 
block and would rebind ahead of it to synthesize a new primer 
232
. However, bypassing a lesion 
by TLS could involve DNA polymerase δ, specifically the POLD3 subunit 
452,453
. 
Template switching 
Another way to bypass DNA lesions is template switching, which uses the nascent DNA strand 
as template to avoid damaged DNA 
442
. Template switching is mediated by poly-ubiquitination 
454
 and SUMOylation of PCNA 
442,455
. 
This mechanism requires the unwinding of nascent strands from parental strands and the 
annealing of both nascent strands to overcome DNA lesions. A DNA helicase, a DNA 
translocase able to perform branch migration, a DNA recombinase and a DNA polymerase to 
extend the stalled nascent DNA are required 
232
. 
There are two models of template switching: one model proposes that replication can resume 
downstream of DNA lesion, leaving a ssDNA gap to be filled postreplicatively, while the second 
model proposes that stalled replication fork can be remodelled into reversed fork to facilitate 
damage bypass  
456,457
. The second model will be further explained in the next section. 
In relation to the first model, it is a process well studied in bacteria 
458
 and yeast 
456,457,459
. 
Studies in budding yeast have allowed the visualization and identification of DNA structures 
involved in this process 
460
. RAD51 and other mediators, such as Rad55 and Rad57, bind to the 
ssDNA gaps behind replication forks to allow recombination 
459
. The recombination reaction is 
initiated by Exo1-mediated gap processing, causing exposure of the newly synthesized strand 
for DNA synthesis 
459,460
. The D-loop is matured into a double Holliday Junction-like structure, 
by the annealing of parental strands and the annealing of nascent strands 
457,460
. The DNA 
synthesis depends on polymerase δ 
459
. The intermediates are resolved  by the action of the 
Sgs1-Top3-Rmi1 (STR) complex in yeast or BLM-TOP3α-RMI1/2 complex in humans 
457,459–461
. 
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Fork reversal 
The other model of template switching proposes the remodelling of stalled fork into a 
reversed fork 
457
. Fork reversal is defined as the transformation of a typical fork structure, a 
three-way junction, into a four-way junction forming a “chicken foot” structure, by the 
annealing of the nascent DNA strands and the re-annealing of the parental strands 
221,334,457
.  It 
was first described as a pathological consequence of replication inhibition, but recent 
evidences have indicated that fork reversal is an important mechanism of protection when 
replication forks encounter DNA lesions. This mechanism enables replication fork to pause and 
restart without chromosomal breakage. However, fork reversal also can lead to chromosomal 
instability if the reannealing causes misalignments or the four-way junction undergoes by 
uncontrolled nucleolytic cleavage 
334
.  
It has been demonstrated that fork reversal is a global response to a wide spectrum of DNA-
damaging and fork stalling agents 
462
. During the last years, compelling evidences have 
contributed to the understanding of the reversed-fork formation. Several enzymes have been 
shown to exhibit fork reversal activity in vitro, including the DNA translocases Rad54 
463
, 
SMARCAL1 
339
, FANCM 
464
, ZRANB3 
465,466
 and HLTF 
467–469
 and the DNA helicases FHB1 
470
, 
RECQ5 
471
, BLM and WRN 
472
. The enzymes that are reported to catalyse fork reversal in vivo 
are DNA translocases SMARCAL1 
335,336
, ZRANB3 
473
 and the DNA helicase FHB1 
470
. The central 
recombinase factor RAD51 is also involved in the formation of reversed forks 
462
, but since it 
does not have fork-remodelling activity on its own, it may stimulate fork reversal through 
other proteins 
463,474
.  
RAD51 binds to both ssDNA and dsDNA with a modest affinity, so RAD51 requires a mediator 
to access the RPA-bound ssDNA. In mammalian cells, the main mediator is the tumour 
suppressor BRCA2 
474,475
. However, BRCA2 is dispensable for the role of RAD51 in fork reversal, 
although it seems relevant for the assembly of RAD51 nucleofilaments on regressed arms to 
protect them from Mre11-dependent degradation 
335,476–478
. Additional proteins are implicated 
in fork protection, such as BRCA1 and FANCD2 by preventing Mre11-dependent degradation 
479
 or BOD1L by stabilizing RAD51 on ssDNA and preventing DNA2-mediated degradation 
480
.  
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Regarding replication fork restart from reversed forks in human cells, two different pathways 
have been described (Figure 13). The first pathway has as a central player the human helicase 
RECQ1. In this case, RECQ1 drives the restart of reversed forks, and its function is inhibited by 
PARP1 (poly(ADP-ribose) polymerase 1) until the damage is repaired or the stress is overcome 
481
. The second pathway involves the DNA2 nuclease and WRN helicase in cooperation to 
process and restart reversed forks. Both DNA2 nuclease and WRN helicase promote a 5’-3’ 
resection creating a 3’ overhang and promoting fork restart, by strand invasion that could be 
mediated by RAD51. In this case RECQ1 limits DNA2 activity by preventing excessive nascent 
DNA degradation. Moreover, DNA2 role in the restart of  reversed forks is not accomplished by 
other nucleases, such as Exo1, Mre11 and CtIP 
220,482
.  
 
Figure 13. Mechanisms of reversed forks processing and restart. Two mechanisms are described for the 
resolution of reversed forks, one dependent on RECQ1 helicase and the other on DNA2 nuclease and 
WRN helicase. Adapted from “Replication stress: getting back on track” 
220
 and “DNA2 drives processing 
and restart of reversed replication forks in human cells” 
482
. 
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Break-induced replication 
Another mechanism for replication fork restart is mediated by the cleavage of reversed or 
stalled forks by endonucleases. When a stalled fork is processed by structure-specific 
endonucleases, such as Mus81-Eme1, a one-ended DSB is generated 
483,484
. However, DSBs are 
not terminal events for replication forks, since these breaks can be solved by an HR pathway 
known as break-induced replication (BIR). BIR initiates by strand-invasion of a broken DNA end 
into a homologous template followed by initiation of DNA synthesis that can copy hundreds of 
kilobases of DNA. This process is particularly important to complete replication close to 
telomeric ends, but for this thesis its relevance lies in its role in recovering collapsed 
replication forks 
220,485,486
. BIR is associated with a high frequency of mutations and 
chromosomal rearrangements, making this unusual mode of DNA replication an important 
source of genomic instability 
487
. 
In Escherichia coli, where replication involves two replication forks moving in opposite 
direction from a single origin and terminating at a single locus, broken replication forks must 
be repaired by a process like BIR. In eukaryotes, BIR is also involved in the restart of collapsed 
forks, although cells are less dependent on BIR due to the presence of dormant origins. 
However, the relevance of BIR in the repair and restart of damaged forks has been recently 
confirmed in human cells 
488
.  
BIR begins with DNA end resection followed by RAD51-mediated strand invasion to form a D-
loop, before replication fork assembly and extensive DNA synthesis (Figure 14) 
489
. From 
studies done in yeast, it has been reported that leading-strand synthesis proceeds in migrating 
D-loop, while lagging-strand synthesis occurs in a conservative manner in which the nascent 
ssDNA is used as a template 
490–492
. In human cells, BIR depends on Rad52 
493
 and POLD3, a 
mammalian homolog for the BIR-specific polymerase δ subunit Pol32 
486,488,492,494
. 
Reversed replication forks that are unable to restart might represent a proper substrate for 
structure-specific endonucleases and might use this mechanism to reinitiate replication. In 
fact, Mus81 nuclease is involved in DSBs formation in response to replication inhibition  
483
 and 
a recent study suggest its role in the cleavage of reversed forks to promote BIR-dependent 
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fork restart 
495
. Moreover, SLX4 endonuclease can cleave similar structures under unregulated 
checkpoint 
496
. 
 
Figure 14. BIR-mediated restart from collapsed forks. The mechanism used to resume replication from 
the nuclease-mediated cleavage of stalled or reversed forks. Collapsed forks are processed to generate a 
one-end DSBs. After that, RAD51-mediated strand invasion event forms a D-loop and DNA synthesis 
proceeds in the migrating D-loop. 
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4. REPLICATION STRESS AND CANCER 
The relevance of the cellular responses to replication stress is highlighted by a collection of 
cancer-prone genetic diseases that are caused by alterations in genes that participate in these 
responses (Table 1) 
221,225
.   
For example, mutations in the pre-replication factors ORC1, ORC4, ORC6 and Cdt1, Cdc6, 
which affect origin licensing in DNA replication 
497
, and mutations in the Cdc45, an essential 
component of pre-IC and CMG helicase complex 
498
, are associated with the Meier–Gorlin 
Syndrome, a disease characterized by severe growth retardation and developmental 
malformations. 
Loss of ATR represents one of the most severe perturbations, as it is a key initiating event in 
replication-stress response. Mutation, splicing defects or protein expression reduction of ATR 
or mutations in ATR’s binding partner, ATRIP, are associated with Seckel syndrome 
499–502
, 
which is characterized by developmental delay, microcephaly and mental retardation. Loss of 
the MRN complex, which activates ATR during replication stress but is also required for DSB 
repair, is also associated with several developmental disorders 
219
. Mutations in the RNase H2 
gene cause the Aicardi-Goutieres syndrome, which is characterized by severe neurological 
dysfunction and a congenital infection-like phenotype 
503
. 
Mutations in proteins involved in chromatin remodelling during DNA replication have also 
been associated with human disorders. Mutations in the SMARCAL1 are associated with the 
Schimke immune-osseous dysplasia 
504–506
. Mutations that affect the RECQ family DNA 
helicases (WRN, BLM and RECQL4), which play an important role in the efficient resolution of 
replication intermediates and arrested forks, are responsible for the genetic syndromes 
Werner, Bloom and Rothmund-Thomson, respectively 
507
. Moreover, mutations in the FA 
complementation groups are responsible for the Fanconi Anaemia disease 
508
, due to its failure 
to repair ICLs, which elevates their genome instability. Finally, mutations in TLS polymerase η 
are linked to Xeroderma pigmentosum, which increases photosensitivity and skin cancer 
predisposition 
509
. 
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Table 1. Human diseases associated with defective proteins involved in the replication stress response. 
Adapted from “Causes and consequences of replication stress” 
219
. Proteins that are not mentioned in 
this thesis are written in grey. 
Human disease Defective protein(s) Affected pathway Characteristics 
Aicardi-Goutieres 
syndrome 
RNase H2, TREX1, 
SAMDH1 
Removal of 
ribonucleotides, RNA-
DNA hybrids 
Neurological dysfunction, 
appearance of chilblains 
Amyotrophic lateral 
sclerosis 4 
Senataxin 
Resolution of RNA-DNA 
hybrids, transcription 
termination 
Childhood- or adolescent-onset 
degeneration of motor control 
Ataxia-ocular apraxia 
2 
Adolescent-onset cerebellar ataxia 
Ataxia-telangiectasia-
like disease 
Mre11 
MRN complex; 
ATR/ATM activation 
Neurodegeneration, ataxia 
Bloom syndrome BLM 
DNA remodelling, 
replication fork structure 
resolution 
Premature aging, growth 
retardation, cancer predisposition 
Cancer Many Many 
Uncontrolled cell growth, leading to 
organ failure 
Fanconi anaemia 
FANC family proteins 
DNA inter-strand 
crosslink repair Heterogenous: bone marrow failure, 
skeletal defects, hypopigmentation, 
cancer predisposition 
FANCD2, BRCA2 
Replication fork 
protection 
Meier-Gorlin 
syndrome 
ORC1, ORC4, ORC6, 
Cdt1, Cdc6, Cdc45 
Origin licensing, 
centrosome 
maintenance,  
origin firing 
Growth retardation, microcephaly 
Nijmegen breakage 
syndrome 
Nbs1 
MRN complex; ATR/ATM 
activation 
Microcephaly, growth retardation, 
cancer predisposition 
Nijmegen breakage 
syndrome-like 
disorder 
Rad50 
MRN complex; ATR/ATM 
activation 
Microcephaly, growth retardation, 
mental retardation 
Rothmund-Thomson 
syndrome 
RecQL4 
DNA remodelling, 
replication fork structure 
resolution 
Premature aging, growth 
retardation, cancer predisposition 
Schimke immuno-
osseous dysplasia 
SMARCAL/HARP 
Replication fork 
stabilization and reversal; 
DNA re-annealing 
Dwarfism, skeletal abnormalities, 
renal failure, immunodeficiency 
Seckel syndrome 
ATR, ATRIP, CENPJ, 
CEN152, PCNT 
ATR signalling 
Growth retardation, dwarfism, 
microcephaly, mental retardation 
Werner syndrome WRN 
DNA remodelling, 
replication fork structure 
resolution 
Premature ageing, growth 
retardation, cancer predisposition 
Xeroderma 
pigmentosum - 
variant 
Polymerase η Translesion synthesis 
Cancer predisposition (especially 
skin cancer) 
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Apart from the genetic conditions described previously, replication stress induces genomic 
instability and potentiates cell transformation and cancer predisposition. In this sense, 
Hanahan and Weinberg modified their original hallmarks of cancer 
510
 to add the enabling 
characteristic of “genome instability and mutation”, among others, to their list 
511
. Moreover, 
DNA damage and DNA replication stress have been proposed as additional hallmarks of cancer 
that describe the state of cancer cells rather than their functional capabilities 
425,512
.  
Upon oncogene expression, DNA damage response and replicative stress response are 
activated in precancerous lesions 
513,514
, inducing senescence or apoptosis programs in 
damaged cells 
515
. Some cells may evade this barrier by various mechanisms (for example, p53 
mutations) to facilitate cancer development 
516
. Interestingly, no significant incidence of 
mutations in ATR or Chk1 is found on human tumours 
517,518
, although their expression are 
frequently upregulated in cancer, probably to deal with the enhanced levels of replication 
stress in tumour cells 
224
. Remarkably, a recent study has demonstrated that cancer risk is 
correlated with the number of stem cell divisions in different tissues, that became due to 
stochastic problems arising during DNA replication 
519
. 
Several mechanisms might enhance replication stress specifically in tumour cells. Some years 
ago, it was thought that the enhanced replication stress stemmed from the rapid proliferation 
and the need to replicate DNA of tumour cells, while differentiated cells rarely or never 
divided. Nowadays, the activity of oncogenes, such as HRas 
248
, Myc 
249
 and cyclin E 
250
, has a 
more important role in the contribution to replication stress. Furthermore, tumour cells often 
lack efficient DNA repair mechanisms, so some general DNA repair deficiency syndromes are 
associated with increased cancer incidence 
520
. 
DNA replication process has been a target of cancer treatment for many years. In this sense, 
DNA replication inhibition is broadly applied due to the high proliferative state of cancer cells. 
Conventional chemotherapy objective is to induce DNA damage by producing replication 
stress (Table 2), leading to programmed cell death 
247,520
.  
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Table 2. Conventional chemotherapy targeting DNA replication or damaging DNA. Adapted from 
“Cellular responses to replication stress: Implications in cancer biology and therapy” 
247
. 
Mechanism to induce 
replication stress  
Drug Application 
Nucleotide synthesis 
inhibitors 
Hydroxyurea 
Chronic myelogenous leukaemia, head and 
neck cancer 
Methotrexate 
Acute lymphoblastic leukaemia, non-Hodgkin 
lymphoma 
5-Fluorouracil 
Gastrointestinal cancers, head and neck 
cancer 
6-Mercaptopurine Acute lymphoblastic leukaemia 
Fludarabine Leukaemia, lymphoma 
Chain elongation 
inhibitors 
Cytarabine (Ara-C®) Leukaemia, lymphoma 
Gemcitabine (Gemzar®) Lung, breast, ovarian, or pancreatic cancer 
Topoisomerase inhibitors 
Topoisomerase I inhibitor: irinotecan, 
topotecan 
Ovarian, lung or colon cancer 
Topoisomerase II inhibitor: etoposide, 
teniposide, mitroxantrone 
Leukaemia, lymphoma, sarcoma, brain 
tumour, lung cancer 
Alkylating agents 
(DNA base modification) 
Nitrogen mustards 
Leukaemia, lymphoma, Hodgkin disease, 
multiple myeloma, sarcoma, carcinoma 
Nitrosoureas 
Alkyl sulfonates 
Triazines 
Ethylenimines 
Platinum compounds 
(DNA base modification) 
Cisplatin, carboplatin, oxaliplatin 
Lymphoma, sarcoma, cervical cancer 
Lymphoma, 
Anti-tumour antibiotics 
(DSBs formation) 
Bleomycin 
Lymphoma, sarcoma, testicular or ovarian 
cancer, malignant pleural effusion 
Anthracyclines 
Leukaemia, lymphoma, multiple myeloma, 
sarcoma or carcinoma 
Mitomycin C Stomach or pancreatic adenocarcinoma 
 
However, even though prolonged replication stress caused by conventional chemotherapy 
increases genomic instability, it promotes cell adaptation. To deal with this problem, small 
molecule inhibitors of specific proteins related to replication stress and cell cycle, such as ATR, 
Chk1, Wee1, PLK1 or CDKs inhibitors, are recently being used in clinical trials for cancer 
treatment in combination with conventional agents. The conventional therapy causes 
replication stress and these inhibitors eliminate the cellular responses of tumour cells to cause 
synthetic lethality 
247
. Another strategy that is being carried out in cancer treatment is to 
promote mitotic catastrophe by eliminating the checkpoint barrier 
521
. 
The ATR/Chk1 pathway is crucial for cellular response to replication stress. Different studies in 
preclinical phase show that ATR and Chk1 inhibitors increase sensitization of different types of 
cancer to a variety of chemotherapies 
522,523
, and that is why ATR and Chk1 inhibitors are being 
tested in clinical trials, alone or in combination with conventional chemotherapy agents 
524–528
.  
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Since all the agents mentioned are related to replication stress and work through different 
mechanisms, it is worth exploring the optimal combinations of conventional and emerging 
agents, as well as the combination of different novel strategies. Further studies are needed to 
identify the most promising targeting inhibitors combinations to determine their mechanism 
and clinical usage.  
Besides ATR/Chk1 pathway, the ATM/Chk2 pathway and DNA-PK are also important targets 
activated by DNA replication stress, due to DSBs formation when replication forks collapse. In 
this sense, inhibitors of ATM, Chk2 or DNA-PK, and their downstream targets, could potentiate 
replication stress 
529,530
. Moreover, targeting DNA repair pathway and proteins, such as RAD51, 
could be also an interesting approach 
531–535
. 
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Our laboratory has focused on studying the replication stress response induced with HU, a 
ribonucleotide reductase inhibitor that promotes a deoxyribonucleotide depletion in the cells 
and inhibits replication due to lack of substrate. 
Previous results from our group showed that the competence to restart is maintained in non-
transformed human cells after acute HU-induced replication stress. However, after a 
prolonged HU-induced replication stress, resumption of DNA replication is compromised due 
to APC/C
Cdh1
 activation in S phase, which causes new origin firing inhibition 536. On the other 
hand, the proteins present on nascent DNA were analysed in order to characterize replication 
stress-induced changes at replication fork level in non-transformed human cells (unpublished 
data). 
The general aim of this thesis was to study the HU-induced replication stress response in a 
prolonged and an acute HU treatment that contributes to regulate DNA replication re-
initiation and to preserve genomic integrity. Three specific objectives were defined for this 
thesis: 
1. To study the contribution of APC/C
Cdh1
 activation after a prolonged HU-induced 
replication stress to preserve genomic integrity. 
2. To analyse the HU-induced changes at replication fork level in non-transformed 
human cells. 
3. To characterize the role of specific proteins present at replication forks in response to 
HU-induced replication stress.  
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CHAPTER 1 
LACK OF APC/CCDH1 ACTIVATION IN S PHASE AFTER A SEVERE 
REPLICATION STRESS ALLOWS RESUMPTION OF DNA SYNTHESIS      
IN TUMOUR CELLS 
 
 
 
 
 
The results presented in this chapter have been obtained  
working in collaboration with Amaia Ercilla, PhD,  
 and they were published in Ercilla et al., NAR, 2016. 
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PREVIOUS DATA 
LOSS OF REPLICATION RECOVERY COMPETENCE IN RESPONSE TO A PROLONGED REPLICATION 
INHIBITION IS APC/CCDH1- DEPENDENT IN hTERT-RPE CELLS 
During DNA replication, cells are susceptible to acquire DNA damage and chromosomal 
instability, a hallmark of cancer 
511
. Therefore, cells have developed several mechanisms or 
checkpoints to ensure the proper completion of each cell cycle phase and coordinate DNA 
repair pathways 
9,254,256
.  Increasing evidences indicate that oncogene overexpression causes 
replication stress in non-transformed human cells, inducing DNA damage and oncogene-
induced senescence (OIS) 
515,537,538
. In this regard, our group has focused on the analysis and 
characterization of the replication stress response 
219
 induced by HU in non-transformed 
human cells, to understand the alterations that tumour cells suffer to bypass OIS.  
Previous results of our group showed that upon prolonged replication stress (10mM of HU for 
14 hours), the resumption of DNA replication and mitotic entry were both compromised in 
non-transformed human cells. By contrast, cells were able to recover replication and entry 
into mitosis after an acute replication stress (10mM of HU for 2 hours). The used model was 
hTERT-RPE cell line, a human retinal pigment epithelial cells line immortalized with hTERT 
(Figure 15). 
 
Figure 15. Replication resumption and mitotic entry are compromised after a prolonged replication 
stress in hTERT-RPE cells. Cells were pulse-labelled with BrdU for 30 minutes and then treated with 
10mM HU for the indicated times or left untreated (control). After HU treatment, cells were released 
into nocodazole-containing media for 24 hours. The average percentage of BrdU positive cells that 
remain in S phase (left panel) or that enter into mitosis (right panel) after HU release are shown in the 
graphs. Error bars represent standard deviation (paired t-test, n=6).  
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Cyclin A2 and Cyclin B1, which are important for cell-cycle progression 
3
, were accumulated 
during an unperturbed S-phase (data not shown), but their levels decreased in response to a 
prolonged HU treatment, although cells were arrested in S-phase. The decrease in cyclins 
levels, which started after 12 hours of HU treatment, correlated with the loss of replication 
recovery competence (Figure 16A). This decrease was due to APC/C
Cdh1
-dependent 
degradation, since Cdh1 depletion restored their levels. Moreover, the levels obtained with 
Cdh1 depletion were the same as the obtained with the addition of MG132 proteome 
inhibitor, indicating that this ubiquitin ligase was the one responsible for their degradation 
(Figure 16B). Furthermore, we showed that APC/C
Cdh1
 activation was at least in part 
responsible for the S phase arrest observed after a prolonged HU treatment, since Cdh1 
depletion significantly rescued replication recovery competence after 14 hours of HU 
treatment (Figure 16C). 
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Figure 16. Replication recovery competence is lost in response to a prolonged HU treatment due to 
APC/C
Cdh1 
activation in hTERT-RPE cells. (A) S-phase synchronized hTERT-RPE cells were treated during 
the indicated times with 10mM HU or left untreated (Cs) and then harvested for Western Blot (WB) 
analysis (bottom panel) or released into nocodazole-containing fresh media for 24 hours. DNA content 
was used to determine the number of cells that remained in S-phase after HU release (upper panel, 
paired t-test, n=4; ** P value < 0.01, **** P value < 0.0001). (B) hTERT-RPE cells were transfected with 
the indicated siRNA and then synchronized in S phase before HU treatment. Cells were harvested during 
the indicated times and harvested for WB analysis. MG132 (MG) was added during the last 6h of 
treatment where indicated. GAP120 and CDK4 were used as a loading control. (C) hTERT-RPE transfected 
cells were synchronized in S phase and treated during 14 hours with HU and then released into 
nocodazole-containing media during 24 hours. DNA content was analysed by flow cytometry to quantify 
the number of cells that remain arrested in S phase after HU release. Means and standard deviation 
(bars) of the fold increase relative to non-target (NT) siRNA are shown in the graph (unpaired t-test, *** 
P value < 0.001). Cyc: Cyclin. 
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Consistently, the levels of Emi1, an APC/C inhibitor that is implicated in the regulation of this 
ubiquitin ligase during a normal cell cycle 
73,76,77,539,540
, decrease upon a prolonged HU 
replication stress, correlating with the timing of APC/C
Cdh1
 activation in hTERT-RPE cells (Figure 
17). 
 
Figure 17. APC/C
Cdh1
 activation correlates with a decrease in Emi1 levels in response to HU treatment. 
hTERT-RPE cells were synchronized in S phase and then treated with 10mM HU during the indicated 
times or left untreated (Cs). Whole cell lysates were analysed by WB with the indicated antibodies. 
GAP120 was used as a loading control.  
 
APC/CCDH1 INHIBITS NEW ORIGIN FIRING IN S PHASE AFTER A PROLONGED REPLICATION STRESS 
IN hTERT-RPE CELLS 
Once it was determined that the capacity of replication recovery was lost after a prolonged HU 
treatment, due to the APC/C
Cdh1
 activation in S-phase, we used DNA fiber assay to analyse the 
effect of Cdh1 depletion in replication recovery. To do so, hTERT-RPE cells were labelled with 
CldU for 30 minutes, then treated with 10mM of HU (a dose of HU which completely stalls 
replication forks) during 2 hours or 14 hours, and finally cells were labelled with IdU for 1 hour 
more.  
A 14 hours of HU treatment caused a decrease in the number of restarted forks and a 
concomitant increase in the number of stalled forks, both in non-target and Cdh1 siRNA 
transfected cells. Interestingly, Cdh1 depletion strongly increased new origin firing events after 
prolonged HU treatment, suggesting that a deficient origin firing was causing the loss of 
replication recovery competence in hTERT-RPE cells (Figure 18). 
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On the other hand, after an acute replication stress, where it had been demonstrated that 
cells were able to recover replication and entry into mitosis (Figure 15), and APC/C
Cdh1 
was not 
activated yet (Figure 16), replication forks restarted after HU release (Figure 18). 
 
Figure 18. APC/C
Cdh1
 inhibits new origin firing in S phase after a prolonged HU treatment in hTERT-RPE 
cells. Cells were transfected with the indicated siRNA and synchronized in S phase before DNA fiber 
labelling. Then cells were treated with 10mM HU during the times indicated or left untreated (control). 
The percentage of replication fork restart (upper-left panel), stalled forks (upper-right panel) and new 
origin firing events (bottom-left panel) relative to total CldU (first labelling) is shown in the graphs. More 
than 1000 fibers from three independent experiments were counted in each condition. Means and 
standard deviation (bars) are shown (paired t-test, n.s.: non-statistically significant, * P value < 0.05, ** P 
value < 0.01). S-phase synchronized untreated cells were harvested for WB analysis, with the indicated 
antibodies (bottom-right panel).  
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RESULTS 
1.1. TUMOUR CELL LINES ARE PREDOMINANTLY DEFICIENT IN APC/CCDH1 ACTIVATION IN S 
PHASE AND ARE ABLE TO RESUME REPLICATION IN RESPONSE TO A PROLONGED HU 
TREATMENT 
To analyse the contribution of APC/C
Cdh1
 activation towards preservation of genomic integrity, 
we studied the effect of replication inhibition on cells that, in contrast to hTERT-RPE cells 
536
, 
did not activate APC/C
Cdh1 
in response to a prolonged HU treatment. To this end, a panel of 
tumour cell lines, which presents a less robust replication checkpoint response 
541,542
, was 
analysed in order to evaluate if this mechanism was activated in response to a prolonged 
replication stress. 
 
Figure 19. Tumour cell lines are predominantly deficient in APC/C
Cdh1
 activation in S-phase in response 
to a prolonged HU treatment. Human tumour cell lines were synchronized in S phase by single thymidine 
block and then treated with 10mM HU during the indicated time or left untreated (Cs). Whole cell 
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extracts were prepared and analysed by WB with the indicated antibodies. MG132 (MG) was added 
during the last 6 hours of treatment in the case of 14h MG or during the last 10 hours of treatment in the 
case of 24h MG. The panel of cell tumour cell lines included human cervix epithelial cancer cells (HeLa), 
colorectal cancer cells (DLD-1, HT29, HCT116), breast cancer cells (MCF7), squamous cancer cells (A431), 
pancreatic cancer cells (HPAF-II, SW1990) and osteosarcoma cells (U2OS). Cyc: cyclins. 
 
Interestingly, as shown in Figure 19, from all the analysed cell lines, only one, MCF7, activated 
APC/C
Cdh1 
in response to a prolonged HU treatment, as shown by Cyclin A2 and Cyclin B1 
degradation, and their correct protein levels recovery when MG132 (proteasome inhibitor) 
was added. In conclusion, tumour cell lines are predominantly deficient in APC/C
Cdh1
 activation 
after a prolonged HU treatment. 
We next wondered if these tumour cell lines were able to resume replication after a severe 
replication stress. To this end, tumour cells were pulse-labelled with BrdU during 30 minutes in 
order to mark cells in S phase. Then, cells were treated with 10mM of HU during 14 hours and, 
after treatment, they were released into nocodazole-containing media for 12 hours. After that, 
cells were collected and analysed by flow cytometry in order to evaluate S-phase resumption 
after HU release.  
In accordance with our previous results, the correlation between APC/C
Cdh1
 activation and loss 
of replication recovery was supported by these results in tumour cell lines, since most of them 
did not activate APC/C
Cdh1
 after a prolonged HU treatment, and six of these nine cell lines were 
able to reinitiate replication when they were released from this replication stress (Figure 20). 
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Figure 20. Tumour cells lines are predominantly able to resume replication after a prolonged HU 
treatment. Asynchronously growing cells were pulse labelled for 30 minutes with BrdU and then treated 
with 10mM HU for 14 hours. Cells were finally released into nocodazole-containing fresh media during 12 
hours (24 hours in the case of hTERT-RPE cells). The labelling and treatment protocol was shown (upper 
panel). DNA content (PI staining) of BrdU positive population was analysed by flow cytometry to quantify 
the average percentage of BrdU positive cells that remain arrested in S phase after release (normalized 
by untreated (control) cells) is shown in the graph (n=3). Means and standard deviation (bars) are shown 
(paired t-test, n.s.: non-statistically significant, * P value < 0.05, ** P value < 0.01). 
 
1.2. NEW ORIGIN FIRING CONTRIBUTES TO REPLICATION RECOVERY IN HCT116 CELLS AFTER A 
PROLONGED HU TREATMENT 
We already knew that the activation of APC/C
Cdh1
 in S phase inhibited origin firing in hTERT-
RPE cells, which prevented replication recovery in those cells. Thus, we decided to analyse 
replication dynamics after a prolonged HU treatment in a previously analysed tumour cell line, 
which did not activate APC/C
Cdh1
 and resumed DNA replication after replication stress release. 
To this end, we chose HCT116 cell line. 
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Figure 21. HCT116 cell line activates new origin firing after a prolonged HU treatment. S-phase 
synchronized (by single thymidine block) HCT116 cells were treated as indicated and then DNA fibers 
were prepared and labelled with anti-BrdU antibodies. A scheme of the labelling protocol is shown 
(upper panel). Representative images are shown (middle panel). The percentage of replication fork 
restart, stalled replication forks and new origin firing events relative to total CldU labelled fibers are 
shown in the graphs (bottom panel). At least 1500 fibers from three independent experiments were 
counted in each condition. Means and standard deviation (bars) are shown (paired t-test, n.s.: non-
statistically significant, ** P value < 0.01, *** P value < 0.001). 
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The CldU analogue was maintained in the media during the first 15 minutes of HU treatment, 
since it was the time needed to completely stall replication forks 
536
. The second labelling 
period was longer since replication forks needed some time to recover replication after HU 
release.  
DNA fiber assay allows us to discern different replication dynamics after replication inhibition 
caused by HU 
243
: restarting forks are represented by replication tracks that have incorporated 
both analogues, stalled forks correspond to CldU only tracks, and new origin firing events 
correspond to IdU only tracks 
543
.   
As shown in Figure 21, HCT116 cells resume replication mainly by restarting replication forks 
after an acute replication stress (10mM HU during 2 hours), as hTERT-RPE cells (shown in 
Figure 18). By contrast, after a prolonged replication stress (10mM HU during 14 hours), there 
was a defect in fork restart, observed by a decrease in the number of restarted forks and a 
concomitant increase in the number of stalled forks. In contrast to what happened in hTERT-
RPE cells, replication restart defect was mainly compensated by increasing the number of new 
origin firing events (Figure 21).  
 
1.3. HCT116 CELLS ACQUIRE GENOMIC INSTABILITY AFTER A PROLONGED HU TREATMENT 
To analyse the role of APC/C
Cdh1
 activation in S phase in preventing genomic instability, we first 
analysed the capacity of HCT116 cells to resume cell cycle and proliferate once released from a 
prolonged replication stress. To this end, colony formation assays were performed. The results 
indicated that HCT116 cell line maintained the ability to resume replication when stress was 
removed, and that those cells were able to proliferate and form colonies, in sharp contrast to 
what happened in hTERT-RPE cells (Figure 22). 
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Figure 22. HCT116 cells maintain the competence to recover from a prolonged HU treatment. HCT116 
and hTERT-RPE cells were synchronized in S phase and then treated during 14 hours with 10mM HU or 
left untreated (control, not shown). Cells were then released into fresh media for 12 hours and diluted 
(250 cells per well on 6-well plates) for colony formation assay. Colonies were harvested 8 days later. The 
average percentage of colonies in HU-treated relative to control was calculated in each case. Means and 
standard deviation (bars) from three independent experiments are shown (unpaired t-test, * P value < 
0.05) 
 
Then, we analysed the acquisition of DNA damage or genomic instability, as measured by the 
presence of G1 cells (analysed by Cyclin D1 positive cells) with 53BP1 foci 
544–546
 and of cells 
presenting micronuclei 
547
. Interestingly, after a prolonged HU treatment, HCT116 cells were 
able to reach the next G1 phase with damage, since there was an increase in the percentage of 
cells with 53BP1 foci in the next G1 and an increase in the number of cells presenting 
micronuclei (Figure 23). 
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Figure 23. HCT116 cells acquire genomic instability after a prolonged HU treatment. Cells were 
synchronized in S phase by single thymidine block, treated with HU during 14 hours or left untreated and 
then released (R) into fresh media during 12 hours, after which cells were fixed and immunostained with 
53BP1 and Cyclin D1 antibodies. Representative images (A, left panel) and the average percentage of 
cells with more than six 53BP1 foci from G1 (Cyclin D1 positive) population (A, right panel) from three 
independent experiments are shown. DNA was counterstained with DAPI to analyse the presence of 
micronuclei. A representative image (B, upper panel) and the average percentage of cells with 
micronuclei (B, bottom panel) of three representative experiments are shown. Means and standard 
deviation (bars) are shown. Values marked with asterisks are statistically significant (paired t-test * P 
value < 0.05). 
 
 
%
 5
3
B
P
1
/
G
1
 p
o
s
it
iv
e
 c
e
ll
s
re
la
ti
v
e
 t
o
 G
1
 t
o
ta
l 
c
e
ll
s
C s + R 1 4 H U + R
0
1 0
2 0
3 0
4 0
*
%
 o
f 
ce
lls
 w
it
h
 5
3
B
P
1
 f
o
ci
 in
 G
1
 
(r
el
at
iv
e 
to
 t
o
ta
l G
1
 c
el
ls
) 
14h HU + R Cs + R 
%
 o
f 
c
e
ll
s
 w
it
h
 m
ic
ro
n
u
c
le
u
s
C s + R 1 4 H U + R
0
2
4
6
8
*
%
 o
f 
ce
lls
 w
it
h
 
m
ic
ro
n
u
cl
ei
 
14h HU + R Cs + R 
B 
A 
HCT116 
14h HU + R 
M
ic
ro
n
u
cl
eu
s 
Cs + R 14h HU + R 
M
er
ge
 
C
yc
D
1
 
5
3
B
P
1
 
HCT116 
LACK OF APC/C
CDH1 
ACTIVATION IN S PHASE AFTER A SEVERE REPLICATION STRESS 
 
 
97 
 
1.4. EMI1 DEPLETION-INDUCED APC/CCDH1 ACTIVATION COMPROMISES REPLICATION 
RESUMPTION AND GENOMIC INSTABILITY ACQUISITION IN HCT116 CELLS 
The previous results showed the correlation between APC/C
Cdh1
 activation and the loss of 
replication recovery after a prolonged replication stress. To analyse the influence of S-phase 
arrest on the maintenance of genomic integrity, we decided to activate APC/C
Cdh1
 artificially in 
HCT116 cells and analyse genomic instability.  
Emi1 depletion had been reported to be enough to induce APC/C
Cdh1
 activation 
76,548,549
. 
Consistently, Emi1 depletion, after thymidine synchronization, induced an artificial APC/C
Cdh1
 
activation in S phase (shown by Cyclin A2 and Cyclin B1 degradation) in HCT116 cells (Figure 
24). Moreover, this activation compromised the ability to resume replication after a prolonged 
HU treatment, as shown by an increase of cells remaining in S phase after HU release (Figure 
24). 
 
  
 
 
 
 
Figure 24. Emi1 depletion activates APC/C
Cdh1
 in S phase and revokes replication resumption in HCT116 
cells. HCT116 cells were transfected with the indicated siRNA and 4 hours later (Ct), thymidine was 
added to synchronize the cells in S phase during 20-24 hours. Then cells were released from thymidine 
and treated with 10mM HU during the indicated time or left untreated (Cs). Whole cell extracts were 
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prepared and analysed by WB with the indicated antibodies (upper panel). After 14 hours of HU 
treatment, cells were released into nocodazole-containing fresh media during 12 hours. DNA content (PI: 
propidium iodide) was analysed by flow cytometry. The histograms were overlaid matching the 
maximum point (bottom-left). Means and standard deviation (bars) of S-phase arrested cells (relative to 
NT siRNA) from three independent experiments are shown (bottom panel, unpaired t-test, ** P value < 
0.01). 
 
Then, we analysed the acquisition of DNA damage or genomic instability, as measured by the 
presence of G1 cells (analysed by Cyclin D1 positive population) with 53BP1 foci 
544–546
 and of 
cells presenting micronuclei 
547
 in Emi1-depleted cells after a release from a prolonged 
replication stress. Interestingly, Emi1 depletion resulted in a decrease in the number of cells 
with 53BP1 foci in the next G1 phase, and also a decrease in the number of cells presenting 
micronuclei under those conditions (Figure 25). 
 
Figure 25. Emi1 depletion contributes to safeguard genomic stability in HCT116 cells. Cells were 
transfected with the indicated siRNA and 4 hours later, thymidine was added to synchronize the cells in S 
phase. Cells were treated with 10mM HU during the 14 hours and then cells were released into fresh 
media during 12 hours, and finally immunostained for 53BP1 and Cyclin D1 analysis. DNA was 
counterstained with DAPI. The average percentage of cells with more than six 53BP1 foci in G1 (left 
panel) and the average percentage of cells with micronuclei (right panel) relative to NT siRNA from three 
independent experiments are shown. Error bars represent standard deviation. Values marked with 
asterisks are statistically significant (unpaired t-test, * P value < 0.05, ** P value < 0.01). 
 
Moreover, the capacity of Emi1-depleted cells to divide and proliferate in a long term after a 
prolonged replication stress was analysed by colony formation assay. The results showed that 
HU treatment or Emi1 depletion decreased the capacity of colony formation, and the decrease 
was even more pronounced when both conditions occurred at the same time (Figure 26).  
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Figure 26. Emi1 depletion compromises colony formation capacity in HCT116 cells. Cells were 
transfected with the indicated siRNA and 4 hours later, cells were treated with 10mM HU during 14 
hours or left untreated (control). 12 hours later, cells were diluted and seeded at 250 cells per well (6-
well plates). After incubation for 8 days, cells were harvested and stained to visualize the number of 
colonies in each condition. Number of colonies relative to NT siRNA control of four independent 
experiments is shown in the graph. Means and standard deviation (bars) are shown. Values marked with 
asterisks are statistically significant (unpaired t-test, * P value < 0.05, ** P value < 0.01, **** P value < 
0.0001). 
 
 
Collectively, all the data presented in this chapter support the idea that the activation of 
APC/C
Cdh1
 in S phase compromises the ability to resume replication and
 
contributes to 
safeguard genome integrity after a prolonged replication stress. Additionally, our results 
indicate that tumour cells have developed mechanisms to avoid APC/C
Cdh1
 activation upon a 
prolonged replication stress, and consequently these cells are able to resume replication 
despite acquiring more genomic instability.  
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CHAPTER 2 
FORK REMODELLING AFTER AN ACUTE  
HU-INDUCED REPLICATION STRESS  
 
 
 
 
 
The results presented in this chapter have been obtained  
working in collaboration with Amaia Ercilla, PhD. 
The results shown in the previous data section are comprised  
at Amaia Ercilla’s PhD thesis.  
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PREVIOUS DATA 
REPLISOME IS DISENGAGED FROM NASCENT DNA UPON AN ACUTE HU TREATMENT, BUT 
MAINTAINS ITS ASSOCIATION WITH CHROMATIN IN hTERT-RPE CELLS 
With the aim to characterize HU-induced replication stress changes at replication fork level in 
non-transformed human cells, an isolation of proteins present on nascent DNA (iPOND), of 
hTERT-RPE cells, was performed after an acute (2 hours) or a prolonged (14 hours) HU 
treatment, using a dose (10mM) that completely stalls replication forks. The iPOND technique 
allows the isolation of protein complexes crosslinked to EdU thymidine analogue-containing 
fragments that are located at active replication forks 
550–552
.  This experiment was performed in 
collaboration with Sergi Aranda, PhD, and Prof. Patrik Ernfors, PhD. As expected, the iPOND 
experiment showed that most of the replisome components were enriched at nascent DNA in 
the pulse and 15’EdU/HU conditions, both in MS and in WB analysis (Figure 27). Surprisingly, 
the results showed that replisome components were displaced away from nascent DNA after 
an acute replication stress induced by HU (Figure 27), but they remained associated to 
chromatin under this condition (Figure 28). Remarkably, proteins involved in maintaining fork 
stability and promoting their restart, such as RAD51, FANCD2 and SMC1/3 cohesins 
329,330,476,479,553
, increased their presence in nascent DNA after an acute replication stress 
(Figure 27).  
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Figure 27. Replisome components are dissociated from nascent DNA after an acute replication stress in 
hTERT-RPE cells. Cells were synchronized in S phase and then treated as indicated. (A) The protein ID of 
the replisome components and the DNA repair-related proteins identified in the iPOND-MS experiment 
and their normalized relative abundance in each condition are represented. (B) The proteins present in 
iPOND extracts were analysed by WB with the indicated antibodies. Input: nuclear extract. Histone 3 (H3) 
was used as a control of immunoprecipitation. l.e.: long exposure. s.e.: short exposure. (-): negative 
control, without EdU. Pulse: 15 minutes of EdU. 15’EdU/HU: 15 minutes of EdU and the first 15 minutes 
of 10mM HU treatment with EdU in the media (time needed to completely stall replication forks). Chase: 
pulse followed by 2 hours with low dose of thymidine (50µM).  
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Figure 28. Replisome components are associated with chromatin after an acute replication stress in 
hTERT-RPE cells. Cells were synchronized in S phase and then treated during the indicated time with 
10mM of HU or left untreated (Cs). Chromatin extracts were prepared and analysed by WB with the 
indicated antibodies. Input: whole cell lysates. Lamin B1, MCM6 and Histone 3 (H3) were used as a 
loading control. 
 
REVERSED REPLICATION FORKS ARE PRESENT AFTER AN ACUTE REPLICATION STRESS IN hTERT-
RPE CELLS 
The fact that replisome components were not associated to nascent DNA but they remained 
associated to chromatin after an acute HU treatment make us wondered whether the 
replication forks might be reversed. To test this, the formation of these structures was 
analysed indirectly under those conditions. BrdU immunofluorescence under native conditions 
has been described to be a sensitive and quick in situ method to analyse the accumulation of 
single-stranded DNA (ssDNA) 
554
. Reversed forks expose a fragment of ssDNA on the 3’ end of 
leading strand, due to DNA2 degradation of reversed forks with a 5’-to-3’ polarity in the 
lagging strand and forming a newly 3’ overhang in the leading one 
482
. This formed ssDNA can 
be detected by BrdU antibodies under nondenaturing conditions, if nascent DNA was 
previously labelled for 10 minutes with BrdU analogue 
337,470
.    
DSBs could interfere with this assay but our group had already validated that replication forks 
were not processed into DSBs after an acute replication stress (data not shown). Thus, the 
presence of single-stranded nascent DNA might most likely be due to fork reversal.  
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The results of this experiment showed that hTERT-RPE cells presented an increase in single-
stranded nascent DNA after an acute replication stress, which was more pronounced upon 
severe replication stress (Figure 29). Notably, replication forks are processed into DSBs (data 
not shown) explaining the increase in native BrdU levels upon 14h HU treatment. 
 
Figure 29. Acute replication stress generates single-stranded nascent DNA in hTERT-RPE cells. Cells 
synchronized in S phase were labelled for 10 minutes with BrdU and treated with 10mM HU during the 
indicated time before performing BrdU immunofluorescence under native conditions. BrdU analogue 
was maintained in the media during the first 15 minutes of HU treatment. The relative native BrdU 
intensities (in arbitrary units (a.u.)), of more than 700 cells from four independent experiments were 
measured in each condition. Box and whiskers show: min, max, median and first quartiles (unpaired t-
test, **** P value < 0.0001). 
 
Consistent with the accumulation of single-stranded nascent DNA observed in Figure 29, we 
observed an increase in the chromatin-bound RPA levels upon an acute HU treatment (Figure 
28). 
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STALLED REPLICATION FORKS ARE ABLE TO RESTART AFTER AN ACUTE REPLICATION STRESS 
WITHOUT COMPROMISING GENOMIC INTEGRITY IN hTERT-RPE CELLS 
As explained in previous results of chapter 1, replication forks of hTERT-RPE cells are able to 
restart after an acute, but not a prolonged HU treatment (Figure 18). At this point, it was 
already known that replisome components were displaced away from nascent DNA, but they 
maintained their association with chromatin. Our group next wondered if the previously 
observed restart 
536
 was due to the activation of nearby origins that could not be distinguished 
in the fiber assay 
135
 or if the previously formed CMG complexes were reused to resume 
replication. Thus, to study the real fork restarting, a DNA fiber assay was performed using 
roscovitine, a CDK inhibitor 
555
, to inhibit CDK2-mediated phosphorylations of replisome 
components, essential for origin firing 
156,173,174
. The efficiency of roscovitine was corroborated 
by the reduction in the number of new origins and the shortening of IdU track length (data not 
shown), due to  the previously described role of CDKs in fork progression 
556
. Remarkably, the 
number of restarted forks was maintained despite roscovitine addition after an acute 
replication stress in hTERT-RPE cells, indicating that restart was not due to nearby fired origins 
(Figure 30). 
 
Figure 30. Replication forks are able to restart after an acute replication stress in the absence of CDK 
activity in hTERT-RPE cells. Asynchronously cells were labelled with CldU for 30 minutes, then cells were 
treated with 10mM of HU in the presence or absence of roscovitine for 2 hours. CldU was maintained in 
the media during the first 15 minutes of HU treatment. Finally, cells were incubated with IdU in the 
presence or absence of roscovitine for 1 hour more. DNA fibers were prepared and stained with BrdU 
antibodies. Around 1500 fibers from three independent experiments were counted in each condition.  
The percentage of stalled and restarted forks and new origin firing events, relative to total CldU labelled 
fibers, are shown. Error bars represent standard deviation (paired t-test, n.s.: non-statistically significant, 
* P value < 0.05). 
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The results from the presence of single-stranded nascent DNA suggested that replication forks 
could be reversed after acute HU treatment and that replication was restarted from the same 
forks. The group had already demonstrated that cells were able to recover replication and 
arrive in mitosis after an acute replication stress induced by 10mM of HU treatment 
536
 
(previous data in chapter 1, Figure 15). The possible acquisition of genomic instability under 
those conditions was studied by analysing the number of cells with 53BP1 foci in the next G1 
phase 
544–546
. Notably, the percentage of G1 cells with 53BP1 foci did not significantly increase 
upon a release from acute HU treatment (data not shown). These results support the idea that 
replication restart from reversed forks does not compromise genomic integrity. 
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RESULTS 
2.1. CMG HELICASE MAINTAINS ITS INTEGRITY AND ASSOCIATION WITH CHROMATIN AFTER 
AN ACUTE REPLICATION STRESS IN hTERT-RPE CELLS 
From previous data, we already knew that CMG was disengaged from nascent DNA. This raised 
the question of how replication forks restarted after an acute replication stress, since the 
assembly of new origins is restricted to G1 phase of the cell cycle, and the activation of new 
origins is impaired under HU conditions, due to the need of CDK activity to fire the pre-
replicative complexes 
187,557
 and the fact that CDK is inhibited under these conditions 
34,558–561
.  
Since we had already demonstrated that replisome components preserved their association 
with chromatin, we wanted to analyse the integrity of CMG complex under this condition. We 
performed a co-immunoprecipitation experiment of MCM3 which demonstrated that the 
integrity of CMG complex in chromatin was maintained upon an acute HU treatment (Figure 
31).  
 
Figure 31. CMG helicase maintains its integrity after an acute HU treatment in hTERT-RPE cells. S-phase 
synchronized cells were treated with 10mM HU during 2 hours or left untreated (Cs). Chromatin fractions 
were incubated with antibodies against MCM3 or non-specific IgG. Protein immunocomplexes were 
pulled down and analysed by WB with the indicated antibodies.  
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2.2. CMG HELICASE IS DISENGAGED FROM NASCENT DNA AFTER AN ACUTE REPLICATION 
STRESS INDIFFERENTLY OF CDK ACTIVITY IN hTERT-RPE CELLS 
Our previous results showed that replication forks could restart upon acute HU treatment, 
even when CMG complex was disengaged. To prove that the observed restart was real and not 
an artifice due to dormant origins activation, we added CDK inhibitor, roscovitine, during DNA 
synthesis reinitiation and we checked that a real restart was observed under these conditions 
(Figure 30).  
We next wondered if in CDK inhibition conditions, replication forks could be stabilized, and 
replisome components could not be disengaged from nascent DNA after an acute replication 
stress. To analyse it, we performed the iPOND technique to corroborate that CDK inhibition 
did not alter the changes that we observed upon acute HU treatment in replication forks and 
that CMG complex was still disengaged from nascent DNA.  
The results in Figure 32 showed that the helicase complex was displaced away from nascent 
DNA upon HU treatment in hTERT-RPE cells, even in the absence of CDK activity. The efficiency 
of roscovitine was corroborated by the reduction of CMG complex in control condition (pulse 
condition with roscovitine) due to the impairment of firing new origins. 
 
Figure 32. CMG complex is disengaged from nascent DNA upon HU treatment even in the absence of 
CDK activity in hTERT-RPE cells. S-phase synchronized cells were treated and harvested for iPOND. 
Roscovitine was added where indicated. The proteins present on iPOND extracts were analysed by WB 
with the indicated antibodies. (-): no EdU. Input: nuclear extract. Histone 3 (H3) was used as an 
immunoprecipitation control. Notice that, as expected, roscovitine addition before the EdU pulse 
compromised EdU incorporation and, thus, protein immunoprecipitation by iPOND.  
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2.3. FBH1 DEPLETION REDUCES THE AMOUNT OF SINGLE-STRANDED NASCENT DNA, BUT 
DOES NOT IMPAIR REPLICATION FORK RESTART IN hTERT-RPE CELLS 
The previous results indicated that replication forks were remodelled after an acute 
replication stress, and seemed to point out that, after 2 hours of HU treatment, replication 
forks were regressed into chicken foot structures 
462,562,563
. To study this, we focused on FBH1, 
since it was the unique helicase that had been demonstrated to have the capacity to promote 
fork reversal in vivo 
470
 at the time these experiments were performed. Since then, several 
other replication fork remodellers have been proposed to have a role on fork reversal, as 
RAD51 
462
, SMARCAL1 
335,339
, polyUB-PCNA and ZRANB3 
473
 or HLTF 
469,564
.  
We analysed if the increase in single-stranded nascent DNA after an acute HU treatment 
(Figure 29) was due to FBH1-dependent fork reversal. To this end, the analysis of ssDNA 
accumulation in the nascent DNA by native BrdU staining 
337
 was performed in FBH1-depleted 
cells.  
The results of this experiment showed an increase in nascent ssDNA upon acute HU 
treatment, which decreased upon FBH1 depletion (Figure 33). This indicates that replication 
stress induced by an acute HU treatment leads to fork reversal in hTERT-RPE cells, with FBH1 
playing a role in this process. However, even though FBH1 depletion decreases the amount of 
single-stranded nascent DNA, native BrdU intensity is still higher than control conditions 
(Figure 33). Thus, it has to be considered that fork reversal could be performed by other 
remodellers. On the other hand, this ssDNA analysis is an indirect method to analyse fork 
reversal and changes in the presence of ssDNA could be explained by other processes, such as 
resection. 
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Figure 33. FBH1 depletion decreases nascent ssDNA upon acute HU treatment in hTERT-RPE cells. Cells 
were transfected with the indicated siRNA (NT: non-target) and then synchronized in S phase. After that, 
cells were labelled for 10 minutes with BrdU and treated with 10mM HU during 2 hours (maintaining 
BrdU during the first 15 minutes) before performing BrdU immunofluorescence under native conditions. 
If forks are reversed as indicated, BrdU antibody can label the ssDNA present on the 3’ end of the leading 
strand (indicated in green in the upper panel). DNA was counterstained with PI. Representative images 
are shown (middle panel). The relative BrdU intensities (in arbitrary units (a.u.)) of more than 600 cells 
was measured in each condition. Box and whiskers show: min, max, median and first quartiles (bottom-
left panel, unpaired t-test, **** P value < 0.0001). In parallel, whole cells extracts were analysed by WB 
with the indicated antibodies (bottom-right panel). Vinculin was used as loading control. The WB was 
performed by Sólveig Hlín Brynjólfsdóttir, PhD (in the laboratory of Prof. Claus Storgaard Sørensen, PhD). 
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Initially, the reversed forks were associated with the accumulation of toxic intermediates 
278,496,562,565,566
, but more recently it is being considered whether fork reversal may have a 
protective role, safeguarding genome integrity 
334
. Furthermore, replication restart from 
reversed forks has been described 
481,482,567
. Thus, considering that fork reversal could have a 
protective role, we next wondered if FBH1 depletion could have an effect on replication fork 
restart after an acute HU treatment. We analysed this hypothesis by DNA fiber assay and, in 
order to study the real fork restart, we performed the experiment using roscovitine
555
. 
Interestingly, the number of restarted forks was maintained despite FBH1 depletion after an 
acute replication stress in hTERT-RPE cells, indicating that restart was maintained in conditions 
where the number of reversed forks had decreased (Figure 34). 
 
Figure 34. FBH1 depletion does not impair replication fork restart after an acute HU treatment in 
hTERT-RPE cells. Cells transfected with the indicated siRNA (NT: non-target) were labelled as indicated 
(upper-left panel) and DNA fibers were prepared and stained with anti-BrdU antibodies. Representative 
images are shown (upper-right panel). At least 300 fibers were counted in each condition for each 
experiment. The percentage of stalled and restarted forks and new origin firing events, relative to total 
forks, of two independent experiments are shown. Error bars represent standard deviation (bottom 
panel). The knockdown was shown in Figure 33.   
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Next, we wondered if the cells, whose replication forks restarted after an acute replication 
stress without being reversed, could resume cell cycle and arrive into mitosis. To answer this 
question, cells in S phase were pulse-labelled with a BrdU pulse for 30 minutes; then they 
were treated with HU during 2 hours and released from the stress into nocodazole-containing 
medium. After 12 hours of release, cells were harvested, and cell cycle was analysed by cell 
cytometer.   
 
Figure 35. FBH1 depletion does not impair mitotic entry after an acute HU treatment in hTERT-RPE 
cells. Cells were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells were 
labelled with BrdU and then treated with 10mM HU or left untreated (12h release) for 12 hours, and 
then released into nocodazole-containing fresh medium for 12 hours. Flow cytometry analysis of 
approximately 15000 cells was performed to analyse the S-phase arrested (BrdU-488 positive) cells after 
12 hours of HU treatment, and the recovery from this stress measuring mitotic (MPM2-647 positive) cells 
from BrdU positive population. The experiment was performed once under those conditions (we 
performed the experiment with different times of HU treatment and the results were the same). The 
knockdown was shown in Figure 33.   
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The results above show that FBH1-depleted cells resumed replication after an acute 
replication stress could arrive into G2-M phases and entered into mitosis, even in a higher 
percentage than cells treated with non-targeted siRNA (Figure 35). 
All these results indicate that even though fork reversal was impaired by FBH1 depletion, the 
cells could restart replication forks, resume cell cycle and enter into mitosis without 
impairment.  
 
2.4. REPLISOME DISENGAGEMENT FROM NASCENT DNA CORRELATES WITH LARGE AMOUNTS 
OF SINGLE-STRANDED PARENTAL DNA AND RPA ACCUMULATION 
After having seen that despite the impairment of fork regression by FBH1 depletion, 
replication forks were able to restart, we wondered how these replication forks look like. 
It has been reported by Zellweger et al. that in human cells, especially in non-transformed 
hTERT-RPE cells, several genotoxic agents that interfere with DNA synthesis (such as HU) 
caused two types of fork-remodelling events: on the one hand a replication fork uncoupling 
between helicase and polymerases, and on the other hand, fork reversal, neither of them 
compromising fork integrity 
462
.  
At this point, we analysed if under our conditions, where reversed forks are present, the 
replication fork uncoupling was also produced. The functional uncoupling of helicases and 
polymerases is expected to cause an accumulation of large amounts of single-stranded 
parental DNA, while fork reversal generates accumulation of single-stranded nascent DNA 
(Figure 36). 
 
Figure 36. Fork remodelling events that generates ssDNA, that can be detected by BrdU 
immunofluorescence under native conditions. Asynchronously growing cells were labelled for 48 hours 
(parental) or 15 minutes (nascent) with BrdU. The presence of ssDNA is detected by BrdU 
immunofluorescence under native conditions. The BrdU-labelled DNA is indicated in light green and the 
ssDNA that is generated in each case is indicated in dark green. 
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We analysed if fork uncoupling was an event that could also occur upon acute HU treatment in 
hTERT-RPE cells. To determine this, we analysed the accumulation of ssDNA on parental 
strands and on nascent strands by quantitative image-based cytometry (QIBC)
239
.  
 
Figure 37. Acute HU treatment generates fork reversal and functional helicase-polymerases 
uncoupling. Asynchronously growing cells were labelled for 48 hours (parental ssDNA) or 15 minutes 
(nascent ssDNA) with BrdU and treated for the indicated time with 10mM HU or left untreated (C). For 
parental ssDNA detection, cells were released overnight in 10µM thymidine before HU treatment. For 
nascent ssDNA detection, BrdU was maintained in the media for the first 15 minutes of HU treatment. 
BrdU under native conditions was analysed by QIBC. Cells were counterstained with DAPI. The relative 
BrdU intensities (in arbitrary units (a.u.)) of at least 5000 cells were measured in each condition 
(unpaired t-test, **** P value < 0.0001). The experiment was performed in Centre for Chromosome 
Stability (CCS) by Amaia Ercilla, PhD. 
 
The results above show a slight increase in nascent ssDNA upon an acute HU treatment (also 
shown in Figure 29 and Figure 33), but they also reflect a much higher accumulation of ssDNA 
in parental strands under the same conditions (Figure 37), indicating that fork uncoupling is a 
predominant event also occurring upon acute HU treatment.  
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We already knew that upon an acute replication stress, large amounts of RPA bound to 
chromatin were accumulated (Figure 28). We wanted to determine if the increase in 
chromatin-bound RPA correlated better with an increase of parental ssDNA or of nascent 
ssDNA. The results showed that chromatin-bound RPA showed a better correlation with the 
amount of ssDNA detected by native BrdU staining in the parental strands, than with the 
amount of ssDNA in the nascent strands (Figure 38). 
 
Figure 38. Cells with more parental ssDNA have more chromatin-bound RPA after an acute HU 
treatment in hTERT-RPE. Asynchronously growing cells were labelled for 48 hours (parental ssDNA) or 15 
minutes (nascent ssDNA) with BrdU and treated for the indicated time with HU or left untreated 
(control). For parental ssDNA detection, cells were released overnight in 10µM thymidine before HU 
treatment. For nascent ssDNA detection, BrdU was maintained in the media for the first 15 minutes of 
HU treatment. BrdU under native conditions and chromatin-bound RPA were analysed by QIBC. Cells 
were counterstained with DAPI. The experiment was performed in Centre for Chromosome Stability (CCS) 
by Amaia Ercilla, PhD. 
 
2.5. NASCENT DNA IS NOT DEGRADED BY MRE11 AFTER AN ACUTE REPLICATION STRESS IN 
hTERT-RPE CELLS 
The results above indicated that the accumulation of ssDNA was more pronounced in the 
parental strands, suggesting that fork uncoupling was the predominant event. But ssDNA at 
parental DNA strands could result from resection of nascent DNA. Mre11-dependent 
degradation of nascent DNA has been well described 
335,476,495,568,569
. To discard that the 
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presence of ssDNA in the parental strands was due to nascent DNA degradation, we 
performed a DNA fiber assay, labelling the nascent DNA before acute HU treatment. When 
cells were treated with HU, in the presence of the second analogue, mirin, a Mre11 inhibitor, 
was also added in the indicated condition 
495,570
. If under this condition, nascent DNA would be 
degraded by Mre11, a decrease in the IdU track length would be obtained. This decrease 
should be rescued by the addition of mirin.  
The results of this experiment demonstrated that nascent DNA was not degraded by Mre11 
upon acute HU treatment, since no increase was obtained when mirin was added (Figure 39A). 
The condition of 14 hours of HU was used as a positive control for mirin, since we already 
knew that under this condition nascent DNA was degraded 
536
, and this experiment showed 
that the degradation is Mre11-dependent after a prolonged HU treatment (Figure 39B). 
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Figure 39. Nascent DNA is not degraded by Mre11 after an acute HU treatment in hTERT-RPE cells. (A) 
Asynchronously growing cells were labelled and treated as indicated (upper panel). DNA fibers were 
prepared and stained. Around 750 fibers were counted in each condition. IdU track length distribution 
and statistical analysis are shown. Scatter plot with mean and SD of a representative experiment is 
shown (bottom-left panel, Mann-Whitney test, n.s.: non-statistically significant). Column graph with 
mean and SD of different experiments is shown (bottom-right panel, paired t-test, n=4, n.s.: non-
statistically significant). (B) Cells were treated as in (A) and DNA fiber assay was performed in 14 hours of 
10mM HU treatment, to used is as a positive control for Mirin 
536
. Representative images are shown (left 
panel). Scatter plot with mean and SD of one experiment is shown (right panel, Mann-Whitney test, 
****P value < 0.0001). 
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2.6. REPLICATION RESUMPTION OCCURS WITHOUT LONG STRETCHES OF SINGLE-STRANDED 
PARENTAL DNA IN hTERT-RPE CELLS 
The information above indicates that, in line with previous reports 
462
, replication stress 
induced by HU can cause fork remodelling, both functional helicase-polymerases uncoupling 
and fork reversal, which does not compromises fork restart. It should be noticed that the 
amount of ssDNA in parental strands suggests that the most predominant event is fork 
uncoupling.  Moreover, our data suggest that replication forks restart from the same CMG 
complexes that have been disengaged from nascent DNA. To define how uncoupled forks 
could resume replication, we analysed the parental ssDNA disappearance and the chromatin-
bound RPA levels upon release from acute HU treatment. The results show that the amount of 
parental ssDNA decreases almost completely after 30 minutes of HU release (Figure 40A). 
Consistently, chromatid-bound RPA levels decrease to levels similar to the control after 30 
minutes to 1-hour release from acute HU treatment (Figure 40B). 
 
Figure 40. Parental ssDNA and chromatin-bound RPA levels decrease almost completely after 30 
minutes or 1 hour from HU release in hTERT-RPE cells. (A) Asynchronously growing cells were labelled 
for 48 hours with BrdU and released overnight in 10µM thymidine before 10mM HU treatment. After 
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that, cells were treated for 2 hours with 10mM HU and then released into fresh media for the indicated 
time. BrdU under native conditions was analysed by QIBC. Cells were counterstained with DAPI. The 
relative BrdU intensities (in arbitrary units (a.u.)) of at least 5000 cells were measured in each condition 
(unpaired t-test, relative to 2h HU, **** P value < 0.0001). The experiment was performed in Centre for 
Chromosome Stability (CCS) by Amaia Ercilla PhD. (B) Synchronic S-phase cells were treated with 10mM 
HU for 2 hours (-) or left untreated (Cs). After HU treatment, cells were released into fresh media for the 
indicated time. Chromatin-enriched fractions were obtained and analysed by WB with the indicated 
antibodies. Lamin B (LamB) was used as a loading control (upper panel). Quantification of chromatin-
bound RPA of two different experiments is shown (bottom panel).  
 
Taken together, the results presented in this chapter indicate that two fork remodelling events 
are occurring upon acute replication stress. On the one hand, fork reversal occurs under these 
conditions, since FBH1 depletion decreases the amount of single-stranded nascent DNA. On 
the other hand, helicase-polymerases uncoupling also occurs, since a large amount of single-
stranded parental DNA is obtained upon an acute replication stress, being this last one the 
predominant event. Moreover, the presence of ssDNA in the parental strands does not involve 
nascent DNA degradation by Mre11. And most interestingly, the uncoupled forks present 
assembled CMG complexes, which are disengaged from nascent DNA, but are able to reinitiate 
DNA synthesis upon HU removal, with the rapid disappearance of single-stranded parental 
DNA. 
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RESULTS 
3.1. RAD51 DEPLETION DOES NOT AFFECT THE NUMBER OF RESTARTED FORKS, BUT IMPAIRS 
FORK PROGRESSION AFTER AN ACUTE REPLICATION STRESS IN hTERT-RPE CELLS 
IPOND analysis of replication forks showed a recruitment of RAD51 upon 2 hours of 10mM HU 
treatment (previous data shown in chapter 2, Figure 27). Under this condition, as it was shown 
in chapter 2, hTERT-RPE cells recover from this HU-induced replication stress mainly by 
restarting replication forks. The aim of this study was to analyse the relevance of RAD51 under 
these conditions.  
First, we wondered if RAD51 was necessary for replication fork restart after acute HU 
treatment. To do so, non-transformed human hTERT-RPE cells were depleted of RAD51 and 
their replication dynamics was analysed. To this end, cells were labelled during 30 minutes 
with the first analogue, CldU, then treated with 10mM of HU for 2 hours, and finally labelled 
during 1 hour with the second analogue, IdU. CldU was maintained in media during the first 15 
minutes of HU treatment, since it was the time needed to completely stall replication forks 
536
. 
As shown in Figure 41, the number of restarted forks after 2 hours of 10mM HU treatment 
was not affected upon RAD51 depletion. But DNA fiber assay did not allow us to distinguish 
between restart and activation of nearby origins 
135
. Thus, to study the real fork restart, we 
also performed the DNA fiber assay using roscovitine, a CDK inhibitor
555
, to inhibit CDK2-
mediated phosphorylations of replisome components, essential for origin firing 
156,173,174
. As 
shown in Figure 41, 90% of forks with real restart (the one observed with roscovitine) was 
maintained despite RAD51 depletion. A slight decrease in the new origin firing events was 
obtained with roscovitine addition, indicating that origin firing was inhibited under roscovitine 
conditions. The results indicate that RAD51 depletion does not affect the number of forks able 
to restart after an acute HU treatment.   
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Figure 41. RAD51 depletion does not affect fork restart after an acute HU treatment in hTERT-RPE cells. 
Cells were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells were harvested 
for WB analysis with RAD51. Lamin B (LamB) was used as a loading control (upper-left panel). hTERT-RPE 
transfected cells were labelled as indicated (upper-right panel). After labelling, cells were harvested and 
prepared for DNA fiber analysis. At least 200 fibers of each condition in each experiment were used to 
calculate the percentage of restart, stalled forks and new origin firing events relative to total forks. 
Means and standard deviation (bars) of three experiments without roscovitine and two experiments with 
roscovitine (+roscov.) are shown (bottom-right panel). The statistical analysis was performed just in HU-
treated cells (paired t-test, n.s.: non-statistically significant). 
 
Then, fork progression after replication restart from the same experiments was analysed, 
measuring the IdU (second analogue) track length in fibers that had incorporated both 
analogues. As shown in Figure 42, while with RAD51 depletion there were no differences in 
fork progression, the addition of roscovitine in RAD51-depleted cells showed a significant 
reduction in fork progression after an acute HU treatment. 
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Figure 42. RAD51 depletion impairs fork progression after replication restart in hTERT-RPE cells. Cells 
were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells were harvested for 
WB analysis with RAD51. Lamin B (LamB) was used as a loading control (upper-left panel). DNA fibers for 
Figure 41 were used to measure IdU track length. Representative images are shown (upper-right panels). 
At least 200 fibers of each condition in each experiment were measured. Means and standard deviation 
(bars) of one representative experiment out of two is shown (bottom panel, Mann-Whitney test, n.s.: 
non-statistically significant, ** P value < 0.01, **** P value < 0.0001).  
 
 
The results above indicate that, although RAD51 depletion does not have effect in the number 
of restarted forks, it impairs fork progression after an acute replication stress. In HU-treated 
conditions, this effect would be compensated by dormant origins that cannot be distinguished 
by DNA fiber assay. 
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3.2. RAD51 DEPLETION DOES NOT CAUSE FORK DEGRADATION AFTER AN ACUTE REPLICATION 
STRESS IN hTERT-RPE CELLS 
Multiple HR proteins protect the nascent DNA at replication forks from nucleases 
degradation
370,476,477,479
. In order to know if RAD51 was necessary to protect DNA from 
degradation of for DNA stabilization upon acute HU treatment, the degradation of nascent 
DNA in RAD51-depleted cells was analysed. To do so, siRNA transfected-cells were labelled 
with CldU for 30 minutes and with IdU for 30 minutes more. Then cells were treated with 
10mM of HU during 2 hours.  
The analysis of IdU track length showed that no significant differences were obtained between 
non-targeted and RAD51-depleted cells after an acute replication stress (Figure 43), which 
indicates that RAD51 is not required at replication forks under these conditions to protect 
nascent DNA. 
 
Figure 43. RAD51 depletion does not cause fork degradation upon acute HU treatment in hTERT-RPE 
cells. Cells were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells were 
harvested for WB analysis with RAD51 antibody. Lamin B (LamB) was used as a loading control (upper-
left panel). hTERT-RPE transfected cells were labelled as indicated (upper-right panel). After labelling, 
cells were harvested and prepared for DNA fiber analysis. Representative images are shown (bottom-
right panels). The IdU track length was measured. At least 300 fibers of each condition in each 
experiment were measured. One representative experiment out of three is shown (bottom-left panel, 
Mann-Whitney test, n.s.: non-statistically significant).  
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3.3. RAD51 DEPLETION DOES NOT IMPAIR REPLICATION RECOVERY AFTER AN ACUTE 
REPLICATION STRESS IN hTERT-RPE CELLS 
We next wondered if RAD51-depleted cells, which were able to restart after an acute 
replication stress, were able to finish S phase and entry into mitosis. To analyse it, cell 
cytometer analysis was performed. hTERT-RPE cells were transfected and 48h later a BrdU 
pulse was done in order to label cells in S phase and analysed their progression through cell 
cycle. Then, cells were treated with 10mM of HU or left untreated in nocodazole-containing 
media (control situation). After HU treatment, cells were released in nocodazole-containing 
media during 12 hours. As shown in Figure 44, RAD51-depleted cells were not affected by 
acute replication stress (2h HU + 12h release), since they were able to finish replication as in a 
control situation (12h release). Remarkably, RAD51 depletion had a strong effect in cell cycle, 
since an accumulation of cells in G2 phase was obtained. These data are in agreement with 
another report, which demonstrate that RAD51 inactivation does not affect S phase but 
provokes a G2 arrest 
571
.  
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Figure 44. RAD51 depletion does not impair replication recovery after an acute HU treatment in hTERT-
RPE cells. Cells were transfected with the indicated siRNA (NT: non-target) and 48h later cells were 
labelled with BrdU and then treated with 10mM HU or left untreated (12h release) into nocodazole-
containing media for 12 hours. HU-treated cells were then released into nocodazole-containing fresh 
medium for 12 hours (2h HU + 12h release). Flow cytometry analysis of approximately 15000 cells was 
performed to analyse the S-phase arrested (BrdU-488 positive) cells after HU treatment, and the 
recovery from this stress measuring mitotic (MPM2-647 positive) cells from BrdU positive population. 
One representative experiment out of two is shown. 
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3.4. RAD51 DEPLETION INCREASES GENOMIC INSTABILITY IN hTERT-RPE CELLS 
The previous data showing the effect of RAD51 depletion in replication fork progression after 
acute HU treatment made us wonder if RAD51 depletion would affect genomic stability. To 
analyse this fact, immunofluorescence of 53BP1 was performed. 53BP1 is described as a 
marker of DSB 
572
 or under-replicated regions of DNA 
544–546
. The results suggested that RAD51 
depletion increased the presence of DNA damage, and this increase was more noteworthy 
after acute HU treatment (Figure 45).                        
 
Figure 45. RAD51 depletion increases 53BP1 foci after an acute HU treatment in hTERT-RPE cells. Cells 
were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells were treated with 
10mM HU for 2 hours or left untreated for 12 hours (Control). After HU treatment, cells were released 
into fresh medium for 12 hours. Finally, 53BP1 immunofluorescence was performed. The control for KD 
was shown (upper-left panel). Representative images from each condition are shown (upper-middle 
panels). Two cells with more than six 53BP1 foci, indicated with a white arrowhead in the representative 
images from RAD51-depleted population, are shown in more detail (upper-right panels). At least 500 
cells were counted for NT-depleted cells and 200 cells were counted for RAD51-depleted cells in each 
experiment. Means and standard deviation (bars) of percentage of cells presenting more than six 53BP1 
foci of two experiments in control and three experiments in HU conditions are shown (bottom-right 
panel). The statistical analysis was performed just in HU-treated cells (unpaired t-test, ** P value < 0.01). 
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3.5. RAD51 INHIBITION DOES NOT AFFECT FORK PROGRESSION IN hTERT-RPE CELLS 
The results above showed that RAD51 depletion had a strong effect in cell cycle, and an 
accumulation of cells in G2 phase was obtained. Thus, the analysis of fork progression was 
performed with a few cells present in S phase (seen by BrdU pulse condition in Figure 44). To 
avoid this problem, we chose to study the effect of RAD51 inhibition by using B02, a recently 
described RAD51 inhibitor, which was identified by high throughput screening 
531
 and acts by 
disrupting RAD51 binding to DNA and formation of the nucleofilament protein
532
. 
First, we analysed if RAD51 inhibition had an effect in fork progression under unperturbed 
conditions in non-transformed human cells. To do so, a DNA fiber assay was performed by 
adding the inhibitor during the second analogue in order to avoid no labelling if RAD51 
inhibition had a significant effect. The results showed that RAD51 inhibition had no effect in 
replication fork progression under normal conditions since IdU (second analogue) track length 
was maintained (Figure 46).  
 
Figure 46. RAD51 inhibition by B02 does not affect replication fork progression under normal 
conditions in hTERT-RPE cells. Cells were labelled as indicated (upper panel), adding the B02 inhibitor 
with the second analogue. After labelling, cells were harvested and prepared for DNA fiber analysis. 
Representative images are shown (bottom-left panels). The IdU track length was measured. At least 200 
fibers of each condition in each experiment were measured. Means and standard deviation (bars) of 
three experiments are shown (bottom-right panel, paired t-test, n.s.: non-statistically significant). 
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3.6. RAD51 INHIBITION DOES NOT AFFECT THE NUMBER OF RESTARTED FORKS, BUT IMPAIRS 
FORK PROGRESSION AFTER AN ACUTE REPLICATION STRESS IN hTERT-RPE CELLS 
In order to validate the results obtained with RAD51 depletion, we first analysed the effect of 
RAD51 inhibition in replication dynamics after acute replication stress. To do so, non-
transformed human hTERT-RPE cells were labelled during 30 minutes with the first analogue 
CldU, then treated with 10mM of HU for 2 hours with or without B02, and finally labelled 
during 1 hour with the second analogue IdU with or without B02. From now on, CldU was 
maintained during HU treatment to label DNA till replication forks were completely stalled.  
As shown in Figure 47, the number of restarted forks after 2 hours of 10mM HU treatment, 
which stalls replication forks, was not affected upon RAD51 inhibition with B02, neither in 
roscovitine-treated conditions. The results validated the previous ones indicating that RAD51 
depletion does not affect the number of restarted forks after an acute HU treatment.   
 
Figure 47. RAD51 inhibition by B02 does not affect fork restart after an acute HU treatment in hTERT-
RPE cells. Cells were labelled as indicated (upper panel), adding the B02 inhibitor and roscovitine with HU 
and the second analogue. After labelling, cells were harvested and prepared for DNA fiber analysis. At 
least 200 fibers of each condition in each experiment were used to calculate the percentage of restart, 
stalled forks and new origin firing events relative to total forks. Means and standard deviation (bars) of 
three experiments with (+roscov.) or without roscovitine are shown (bottom-right panel, paired t-test, 
n.s.: non-statistically significant, * P value < 0.05, ** P value < 0.01). 
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Then, fork progression after fork restart from the same experiments was analysed, measuring 
the IdU (second analogue) track length in fibers labelled with both analogues. As shown in 
Figure 48, RAD51 inhibition with B02, with or without roscovitine, showed a significant 
reduction in fork progression after 2 hours of HU treatment.  
 
 
Figure 48. RAD51 inhibition by B02 impairs fork progression after replication restart in hTERT-RPE cells. 
DNA fibers for Figure 47 were used to measure IdU track length (second analogue). Representative 
images are shown (upper panels). At least 200 fibers of each condition in each experiment were 
measured. One representative experiment out of three is shown (bottom-left panel, Mann-Whitney test, 
**** P value < 0.0001). Means and standard deviation (bars) of three experiments with (+roscov.) or 
without roscovitine are shown (bottom-right panel, paired t-test, n.s.: non-statistically significant, * P 
value < 0.05, ** P value < 0.01, *** P value < 0.001). 
 
The efficiency of roscovitine was corroborated by the reduction in the number of new origins 
(Figure 47) and the shortening of IdU track length (Figure 48), due to the previously described 
role of CDKs in fork progression 
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3.7. RAD51 INHIBITION DOES NOT CAUSE FORK DEGRADATION AFTER AN ACUTE REPLICATION 
STRESS IN hTERT-RPE CELLS 
In order to know if the inhibition of RAD51 during HU treatment was not affecting the nascent 
DNA, as we had seen in RAD51-depleted cells, we used the same experiments of DNA fiber 
assay performed previously (Figure 47 and Figure 48). The CldU (first analogue) was measured 
to analyse the stability of nascent DNA, since it labelled the replicated DNA just before the 
replication stress agent was added. The analysis of CldU track length showed that no 
significant differences were obtained with or without RAD51 inhibitor (Figure 49), which 
indicated that its inhibition during an acute replication stress and after its release, did not 
affect the stability of nascent DNA. 
 
Figure 49. RAD51 inhibition by B02 does not affect stability of nascent DNA after an acute HU 
treatment in hTERT-RPE cells. DNA fibers for Figure 47 and Figure 48 were used to measure CldU track 
length (first analogue). At least 300 fibers of each condition were measured. One representative 
experiment out of three is shown (left panel, Mann-Whitney test, n.s.: non-statistically significant). 
Means and standard deviation (bars) of three experiments with (+roscov.) or without roscovitine are 
shown (right panel, paired t-test, n.s.: non-statistically significant). 
 
3.8. RAD51 IS NECESSARY FOR AN EFFICIENT FORK RESTART AND PROGRESSION AFTER AN 
ACUTE REPLICATION STRESS IN hTERT-RPE CELLS 
Due to the fact that RAD51 inhibition did not affect the number of restarted forks but its fork 
progression was impaired, we wanted to know if RAD51 was involved in fork progression after 
its restart or in replication restart efficiency after an acute replication stress. To elucidate this, 
a DNA fiber assay was performed, adding the B02 inhibitor at different times. In the first 
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activity is important for the progression of restarted forks, since we already knew that 
replication forks needed 30 minutes to restart from an acute replication stress (data not 
shown). In the second condition, we added B02 during the last 15 minutes of HU treatment 
and during the hour of IdU labelling, in order to know if RAD51 activity is important for an 
efficient fork restart.  
As shown in Figure 50, the addition of B02 during the last 30 minutes of IdU labelling 
decreased the IdU track length. But the addition of B02 during the last minutes of HU 
treatment and during the IdU labelling decreased the IdU track length even more, maybe due 
to the sum of both effects. The results showed that fork progression and effective fork restart 
were both affected due to RAD51 inhibition.  
 
 
 
Figure 50. RAD51 is necessary for efficient fork restart and progression after an acute HU treatment in 
hTERT-RPE cells. Cells were labelled as indicated (upper panel), adding the B02 inhibitor where indicated. 
After labelling, cells were harvested and prepared for DNA fiber analysis. Representative images are 
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shown (middle panels). At least 200 fibers of each condition in each experiment were measured. One 
representative experiment out of three is shown (bottom-left panel, Mann-Whitney test, **** P value < 
0.0001). Means and standard deviation (bars) of three experiments are shown (bottom-right panel, 
paired t-test, * P value < 0.05). 
 
3.9. RAD51 INHIBITION AFFECTS CELL CYCLE PROGRESSION IN hTERT-RPE CELLS 
To analyse the effect of RAD51 inhibition in cell cycle progression, a cell cytometer analysis 
was performed. hTERT-RPE cells were pulse-labelled with BrdU, in order to label cells that 
were in S phase and analyse its progression through cell cycle.  
On the one hand, to analyse the effect of B02 inhibitor in a control situation, cells were left 
untreated in nocodazole-containing media after BrdU pulse, with or without RAD51 inhibitor, 
for 12 hours. As shown in Figure 51, the entry into mitosis of population that initially was in S 
phase (BrdU-488-positive population) after a period of 12 hours was significantly affected 
when B02 was added in an unperturbed situation. It should be noted that arrival into G2-M 
phases (shown by black DNA profiles) was not affected. 
On the other hand, to analyse the effect of B02 in a replication stress situation, cells were 
treated with 10mM of HU after BrdU pulse during 2 hours, and then released in nocodazole-
containing media for 12 hours. During this release, B02 was added to the media at different 
times (using the same as in  Figure 50): in one condition B02 was added 30 minutes after HU 
release, and in the other condition B02 was added during the last 15 minutes of HU treatment 
and maintained during the HU release. As shown in Figure 52, recovery of acute replication 
stress was impaired when B02 was added, regardless of when the inhibitor was added. 
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Figure 51. RAD51 inhibition by B02 affects mitotic entry under unperturbed conditions in hTERT-RPE 
cells. Cells were labelled with BrdU and then left untreated for 12 hours into nocodazole-containing fresh 
medium, without (12h Noc) or with RAD51 inhibitor (12h B02) (upper panel). Flow cytometry analysis of 
approximately 15000 cells was performed to analyse the S-phase population, initially labelled with BrdU 
analogue (BrdU-488 positive cells) after 12 hours. Cell cycle progression was analysed by measuring 
mitotic cells (MPM2-647 positive from BrdU-488-positive population) relative to cells into G2-M phases 
(obtained by black DNA profiles from BrdU-488-positive population). A representative experiment is 
shown (middle panel). Means and standard deviation (bars) of six experiments are shown (bottom panel, 
paired t-test, ** P value < 0.01).  
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Figure 52. RAD51 inhibition by B02 affects mitotic entry after an acute HU treatment in hTERT-RPE 
cells. Cells were labelled with BrdU and then treated with 10mM HU during 2 hours. Then, cells were 
released (R) into nocodazole-containing fresh medium for 12 hours, adding RAD51 inhibitor, B02, at the 
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indicated times (upper panel). Flow cytometry analysis of approximately 15000 cells was performed to 
analyse the S-phase arrested (BrdU-488 positive) cells after 2 hours of HU treatment, and the recovery 
from this stress measuring, within the BrdU-positive population, the relation between mitotic cells 
relative to the cells in G2-M phases. A representative experiment is shown (middle panel). Means and 
standard deviation (bars) of six experiments are shown (bottom panel, paired t-test, n.s.: non-statistically 
significant, *** P value < 0.001, **** P value < 0.0001). 
 
Remarkably, the impairment of mitotic entry when B02 was used increased significantly after 
an acute replication stress response compared to the control situation (Figure 53).   
 
Figure 53. RAD51 inhibition by B02 has a higher effect on mitotic entry after an acute HU treatment in 
hTERT-RPE cells. Data from Figure 51 and Figure 52 were used to compare the B02 conditions in control 
situation and after an acute replication stress. Means and standard deviation (bars) of six experiments 
are shown (bottom panel, paired t-test, * P value < 0.05, ** P value < 0.01). 
 
3.10. RAD51 INHIBITION INCREASES GENOMIC INSTABILITY AFTER AN ACUTE REPLICATION 
STRESS IN hTERT-RPE CELLS 
The previously results described the effect on mitotic entry when RAD51 was inhibited after an 
acute replication stress, so the next objective was analysed its contribution on genomic 
instability. To do so, the presence of 53BP1 foci was analysed in non-treated cells compared 
with HU-treated cells, with or without RAD51 inhibitor. In this case, an EdU pulse was 
performed before HU treatment in order to label S-phase cells to analyse them. 
As shown in Figure 54, the analysis of cells positives both for EdU and 53BP1 foci relative to 
the population that was in S phase initially (EdU-labelled) increased significantly when RAD51 
inhibitor was added during the release of 12 hours from an acute HU treatment.  
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Figure 54. RAD51 inhibition increases genomic instability after an acute HU treatment in hTERT-RPE 
cells. Cells were pulse-labelled with EdU analogue during 30 minutes (Control). Then, cells were treated 
with 10mM HU for 2 hours or left untreated for 12 hours, without or with B02 inhibitor (12h R or 12h 
B02, respectively). After 2 hours, the HU-treated cells were released (R) into fresh medium for 12 hours, 
without or with B02 inhibitor (2h HU + 12h R or 2h HU + 12h B02, respectively). Finally, click reaction and 
53BP1 immunofluorescence were performed. Representative images are shown (upper panels). At least 
100 cells were counted for condition in each experiment. Means and standard deviation (bars) of three 
experiments in control and four experiments in other conditions are shown. The percentage of cells 
presenting both EdU and 53BP1 foci (more than six) relative to EdU positive cells is shown (bottom panel, 
paired t-test, n.s.: non-statistically significant, * P value < 0.05, ** P value < 0.01).  
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3.11. RAD51 INHIBITION AFFECTS FORK PROGRESSION DURING A MILD REPLICATION STRESS 
IN hTERT-RPE CELLS 
Due to the consequences that RAD51 inhibition had on acute replication stress response, we 
wondered if it would have an effect in a mild replication stress response, where replication 
forks could progress. To do so, a DNA fiber assay was performed upon 1mM HU treatment. 
hTERT-RPE cells were pulse labelled with the first analogue CldU, and then the second 
analogue IdU was added during the HU treatment. This mild replication stress allows IdU 
incorporation, but the labelling time is much longer to be able to analyse the IdU track length, 
since fork progression is undoubtedly impaired under these conditions.   
As shown in Figure 55, IdU track length during a mild replication stress decreases when B02 is 
added. Thus, replication fork progression is impaired when RAD51 is inhibited during a mild 
replication stress caused by 1mM HU treatment. 
 
Figure 55. RAD51 inhibition by B02 impairs fork progression during a 1mM HU treatment in hTERT-RPE 
cells. Cells were labelled as indicated (upper panel), adding the B02 inhibitor during the second analogue 
and HU treatment. After labelling, cells were harvested and prepared for DNA fiber analysis. 
Representative images are shown (bottom-right panels). At least 300 fibers of each condition in each 
experiment were measured. One representative experiment out of two is shown (bottom-left panel, 
Mann-Whitney test, **** P value < 0.0001).  
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Since 1mM of HU treatment is a mild replication stress that slows the replication fork 
progression in a significant manner, we decided to use a 0.1mM of HU treatment, which we 
consider that represents a more physiological replication stress. First of all, we analysed if 
hTERT-RPE cells activated replication checkpoint (by analysing phosphorylated Chk1) upon a 
0.1mM of HU treatment. As shown in Figure 56, Chk1 is not phosphorylated in Ser296 upon a 
replication stress induced by 0.1mM of HU, neither in synchronic nor asynchronic conditions, 
while 10mM of HU had already induced checkpoint activation in 1 hour of treatment, in both 
conditions. In this sense, we defined this 0.1mM HU treatment as a bearable replication stress, 
since no replication checkpoint response was observed. 
 
Figure 56. Replication checkpoint is not activated upon a 0.1mM of HU treatment in hTERT-RPE cells. 
Cells were synchronized in S-phase were indicated or left asynchronic. Then cells were treated with HU 
with the doses indicated during the indicated times or left untreated (S-phase synchronic cells (Cs) or 
asynchronic cells (C)). Whole cell extracts were prepared and analysed by WB with the indicated 
antibodies. GAP120 was used as a loading control. 
 
After that, we analysed if under a bearable replication stress, RAD51 inhibition had an effect in 
fork progression in hTERT-RPE cells by performing a DNA fiber assay with 0.1mM of HU 
treatment. As shown in Figure 57, the addition of RAD51 inhibitor B02 impaired fork 
progression significantly also during a bearable replication stress, shown as a shorter IdU track 
length under those conditions. 
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Figure 57. RAD51 inhibition by B02 impairs fork progression during a 0.1mM HU treatment in hTERT-
RPE cells. Cells were labelled as indicated (upper panel). HU was added 30 minutes before labelling, since 
the dose of HU used is supposed to not have a strong effect on replication. The B02 inhibitor was added 
where is indicated. After labelling, cells were harvested and prepared for DNA fiber analysis. 
Representative images are shown (middle panels). At least 250 fibers of each condition in each 
experiment were measured. One representative experiment out of four is shown (bottom-left panel, 
Mann-Whitney test, **** P value < 0.0001). Means and standard deviation (bars) of four experiments 
are shown (bottom-right panel, paired t-test, * P value < 0.05). 
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3.12. RAD51 INHIBITION AFFECTS FORK PROGRESSION IN COLORECTAL CANCER CELLS 
Recent findings indicate that replication stress is a feature present in most cancers
425,516
. Since 
we had demonstrated that RAD51 had a role in fork progression during a mild and bearable 
replication stress, we wondered if RAD51 inhibition could influence fork progression in 
unperturbed conditions in cancer cells, with a basal increased replication stress. 
To analyse this issue, we chose a colorectal cancer cell line as a model: HCT116 cell line with a 
functional p53 gene. First of all, the levels of phosphorylated Chk1 in this cell line were 
compared with hTERT-RPE cell line and we verified that this cell line presented an increased 
replication stress compared with the non-transformed cell line, hTERT-RPE, under 
unperturbed conditions (Figure 58). 
  
Figure 58. HCT116 cell line presents an increased replication stress compared to non-transformed 
hTERT-RPE cell line. HTC116 and hTERT-RPE cell lines were seeded and 48 hours later cells were 
harvested and analysed by WB with the indicated antibodies. Cyclin A (CycA) was used as a control of S-
phase cells. 
 
Since HCT116 cell line presented an increased replication stress, we studied the effect of 
RAD51 in replication fork progression in this tumour cell line under unperturbed conditions. To 
do so, DNA fiber assay was performed, by adding the inhibitor during the second analogue. 
The results showed that RAD51 inhibition decreased replication fork progression under normal 
conditions in HCT116 cell line (Figure 59A). On the other hand, the replication dynamics were 
not affected by the inhibition of RAD51 (Figure 59B).   
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Figure 59. RAD51 inhibition by B02 reduces fork progression in HCT116 cell line but does not affect 
replication dynamics under normal conditions. (A) Cells were labelled as indicated (upper panel), adding 
the B02 inhibitor with the second analogue. After labelling, cells were harvested and prepared for DNA 
fiber analysis. Representative images are shown (middle panels). The IdU track length was measured. At 
least 250 fibers of each condition in each experiment were measured. One representative experiment 
out of three is shown (bottom-left panel, Mann-Whitney test, **** P value < 0.0001). Means and 
standard deviation (bars) of three experiments are shown (bottom-right panel, paired t-test, * P value < 
0.05). (B) DNA fibers were used to calculate the percentage of restart, stalled forks and new origin firing 
events relative to total forks. Around 1500 fibers from three independent experiments were counted in 
each condition. The average of those experiments is shown. Error bars represent standard deviation 
(paired t-test, n.s.: non-statistically significant). 
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Collectively, the data presented in this chapter support the idea that RAD51 is important to 
maintain replication fork progression after acute replication stress. Although the number of 
restarted forks is not impaired with RAD51 depletion or inhibition, RAD51 is necessary for 
efficient fork restart and progression after an acute replication stress in hTERT-RPE cells. In 
contrast to what is thought, in our conditions RAD51 depletion or inhibition does not cause 
fork degradation after an acute replication stress. 
Moreover, RAD51 inhibition has an effect on cell cycle progression, which is more pronounced 
after acute HU treatment. In addition, after acute replication stress conditions, RAD51 
inhibition increases genomic instability. 
Interestingly, RAD51 is also relevant for replication fork progression during a mild or bearable 
replication stress, in HU-treated hTERT-RPE cells or untreated HCT116 cells, which presents a 
higher basal replication stress. The physiological relevance of RAD51 under those conditions 
has not been elucidated yet. 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
CHAPTER 4 
OZF IS ESSENTIAL TO MAINTAIN FORK PROGRESSION RATE  
UNDER REPLICATION STRESS CONDITIONS 
 
 
 
 
 
 
The results shown in the previous data section are comprised  
at Alba Llopis’s PhD thesis.  
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PREVIOUS DATA 
CLASPIN INTERACTS WITH OZF 
Due to the role of Claspin on the activation of replication checkpoint 
304,308,573,574
 and to 
discover new Claspin-interacting proteins, a two-hybrid system was performed in the 
laboratory of Prof. Raimundo Freire, PhD. The experiment was done with a Claspin-encoding 
cDNA fragment that codifies for the last 347 amino acids of the protein. The results showed 
that 9 of 39 positive hits obtained were proteins with multiple zinc-finger (ZnF) domains of the 
Krüppel subfamily, which was discovered in 1991 
575
 (Figure 60).  
            
 
 
 
 
 
 
Figure 60. Two-hybrid system to discover new Claspin-interacting proteins. Detail of the results 
obtained from the analysis with the C-terminal domain of Claspin. Experiments performed by Prof. 
Raimundo Freire, PhD. 
 
The main focus was set on ZNF146/OZF (Only zinc-finger) protein, since it was an only zinc 
finger protein that was described as a nuclear protein of 33kDa which binds to DNA. It consists 
of ten consecutive ZnF domains of C2H2 
576,577
. In contrast to the other members of the Krüppel 
subfamily, it does not contain a transactivation domain 
576,577
. With an unknown function, it 
has been shown to interact with a telomeric protein, hRap1, and with the SUMO-1 conjugating 
enzyme UBC9 
578,579
. 
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The interaction of Claspin and OZF was confirmed by co-immunoprecipitation of exogenously 
expressed proteins, and also of the endogenous ones (Figure 61). The interaction of OZF and 
Claspin was maintained even under replication stress conditions (Figure 61C). 
 
Figure 61. OZF interacts with Claspin. (A) HEK293T cells were transfected with both FLAG-Claspin and 
HA-OZF. FLAG-Claspin was immunoprecipitated from nuclear extracts and FLAG and HA were detected by 
WB. (B) HEK293T cells were transfected with HA-OZF, and it was immunoprecipitated from nuclear 
extracts. HA and endogenous Claspin were detected by WB. (C) HEK293T cells were enriched in S phase 
and treated with 1.5mM HU during 7 hours (HU) or left untreated (C), and immunoprecipitation of 
Claspin was performed. Endogenous Claspin and OZF were detected by WB. Experiments performed by 
Alba Llopis, PhD. 
 
OZF LOCALIZES AT ONGOING REPLICATION FORKS 
In order to gain insight into the OZF role, their protein levels during cell cycle were analysed. 
For this purpose, different cell lines were used, and it was found that OZF protein levels were 
low during G0 (cells in serum starvation), while their levels increased after the addition of 
serum during S phase, reaching its maximum in G2/M phases (results not shown). 
It was already known that OZF is a nuclear protein, so cell fractionation experiments were 
performed to know if it was bound or not to chromatin. The results showed that OZF was a 
chromatin-bound protein, as well as Claspin, which was according with literature 
580–584
 (Figure 
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62A). It was already know that Claspin is found in replication forks and that it interacts with 
different components of the replisome 
580–582
. To analyse the presence of OZF in replication 
forks, the iPOND technique was used. This technique allows the isolation of protein complexes 
crosslinked to EdU thymidine analogue-containing fragments that are located at active 
replication forks 
550–552
. The results indicated that OZF interacted with nascent DNA together 
with Claspin or PCNA, demonstrating the presence of OZF in ongoing replication forks (Figure 
62B). 
 
Figure 62. OZF and Claspin colocalize in the replication forks. (A) Cell fractionation from HEK293T cells. 
The levels of OZF, Clapin and LaminB were analysed by WB. Cyt: cytoplasm; Nucl: nuclei; S: soluble; NS: 
non-soluble. Experiment performed by Alba Llopis. (B) hTERT-RPE cell lines were treated, where 
indicated, with EdU for 15 minutes. EdU was immunoprecipitated and the associated proteins were 
analysed by WB. Experiment performed by Amaia Ercilla, PhD. 
 
 
 
A 
OZF 
Lamin B 
Claspin  
Cyt Nucl NS S 
Nucl 
iPOND  
IP: EdU  
Claspin  
OZF  
PCNA  
H4  
EdU EdU+R - 
Input 
EdU EdU+R - 
B 
RESULTS  
154 
 
RESULTS 
4.1. OZF INTERACTS WITH CDC45 AND MCM 
Since we already knew that OZF was located in replication forks, its interaction with Claspin, 
and the interaction of Claspin with diverse replisome components, we investigated if OZF 
could interact with some replisome components by performing chromatin-bound OZF 
immunoprecipitation. The results showed that OZF interacted with Cdc45, MCM6 and MCM2, 
all components of CMG complex (Figure 63). Co-immunoprecipitation between OZF with 
Cdc45, a part of the MCMs, indicates that OZF interacts with activated origins, not just 
licensed.  
 
Figure 63. OZF interacts with components of CMG complex. HEK293T cells were transfected with HA-
OZF. HA-OZF was immunoprecipitated from nuclear extracts and HA and different replisome components 
were detected by WB. The arrow indicates the specific band corresponding to MCM2. The asterisk 
indicates the band corresponding to MCM6. 
 
4.2. OZF IS NOT ESSENTIAL FOR REPLICATION IN hTERT-RPE CELLS 
Due to OZF presence in replication forks and its interaction with some replisome components 
and the role of Claspin in a normal S-phase progression, we studied the effect of OZF in fork 
progression in non-transformed human cells under unperturbed conditions. To do so, hTERT-
RPE cells were depleted of OZF and, approximately 48 hours after siRNA transfection, DNA 
fiber assay was performed. The results showed that OZF depletion had no effect in replication 
fork progression under normal conditions since IdU (second analogue) track length was 
maintained (Figure 64). 
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Figure 64. OZF depletion does not affect replication fork progression under unperturbed conditions in 
hTERT-RPE cells. Cells were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells 
were harvested for WB analysis with OZF. Actin was used as a loading control (middle-left panel). hTERT-
RPE transfected cells were labelled as indicated (upper panel). After labelling, cells were harvested and 
prepared for DNA fiber analysis. Representative images are shown (middle-right panels). The IdU track 
length was measured. At least 250 fibers of each condition in each experiment were measured. One 
representative experiment out of three is shown (bottom-left panel, Mann-Whitney test, n.s.: non-
statistically significant). Means and standard deviation (bars) of three experiments are shown (bottom-
right panel, paired t-test, n.s.: non-statistically significant).  
 
It has been recently proposed that Claspin has a function in DNA replication origin firing via its 
interaction with Cdc7 
187,585
, so replication dynamics were analysed after OZF depletion under 
unperturbed conditions to know if this Claspin-interacting protein may participate on this role. 
No differences were found between non-target and OZF-depleted hTERT-RPE cells in new 
origin firing events and the number of restarted forks (Figure 65). 
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Figure 65. OZF depletion does not affect replication dynamics under normal conditions in hTERT-RPE 
cells. DNA fibers for Figure 64 were used to measure the percentage of restart, stalled forks and new 
origin firing events relative to total forks. Around 1500 fibers from three independent experiments were 
counted in each condition. The average of those experiments is shown. Error bars represent standard 
deviation (paired t-test, n.s.: non-statistically significant, * P value < 0.05).  
 
4.3. OZF DEPLETION REDUCES FORK PROGRESSION UNDER MILD REPLICATION STRESS 
CONDITIONS IN hTERT-RPE CELLS 
After analysing the effect of OZF depletion in unperturbed conditions, the role of OZF under 
mild replication stress conditions, which allows replication fork progression, was analysed. For 
this reason, 1mM of HU was used.  Due to the role of Claspin in the activation of Chk1 by ATR 
586
, we first analysed whether OZF was involved in this process. The WB analysis shows that 
OZF depletion did not prevent Chk1 phosphorylation after 12 hours of HU treatment (Figure 
66). It should be noted that 12 hours after HU release, the phosphorylated Chk1 decreased 
until control levels in both cases, indicating a recovery from this mild replication stress. The 
results showed that OZF did not have a role in checkpoint activation upon 1mM HU treatment.  
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Figure 66. OZF is not essential for checkpoint activation upon 1mM HU treatment in hTERT-RPE cells. 
Cells were transfected with the indicated siRNA (NT: non-target) and 48h later cells were treated with 
1mM HU or left untreated (Control) for 12 hours, and then released into fresh medium for 12 hours. 
Whole cell extracts were prepared and analysed by WB with the indicated antibodies. GAP120 was used 
as a loading control. 
 
To further analyse if OZF had a role in fork progression under replication stress conditions, 
DNA fiber assay was performed upon 1mM HU treatment. As shown in Figure 67, OZF 
depletion resulted in a significant reduction in replication fork progression during this mild 
replication stress, shown by a shorter IdU track length.  
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Figure 67. OZF depletion reduces fork progression during 1mM HU treatment in hTERT-RPE cells. Cells 
were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells were treated and 
labelled as indicated (upper panel). After labelling, cells were harvested and prepared for DNA fiber 
analysis. Representative images are shown (middle panels). The IdU track length was measured. At least 
250 fibers of each experiment were measured. One representative experiment out of three is shown 
(bottom-left panel, Mann-Whitney test, **** P value < 0.0001). Means and standard deviation (bars) of 
three experiments are shown (bottom-right panel, paired t-test, * P value < 0.05). The siRNA transfection 
control is shown in Figure 66. 
 
Under these conditions, replication dynamics were analysed. The results indicated that OZF 
depletion, although it had an effect in fork progression, did not alter replication dynamics 
upon 1mM HU treatment (Figure 68). 
 
Figure 68. OZF depletion has no effect in replication dynamics during 1mM HU treatment in hTERT-RPE 
cells. DNA fibers for Figure 67 were used to measure the percentage of restart, stalled forks and new 
origin firing events relative to total forks. Around 1500 fibers from three independent experiments were 
counted in each condition. The average of those experiments is shown. Error bars represent standard 
deviation (paired t-test, n.s.: non-statistically significant).  
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Since 1mM of HU treatment is a mild replication stress that slows the replication fork 
progression in a significant manner, we did the DNA fiber assay with 0.1mM of HU treatment, 
which represents a bearable replication stress that does not activate replication checkpoint 
(Figure 56).  As shown in Figure 69, OZF depletion resulted in a significant reduction in 
replication fork progression upon a 0.1mM HU treatment, shown as a shorter IdU track length. 
 
 
Figure 69. OZF depletion reduces fork progression during 0.1mM HU treatment in hTERT-RPE cells. 
Cells were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells were harvested 
for WB analysis with the indicated antibodies. Lamin B (LamB) was used as a loading control (middle-left 
panel). hTERT-RPE transfected cells were labelled as indicated (upper panel). After labelling, cells were 
harvested and prepared for DNA fiber analysis. Representative images are shown (middle-right panels). 
The IdU track length was measured. At least 300 fibers from one experiment were measured (bottom-
left panel, Mann-Whitney test, **** P value < 0.0001).  
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4.4. OZF DEPLETION DOES NOT INCREASE GENOMIC INSTABILITY IN hTERT-RPE CELLS 
The previous data showing the effect of OZF depletion in replication fork progression upon 
1mM HU treatment made us wonder if OZF silencing would affect genomic stability. First, we 
studied the mitotic entry after 12 hours of release from 1mM HU treatment. S phase cells 
were labelled with BrdU analogue and then cells were followed through cell cycle after HU 
release.  
As it was seen in Figure 70, 1mM of HU treatment slowed replication noticeably, since BrdU 
positive cells remained in S phase after 12 hours of 1mM HU treatment, and remained there 
even after 72 hours (data not shown). After this mild replication stress, cells seemed to 
recover replication, to finish S phase and to arrive into G2-M phases due to the presence of 
nocodazole (as it was shown by DNA profiles). The entry in mitosis, shown as MPM2 positive 
cells, did not seem to be affected by OZF depletion (even there were some more mitotic cells 
under those conditions). 
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Figure 70. OZF depletion does not affect mitotic entry after 12 hours release from 1mM HU treatment 
in hTERT-RPE cells. Cells were transfected with the indicated siRNA (NT: non-target) and 48 hours later 
cells were labelled with BrdU and then treated with 1mM HU for 12 hours or left untreated (Control), 
and then HU-treated cells were released into nocodazole-containing fresh medium for 12 hours. Flow 
cytometry analysis of more than 10000 cells was performed to analyse the S-phase arrested (BrdU-488 
positive cells) cells after 12 hours of HU treatment, and the recovery from this stress measuring mitotic 
(MPM2-647 positive) cells from BrdU positive population. The experiment shown was performed once, 
and the KD control is shown in Figure 66. 
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Due to the fact that no noteworthy effect was seen in mitotic entry, we wondered if there was 
some effect in DNA damage that could stem from the slowing of replication fork progression. 
To analyse this, we performed an immunofluorescence of 53BP1 and ɣH2AX, both markers of 
DNA damage. The results suggested that no substantial differences in the percentage of cells 
presenting both 53BP1 and ɣH2AX foci appeared when OZF was depleted after a mild 
replication stress (Figure 71). 
 
Figure 71. OZF depletion does not have an effect in DNA damage after 1mM HU treatment in hTERT-
RPE cells. Cells were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells were 
treated with 1mM HU or left untreated (Control) for 12 hours, and then HU-treated cells were released 
into fresh medium for 12 hours. Finally, 53BP1 and γ-H2AX immunofluorescences were performed. At 
least 200 cells were counted for each condition. The percentage of cells presenting more than six 53BP1 
and more than ten γ-H2AX foci is shown. The experiment shown was performed once, and the KD control 
is shown in Figure 66. 
 
In order to evaluate the long-term viability after treatment, colony formation was analysed 
under those condition. OZF depletion did not seem to affect colony formation capacity, 
neither in control conditions (these results were already obtained in our lab) nor after 1mM 
HU treatment (Figure 72).  
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Figure 72. OZF depletion does not have an effect in colony formation after 1mM HU treatment in 
hTERT-RPE cells. Cells were transfected with the indicated siRNA (NT: non-target) and 48 hours later cells 
were treated with 1mM HU for 12 hours or left untreated (Control), and then released into fresh medium 
for 12 hours. Finally, cells were plated diluted (200 cells per well on 6-well plate, in triplicate) for colony 
formation assay. Colonies were harvested and stained 7 days later. The average percentage of colonies 
of three plates was calculated in each case, and the graph shows the percentage of colonies relative to 
NT siRNA control situation. The experiment shown was performed once, and the KD control is shown in 
Figure 66. Experiment performed by Fernando Unzueta, PhD student. 
 
The analyses of genomic stability by cell cycle analysis, the presence of DNA damage or long-
term viability, indicated that no effect was obtained from OZF depletion after HU treatment, 
despite its effect in fork progression. It has to be noted that all the analyses were performed in 
one specific time after release (12h), which does not exclude a possible delay in cell cycle 
progression.  
 
4.5. OZF DEPLETION REDUCES FORK PROGRESSION IN COLORECTAL CANCER CELLS 
Previous studies of OZF described its overexpression in pancreatic cancer 
587
 and in more than 
80% of colorectal cancer 
588
. In this last case OZF overexpression was already observed in low-
grade adenomas, indicating that occurs in an primary stage of tumour progression 
588
.  
Moreover, OZF is a c-Myc oncogene-target gene 
589
.  
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Since it was already described that DNA replication stress is a feature present in most cancers 
425,516
,  we wondered if OZF depletion could have an effect on colorectal  cancer cells. 
To study this matter, we chose a colorectal cancer cell line, HCT116, as a model, which has a 
functional p53 gene. First of all, the levels of OZF protein were analysed in this cell line 
compared with hTERT-RPE cell line, and it was verified that this cell line presented OZF 
overexpression (Figure 73).  
 
Figure 73. OZF is overexpressed in HCT116 cell line compared to non-transformed hTERT-RPE cell line. 
HTC116 and hTERT-RPE cell lines were seeded and 48 hours later cells were harvested and analysed by 
WB with the indicated antibodies. Cyclin A (CycA) was used as a control of S-phase cells. 
 
Since HCT116 cell line presented an increased basal replication stress (chapter 3, Figure 58), 
we studied the effect of OZF in fork progression in this tumour cell line under unperturbed 
conditions. To do so, HCT116 cells were depleted of OZF and, approximately 48 hours after 
siRNA transfection, DNA fiber assay was performed. The results showed that OZF depletion 
decreased replication fork progression under normal conditions, shown as a shorter IdU track 
length (Figure 74A), but did not affect replication dynamics (Figure 74B). 
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Figure 74. OZF depletion reduces fork progression in HCT116 cell line but does not affect replication 
dynamics under normal conditions. (A) Cells were transfected with the indicated siRNA (NT: non-target) 
and 48 hours later cells were harvested for WB analysis with OZF. Lamin B (LamB) was used as a loading 
control (middle-left panel). HCT116 transfected cells were labelled as indicated (upper panel). After 
labelling, cells were harvested and prepared for DNA fiber analysis. Representative images are shown 
(middle-right panel). The IdU track length was measured. At least 250 fibers of each condition in each 
experiment were measured. One representative experiment out of three is shown (bottom-left panel, 
Mann-Whitney test, **** P value < 0.0001). Means and standard deviation (bars) of three experiments 
are shown (bottom-right panel, paired t-test, * P value < 0.05). (B) DNA fibers were used to measure the 
percentage of restart, stalled forks and new origin firing events relative to total forks. Around 1500 fibers 
from three independent experiments were counted in each condition. The average of those experiments 
is shown. Error bars represent standard deviation (paired t-test, n.s.: non-statistically significant). 
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Taken together, the results presented in this chapter demonstrate that OZF, a novel Claspin-
interacting protein, is found on replication forks and interacts with components of CMG 
complex, although its depletion does not affect DNA replication under unperturbed conditions 
in hTERT-RPE cells. Interestingly, OZF depletion impairs replication fork progression in cells 
under replication stress, such as HU-treated hTERT-RPE cells or HCT116 cells with higher basal 
replication stress, although its physiological relevance has not been elucidated yet.  
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DNA replication is an essential process that has to be properly and accurately completed only 
once per cell cycle to avoid loss of information and the acquisition of genomic instability, a 
hallmark of cancer 
4,5
. Several endogenous and exogenous factors challenge DNA duplication, 
inducing replication stress. In this sense, cells have developed mechanisms or checkpoints to 
monitor the fidelity of copying DNA. In fact, kinases involved in DNA replication checkpoint are 
active in a non-perturbed S phase in a basal level 
282
, and their depletion results in embryonic 
lethality 
262,263
, which indicates their relevance in preserving genome integrity.  
In response to replication stress, replication checkpoint is activated to maintain fork stability 
and to coordinate the reversible cell cycle arrest and DNA repair with the resumption of DNA 
replication 222,225,257.  The role of this checkpoint is the prevention of cell cycle progression until 
the stress is overcome. If the arrest persists for a long period of time, replication forks 
collapse, causing DSBs. In the cases of persistent damage, cells withdraw from cell cycle by 
apoptosis or senescence to avoid cell division with damaged or unreplicated DNA 
219,221,223–
225,425
. 
Replication checkpoint mechanisms are essential to maintain genomic integrity and, thus, to 
avoid cancer development 
9
. Hence, DNA damage response has been well studied in 
transformed cells, and replication stress response has attracted much attention in the recent 
years, especially in transformed cells. For this reason, during the last years, our group has 
focused in defining and characterizing the replication stress response pathways that 
contribute to preserve genomic integrity of non-transformed human cells.  
During this thesis, and the previous ones of the group, we have focused on studying the 
response of non-transformed human cells after an acute (2h) or a prolonged (14h) replication 
inhibition induced by 10mM HU. After an acute replication stress, cells are able to restart and 
resume cell cycle progression without the acquisition of genomic instability, while after a 
prolonged replication stress, cells have lost the capacity to recover DNA replication 
536
. With 
these premises, we have tried to define the mechanisms involved in such processes.  
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I. LACK OF APC/CCDH1 ACTIVATION IN S PHASE AFTER A SEVERE REPLICATION STRESS 
ALLOWS RESUMPTION OF DNA SYNTHESIS IN TUMOUR CELLS 
Previous data from our group demonstrated that, after a prolonged HU treatment, non-
transformed human cells are not able to recover replication due to activation of APC/C
Cdh1
 in S 
phase, which inhibits origin firing 
536
.  
It is well known that oncogene expression induces replication stress. Replication stress and 
DNA damage responses are activated to act as a tumorigenic barrier 
516,590
. The data presented 
in chapter 1 from this thesis indicates that APC/C
Cdh1
 is a new element of this barrier. 
Consistently, APC/C presents heterozygous mutations in human colon cancer cells 
591
.  
In this sense, our results indicate that tumour cells are predominantly deficient in APC/C
Cdh1
 
activation in S phase in response to a prolonged HU treatment. Moreover, these tumour cell 
lines are predominantly able to resume replication after a prolonged replication stress 
536
. 
Taking the HCT116 colorectal cancer cell line as a model, the results indicate that HCT116 cells 
resume replication after a prolonged HU treatment and these cells are able to divide in spite of 
the presence of DNA damage, as observed by the presence of 53BP1 foci in the next G1 phase, 
and the presence of genomic instability, as observed by the presence of cells with micronuclei. 
The kinases essential for the induction of origin firing in S phase are Cdk2/A-type cyclin and 
Cdc7/Dbf4 
158
, the regulatory subunits of which are substrates of APC/C
Cdh1
 
83,84,363
. Since 
APC/C
Cdh1
 is not activated in tumour cells, a possible explanation for their recovery was the 
activation of new origins. We corroborated this hypothesis in HCT116 cells by DNA fiber assay, 
where we showed that after a prolonged HU treatment the activation of new origins was 
produced. Related with this result, a recent study showed that a release from an aphidicolin-
induced replication stress results in a marked increase in the number of initiation sites 
detected by nascent strand abundance sequencing 
592
.  
A similar observation was shown in U2OS cells, in which most stalled forks are inactivated 
after a long HU-mediated replication stress and replication is resumed by new origin firing. 
Under these conditions, replication forks of U2OS cells are collapsed and DSBs need to be 
repaired by HR to prevent genomic instability 
370
. Under our conditions, we do not know if 
DSBs are present due to fork collapse in HCT116 cells, although this would explain the genomic 
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instability that these cells acquire after a prolonged HU treatment. Moreover, in the case that 
stalled forks were processed into DSBs, a recent study suggests the role of APC/C
Cdh1 
in 
choosing the repair pathways. The inactivity of APC/C
Cdh1
 promotes the DSBs repairing by 
NHEJ, an error-prone mechanism, since the deubiquitinating enzyme USP1, which removes the 
poly-ubiquitin chains on histones that promotes BRCA1 recruitment, is not degraded by 
APC/C
Cdh1 410
. 
We next studied the contribution of APC/C
Cdh1
 activation in genomic stability. Since Emi1 
depletion has been reported to be enough to induce APC/C
Cdh1
 activation 
76,548,549
, we 
artificially induced APC/C
Cdh1
 activation during S phase by depleting Emi1 in HCT116 cells. It 
has to be noted that Emi1 depletion promotes rereplication 
548
, which undergoes to DNA 
damage 
549,593
. To prevent rereplication, Emi1 was depleted in S-phase arrested cells, first by a 
thymidine block after siRNA transfection and then by HU treatment. Nevertheless, the 
presence of cells with a DNA content higher than 4n observed in the flow cytometry analysis 
(Figure 24) suggests that, after HU release, Emi1-depleted cells that maintain the ability to 
resume replication are actually able to rereplicate. Despite this pool in the Emi1-depleted 
population, the rest of the cells are arrested in S phase due to APC/C
Cdh1
 activation upon a 
prolonged HU treatment. Moreover, induced APC/C
Cdh1
 activation in HCT116 cells by Emi1 
depletion decreases the number of cells that divide with the presence of DNA damage or 
genomic instability, indicating its contribution to safeguard genomic stability. 
Finally, the capacity to proliferate was analysed by colony formation assay. In this sense, Emi1 
depletion promotes by itself a decrease in the number of colonies, similar to the one induced 
by prolonged HU treatment in HCT116 cells. But, if we add to Emi1-depleted cells a prolonged 
replication stress, an additive effect was observed, inducing a significant decrease in the 
proliferation. 
Collectively, our results suggest that the activation of APC/C
Cdh1
 after a prolonged replication 
stress is a mechanism activated in non-transformed human cells that contributes to safeguard 
genomic stability, although it compromises the ability to resume replication. Transformed 
human cells have incorporated mechanisms to avoid APC/C
Cdh1
 activation upon a prolonged 
HU treatment and, consequently, tumour cells are able to recover replication by activating 
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new origins and resume cell cycle progression, despite the acquisition of more genomic 
instability.  
Tumour cells might have developed several mechanisms to avoid APC/C
Cdh1
 activation. On the 
one hand, overexpression of its regulators, such as Emi1, which is frequently overexpressed in 
malignant tumours 
594
. Moreover, it has been recently demonstrated that Emi1 overexpression 
promotes chromosome instability and the formation of multiple solid tumours in vivo, which 
are more proliferative and metastatic than control tumours 
595
. These results are in 
accordance with ours, where we show that APC/C
Cdh1
 inactivation promotes cell cycle 
resumption upon release from replication stress but with an increase in markers of DNA 
damage or genomic instability. Since EMI1 mutations or genomic amplifications are rare in 
human solid cancers, it is likely that this overexpression occurs through a defective pRb 
pathway signalling 
75,596
 or through its stabilization by Evi5 oncogene 
79
. 
On the other hand, other proteins could be responsible for low APC/C activity in tumour cells. 
Conceivably, deubiquitinases like USP28 
109,597
 are found to be overexpressed in colon and 
breast carcinomas 
598,599
, and also in non-small cell lung cancer, where they were correlated 
with low survival rate 
600
. Another possibility is a low strength of premature APC/C induction 
112
. 
Finally, the fact that APC/C is mutated in some human colon cancer cells, such as HT29 
591
, 
could explain the APC/C
Cdh1
 inactivation in some cases, although the model chosen for our 
work, HCT116 cell line, exhibit wild-type APC/C. 
Collectively, the results suggest that the forced activation of APC/C
Cdh1
 in tumour cells in 
response to a prolonged replication stress induces an irreversible cell cycle exit. This could 
provide an opportunity to develop new strategic therapies and Emi1 represents a potential 
target for cancer therapy, as its inhibition could enhance the effect of chemotherapy directed 
to induce replication stress by an irreversible cell cycle exit. 
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II. FORK REMODELLING AFTER AN ACUTE HU-INDUCED REPLICATION STRESS 
As previously explained, replication forks stall for different causes, such as replication and 
transcription machineries collision, the presence of DNA damage or insufficient nucleotides. 
One of the functions of replication checkpoint is the stabilization of replication forks, although 
the fate of replisome is not clear.  
We were interested in defining the mechanisms involved in replication fork stability and 
restart, which occurs after an acute HU treatment, and in the loss of replication recovery, 
which occurs after a prolonged HU treatment. To do so, we used the iPOND technique, which 
allows the isolation of protein complexes crosslinked to EdU thymidine analogue-containing 
fragments that are located at active replication forks 128,550–552,601. This is a powerful tool to 
analyse the HU-induced changes in the replication forks in hTERT-RPE cells. The robust 
methodology of our iPOND experiments was validated by the enrichment of known replisome 
components in the pulse condition. 
The iPOND results of non-transformed human cells showed that, after a prolonged replication 
stress, there is a dissociation of replisome components and also of other proteins involved in 
DNA repair, such as FANCD2 and RAD51, both in the replication forks and in chromatin. This 
would explain the lack of replication fork restart under these conditions. Moreover, the lack of 
repair proteins BRCA2
477
, FAND2
479
 and RAD51
476
 would promote the Mre11-dependent 
degradation of nascent DNA that we observe under these conditions (Figure 39). In addition, it 
has been recently described the role of mitotic regulators, such as Aurora A, in protecting DNA 
replication forks 
602
. Aurora A, as a substrate of APC/C
Cdfh1
, is degraded after a prolonged HU-
induced replication stress, which would cause a deprotection of replication forks and induce 
their degradation 
602
. Nascent DNA degradation could promote the dissociation of replisome 
components and other proteins from chromatin after a prolonged replication stress. 
Surprisingly, the iPOND results also show that replisome components are dissociated from 
nascent DNA already after an acute replication stress, but this does not result in the 
dissociation of those proteins from chromatin at this time. These results suggest that 
replisome components are displaced away from nascent DNA more than dissociated from 
replication forks after an acute replication stress. Moreover, proteins involved in maintaining 
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fork stability and promoting fork restart, such as RAD51, FANCD2 and SMC1/3 cohesins 
329,330,476,479,553
, are recruited in nascent DNA after an acute replication stress. Under these 
conditions, replication forks present single-stranded nascent DNA. Restart from the same 
replication forks occurs without compromising genome integrity in hTERT-RPE cells. 
It was previously reported that replisome components were stably bound to nascent DNA 
upon HU treatment 
426
. The discrepancy with our results could be clarified by several 
explanations. On the one hand, the cellular model used is different: while we use hTERT-RPE 
cells, Dungrawala et al. used HEK293T cells. On the other hand, the dose of HU used is 
different in both cases: our work was done with a dose of 10mM HU, which completely stalls 
replication after 15 minutes of HU addition 
536
, while they used a lower dose of HU (3mM HU), 
which does not completely block EdU incorporation. Thus, EdU was maintained in the media 
during the HU treatment. 
Previous results showed that replication forks of hTERT-RPE cells maintain the competence to 
restart, even in the presence of CDK inhibitor roscovitine, after an acute HU treatment and 
that replisome is displaced away from nascent DNA. In this thesis we have showed that, 
despite the addition of roscovitine, replication forks are not altered, and CMG complex 
maintains its disengagement from nascent DNA. Moreover, the loading of MCM helicases is 
impaired under HU conditions in which cells are arrested in S phase. We have also 
demonstrated that CMG helicase maintains its integrity and association with chromatin after 
an acute replication stress. This, together with the fact that replication forks are able to restart 
after HU release, reinforces the idea that CMG maintains its association with chromatin in 
order to be reused to restart DNA replication.  
The previous results suggested that there was a remodelling event after an acute replication 
stress. The presence of single-stranded nascent DNA suggested that fork reversal could occur 
under our conditions 
470
. In this sense, the work done in this thesis with FBH1, a helicase that 
has been demonstrated to have the capacity to perform fork reversal in vivo 
470
, confirms this 
hypothesis. The presence of single-stranded nascent DNA that appears after an acute 
replication stress decreases after FBH1 depletion in hTERT-RPE cells. Under these conditions, 
where fork reversal is impaired, replication forks are also able to restart, and cell cycle 
progression is resumed. It has to be noted that although single-stranded nascent DNA 
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decreases after acute replication stress in FBH1-depleted cells, it is still significantly different 
from control conditions. In this sense, there are several remodellers that can also have a role 
in fork reversal in our conditions, as SMARCAL1 
335,336
 or ZRANB3 
473
. 
Another possible remodelling event is the uncoupling of helicase and polymerase activities. To 
investigate it, the ssDNA in nascent and parental strands was analysed. The larger amount of 
single-stranded parental DNA obtained upon an acute replication stress suggests that the 
helicase-polymerases uncoupling is the predominant remodelling event under these 
conditions. This could also explain the increased chromatin-bound RPA after acute replication 
stress, which could not be explicated by reversed forks.  
The presence of single-stranded parental DNA after acute replication stress in non-
transformed cells could be due to resection. In this sense, Mre11-dependent degradation may 
cause an accumulation of single-stranded parental DNA 
476
. But our results show that an acute 
replication stress does not cause Mre11-dependent DNA degradation in non-transformed 
human cells, contrary to what happens after a prolonged replication stress. 
Actually, uncoupling of helicase and polymerases activities in replication forks have been 
described to occur in response to several replication stresses agents 
279,462
. Moreover, some 
studies suggest that this uncoupling generates RPA-ssDNA, which was required for checkpoint 
activation 
277,279
. But, the current accepted model of the uncoupling of helicase and 
polymerases activities does not include the disengagement of replisome components from 
nascent DNA, and consequently reinitiation could easily occur. Our proposed models are 
based on the observation that upon 2 hours of HU treatment, replisome components do not 
interact with nascent DNA, although they are bound to chromatin, and that CMG integrity is 
maintained and can be reused once replication stress is removed. On the one hand, the 
presence of nascent ssDNA that decreases after FBH1 depletion indicates that reversed forks 
are present in our conditions. And, on the other hand, the accumulation of long stretches of 
parental ssDNA indicates that there is a functional uncoupling between helicase and 
polymerases activities which results in replisome disengagement from nascent DNA (Figure 
75). 
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Figure 75. Our proposed model after an acute replication stress induced by HU. Under our conditions, 
hTERT-RPE cells remodel their ongoing forks after an acute replication stress. Our results suggest that 
there are two proposed models based on our observations: the reversed forks and the functional 
uncoupling of helicase and polymerases activities with disengagement of nascent DNA. Despite this 
remodelling, these forks are able to restart replication by reusing the same CMG complex. RS: replication 
stress. 
 
Finally, and most interestingly, our data show that the remodelled forks are able to reinitiate 
DNA synthesis upon HU release, although replisome components are displaced away from 
nascent DNA, without compromising genomic stability.  
In the reversed forks, replication fork restart would occur through two different pathways. The 
first pathway has as a central player RECQ1 helicase, which drives fork restart of reversed forks 
by branch migration 
481
. The second pathway includes DNA2 nuclease and WRN helicase that 
process reversed forks and a branch migration factor, such as RAD51, would be needed to 
induce replication fork restart 
482
. 
In the proposed model, in which there is a functional uncoupling of helicase and polymerases 
activities and a disengagement of replisome from nascent DNA, the possible mechanisms of 
replication fork restart are only hypothesis. As explained in the introduction, the lagging-
strand synthesis could be easily reinitiated by the polymerase α binding de novo to the 
replisome after HU release 
232,278
. On the other hand, reinitiation of leading-strand synthesis 
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could be more complex: the 3’ end of nascent DNA has to be carried to the replisome by some 
linker molecule or some polymerase has to work independently of the replisome. Since our 
data show that the bulk of single-stranded parental DNA and phosphorylated chromatin-
bound RPA disappeared rapidly once replication is restarted, a possible explanation could be 
fork repriming by PrimPol or DNA polymerase α. Moreover, RAD51 is also recruited in nascent 
DNA after an acute replication stress, and its interaction with polymerase α 
335
 could promote 
replication fork restart under our conditions. Another possibility could be that the soluble (not 
bound to replisome) polymerase δ would be engaged to the 3’ end of nascent DNA and 
synthesise DNA until catches the CMG complex, when it would be dissociated by collision 
release 
437
.  
Interestingly, our results demonstrate that replication forks are more plastic that one could 
expect, and they can restart replication, even when there is a disengagement of the replisome 
from the nascent DNA, without inducing genomic instability. 
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III. ROLE OF RAD51 IN REPLICATION FORKS IN RESPONSE TO REPLICATION STRESS 
We are also interested on elucidating the mechanisms and proteins important to promote fork 
restart to better understand the mechanisms that cells use to deal with replication stress. 
Since RAD51 could be involved in the restart of the remodelled replication forks after acute HU 
treatment, and it is recruited to nascent DNA under these conditions, we wanted to analyse its 
role in replication forks under replication stress conditions. 
RAD51 is a protein well conserved during evolution from its bacterial RecA to human ortholog 
RAD51, since it is a key element of HR, having a critical role in DNA homology search and in 
catalysing strand invasion 
603
. Moreover, emerging roles in replication fork protection and 
restart have been identified for RAD51 and other mediators, such as BRCA2 
476,477,479
. 
The recruitment of RAD51 to nascent DNA observed after acute HU treatment make us 
wonder if RAD51 could have a role in fork protection 
335,476,479,568,604–606
 or in fork restart 
370,476
 
in hTERT-RPE cells. The work has been done with two different approaches: on the one hand 
RAD51 depletion with siRNA, and on the second hand RAD51 inhibition with B02. B02 is a 
small molecule inhibitor of RAD51, which was identified by a high-throughput screening 
531
. 
This molecule specifically inhibits the strand exchange activity of RAD51, inhibiting the HR 
repair mechanism and increasing sensitivity to DNA damage agents 
532–534
. 
First, we analysed if RAD51 had a role in replication fork restart after acute replication stress. 
The two approaches (both RAD51 silencing or inhibition by B02) does not affect the number of 
restarted forks, although the IdU (second analogue) track length is impaired under these 
conditions. Thus, RAD51 seems to be important for efficient fork restart or progression after 
an acute replication stress. In RAD51 silencing, the impairment in fork progression is obtained 
only when roscovitine is added to avoid the activation of new origins. In HU conditions without 
roscovitine, dormant origins that cannot be distinguish by DNA fiber assay would compensate 
replication. This does not happen with RAD51 inhibition, since the impairment is already 
observed in conditions without roscovitine. These differences could be explained for the 
timing of RAD51 silencing or inhibition: the siRNA transfection takes place 48 hours before the 
DNA labelling, so cells might have adapted by the time DNA labelling was performed, while the 
RAD51 inhibition is performed during DNA labelling, with no time for adaptation. Moreover, it 
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should be noted that the number of cells in S phase 48 hours after siRNA transfection is 
significantly reduced, since RAD51 depletion has a strong effect on cell cycle, generating an 
accumulation of cells in G2 phase, as has been previously described
571
. 
Next, we analysed if RAD51 had a role in replication fork protection. In chapter 1, we 
demonstrate that there is no Mre11-dependent degradation after an acute replication stress 
in hTERT-RPE cells. In this sense, we analysed the nascent DNA labelled before HU addition to 
study RAD51 contribution in protecting nascent DNA from degradation under our conditions. 
Despite having an effect on efficient fork restart or progression, RAD51 depletion or inhibition 
does not cause fork degradation after an acute replication stress in contrast to what is 
described, since no decrease in nascent labelled DNA is observed under these conditions. 
Thus, after an acute replication stress induced by 10mM HU, RAD51 is recruited to nascent 
DNA to promote efficient fork restart or progression, but not to protect nascent DNA in hTERT-
RPE cells. 
As mentioned, RAD51 depletion had a great effect on cell-cycle, resulting in accumulation of 
cells in G2 phase, where it is required for HR repair, so we performed the next experiments 
only with RAD51 inhibitor.  
RAD51 inhibition by itself has no effect on fork progression in hTERT-RPE cells, although it has 
an effect on mitotic entry under unperturbed conditions. As previously described, RAD51 is 
dispensable for DNA replication but is required in G2 to resolve DNA structures that would 
impede mitotic entry 
571,607
. Moreover, it has to be noted that the mitotic entry is more 
impaired after an acute HU treatment, when RAD51 inhibition has an effect in replication fork 
progression in hTERT-RPE cells.  
To decipher which role RAD51 has in fork progression after acute replication stress, we 
performed a DNA fiber assay, adding the B02 inhibitor at different times: during all the HU 
release or after 30 minutes of HU release. We already knew that most replication forks of 
hTERT-RPE cells need 30 minutes to restart after an acute HU treatment (data not shown), so 
the last condition allowed us to know if RAD51 is important for fork progression after 
replication fork restart. The first condition may be important for the recognition of RAD51 as 
an important protein for efficient replication fork restart. The results show that the labelling of 
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the second analogue during HU release is impaired in both conditions, having more effect in 
the condition where the inhibitor is maintained through all the HU release, suggesting that 
both efficient fork restart and fork progression are affected due to RAD51 inhibition after an 
acute replication stress in hTERT-RPE cells. 
Due to RAD51 role in replication forks after an acute HU treatment, we next analysed its 
contribution to genomic stability. In order to analyse the cells that were in S phase just before 
HU treatment, an EdU pulse was performed previously to label replicating cells and the 
presence of more than six 53BP1 foci was analysed in the S-phase population. Although RAD51 
inhibition has a small effect in mitotic entry under unperturbed conditions, this was not 
reflected with an increase in genomic instability. Instead, after an acute HU treatment, where 
the effect on mitotic entry was more pronounced by RAD51 inhibition, the number of EdU-
labelled cells with more than six 53BP1 foci increases significantly when RAD51 inhibitor was 
added during HU release in non-transformed human cells.  
Finally, after analysing the consequences that RAD51 inhibition had on replication forks after 
an acute replication stress in hTERT-RPE cells, we analysed if this protein was also relevant for 
replication fork progression during a mild or bearable replication stress. As a mild replication 
stress, we used a lower dose of HU (1mM) that allows DNA replication in hTERT-RPE, even 
though fork progression is significantly impaired, activating the replication checkpoint 
response. As a bearable replication stress, which represents a more physiological replication 
stress, we used, on the one hand, an even lower dose of HU (0.1mM) in hTERT-RPE that does 
not activate replication checkpoint response and, on the other hand, a colorectal cancer cell 
line, HCT116, that presents a higher basal replication stress compared with the non-
transformed human cell line hTERT-RPE. In all cases, RAD51 inhibition with B02 impairs 
replication fork progression. In conclusion, RAD51 is also relevant for replication fork 
progression during a mild or bearable replication stress, although the consequences of its 
inhibition on genome instability and survival have to be elucidated. 
Our results are slightly misaligned with a work done by Yoon et al. with mouse embryonic 
stem cells (mESCs) that indicates that RAD51 suppression does not affect replication fork 
progression and speed 
607
. It has been previously described that ESCs proliferate rapidly and 
exhibit a high degree of replication stress 
608–610
 . In this sense, we would expect that RAD51 
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suppression to have an effect in replication fork progression under basal increased replication 
stress conditions, as we have seen in HCT116 cell line. Instead, results from Yoon et al. are 
more similar to the ones obtained with hTERT-RPE cell line. Moreover, they suggest that 
replication dynamics do not differ in RAD51-depleted cells when compared with control cells 
607
, as also shown in our data. However, Yoon et al. analyse the replication dynamics by IdU 
and CldU labelling foci, but no significant differences in IdU-CldU foci colocalization were 
obtained with RAD51 depletion 
607
. 
On the other hand, there is another study performed by Kim et al. in mESC that used two 
RAD51 mutants, one defective for ATP binding and one defective for ATP hydrolysis. Although 
they do not affect RAD51-protein interaction, ATP binding is critical for assembly and 
stabilization of nucleofilament, essential for proper RAD51 function. Both mutants exhibit 
impaired cellular proliferation and reduced replication fork restart after a mild replication 
stress 
611
. Under our conditions, replication dynamics are not affected with RAD51 inhibition, 
although the conditions of the experiment are different. As mentioned, mESC are supposed to 
exhibit a higher basal replication stress 
608–610
, and Kim et al. use a dose of 2mM of HU during 2 
hours. The IdU labelling after HU release is very short (about 20 minutes), so it is possible that 
replication forks do not have time enough to restart replication. Moreover, since we know that 
RAD51 has a role in the efficient fork restart and progression after an acute replication stress, 
it is possible that this short time in IdU labelling is turned into an increase in the number of 
stalled forks under these conditions.  
Interestingly, RAD51 is overexpressed in a wide range of human tumours, contributing to their 
drug resistance 
612–615
. In this sense, tumour cells in which RAD51 expression is suppressed 
612,615,616
 or its activity is inhibited 
532–534,615
 become susceptible to DNA-damaging agents. All 
these studies, together with our data, suggest that RAD51 is a potential target for cancer 
therapy, the inhibition of which could enhance not only the effect of DNA damage-based 
chemotherapy but could also enhance the effect of replication stress-induced chemotherapy. 
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IV. OZF IS ESSENTIAL TO MAINTAIN FORK PROGRESSION RATE UNDER REPLICATION STRESS 
CONDITIONS 
OZF was identified as a zinc-finger protein 
576
 that interacts with a telomeric protein, hRap1 
578
, 
and with the SUMO-1 conjugating enzyme UBC9 
579
, although its function remains unknown.  
Previous work of our group has defined OZF as a novel Claspin-interacting protein that 
localizes at ongoing replication forks in control situation in hTERT-RPE cells. Since Claspin is an 
important protein for the correct replication in a normal cell cycle 
186,583,585,617,618
 and also for 
the replication checkpoint response 
308,574,619
, it made us wonder if OZF would have a role in 
these processes. 
Our data show that OZF interacts with Cdc45, MCM2 and MCM6, all components of CMG 
complex. Thus, OZF is located in activated origins, which correlates with the fact that it is also 
present in the ongoing replication forks. Nevertheless, its depletion does not affect fork 
progression neither replication dynamics under unperturbed conditions in hTERT-RPE. Hence, 
OZF does not have a role in replication in a control situation in non-transformed human cells. 
Interestingly, OZF depletion impairs replication fork progression, but does not affect 
replication dynamics, under mild or bearable replication stress conditions in hTERT-RPE. On 
the other hand, OZF is not essential for replication checkpoint activation, since OZF-depleted 
cells also activate Chk1 after a mild replication stress induced by 1mM HU treatment.  
Due to the effect that OZF silencing has in fork progression during a mild or bearable 
replication stress in hTERT-RPE cells, we analysed its contribution in genomic stability. Cell 
cycle progression, the presence of cells with 53BP1 and ɣH2AX foci and colony formation were 
analysed after a release of 1mM HU treatment. The results show that OZF depletion does not 
affect cell cycle progression nor mitotic entry. These cells do not present more DNA damage, 
and colony formation is not affected either. Thus, the impairment in fork progression seems to 
have no effect on cell cycle progression, on DNA damage nor on cell viability in OZF-depleted 
hTERT-RPE cells, since these cells are able to deal with these differences in replication fork 
progression without major consequences. 
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Since previous studies of OZF described its overexpression in pancreatic cancer 
587
 and in 
colorectal cancer 
588
, we wanted to analyse its relevance in the colorectal cancer cell line, 
HCT116, which exhibits a higher basal replication stress than the non-transformed human cells 
hTERT-RPE. Our results show that OZF depletion impairs replication fork progression in tumour 
HCT116 cell line under unperturbed conditions. The consequences in genomic stability, which 
could be different from hTERT-RPE cells, remain to be elucidated. The non-transformed human 
cells could deal with replication stress and could repair the DNA damage, while tumour cells 
could be more OZF-dependent because they might not repair the DNA damage so well. 
Such as it is described, OZF overexpression is restricted to tumour cells 
587
 and is already 
observed in low-grade adenomas, occurring in the primary stage of tumour progression 
588
. 
Moreover, OZF is a c-Myc oncogene-target gene 
589
.  A possible explanation is that c-Myc 
oncogene activity induces rapidly replication stress 
620
 and also could induce OZF 
overexpression that would maintain replication forks progression rate under replication stress 
conditions. Since OZF expression is dysregulated as an early event in tumour formation, it 
could be a potential indicator and also a therapeutic target if its physiological relevance is 
demonstrated.  
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As a summary of all the results included in this thesis, a final model is shown (Figure 76). In 
HEK193T cells, transfected OZF interacts with several components of CMG complex. Since 
previous data showed that OZF was present in nascent DNA under unperturbed conditions in 
hTERT-RPE cells, we assume that OZF is interacting with replisome in their ongoing replication 
forks. In this case, OZF does not have a clear function in replication fork progression, but it 
could be there prepared for a replication stress situation. In case of bearable (0.1mM HU) or 
mild replication stress (1mM HU), during which replication forks are able to duplicate DNA, 
both OZF and RAD51 are important for replication forks progression in hTERT-RPE cells. 
Moreover, in tumour cells such as HCT116 cell line, which present a higher basal replicative 
stress, these proteins are also important for replication fork progression during unperturbed 
conditions. 
After an acute replication stress (10mM HU during 2h), stalled forks are able to restart once 
the stress is released, both in hTERT-RPE cells and HCT116 cells. We have deeply studied the 
remodelling events that occur in response to acute replication stress in non-transformed 
human cells. In this case, HU-induced replication inhibition causes both fork reversal and, 
predominantly, a functional helicase-polymerases uncoupling with replisome disengagement 
from nascent DNA. In reversed forks we have demonstrated that FBH1 has a role in this 
remodelling event, although we cannot rule out that other remodellers participate in this 
process. Moreover, in response to acute replication stress, RAD51 is recruited to nascent DNA 
and our results suggest that this protein has a role in efficient fork restart and progression 
once HU is removed. These remodelling events do not compromise replication fork restart 
neither genome integrity in hTERT-RPE cells.  
After prolonged replication stress (10mM HU during 14 hours), non-transformed human cells 
activate APC/C
Cdh1
 during S phase, which compromises the ability to resume replication by 
inhibiting origin firing and contributes to safeguard genomic stability 
536
. Moreover, replication 
forks collapse and nascent DNA is degraded by Mre11. Instead, transformed human cells have 
incorporated mechanisms to avoid APC/C
Cdh1
 activation upon a prolonged HU treatment. 
Consequently, tumour cells, such as HCT116, are able to recover replication by the activation 
of new origins and resume cell cycle progression, despite the acquisition of genomic 
instability. 
  
Figure 76. Final model. 
Our results suggest that 
different mechanisms and 
molecules are involved in 
replication stress response. In 
response to a bearable or mild 
replication stress, RAD51 and 
OZF are required for fork 
progression in both hTERT-
RPE and HCT116 cell lines. In 
response to acute replication 
stress, some remodelling 
events occur at replication 
fork level in hTERT-RPE cell 
line: fork reversal and, 
predominantly, a functional 
uncoupling of helicase-
polymerases activities with 
replisome disengagement 
from nascent DNA.  RAD51 
has a role in replication fork 
restart after acute replication 
stress in hTERT-RPE cells. 
After a prolonged replication 
stress, the activation of 
APC/C
Cdh1
 compromises the 
ability to resume replication in 
hTERT-RPE, while transformed 
cells avoid this mechanism at 
the expense of acquisition of 
genomic instability. 
RS: replication stress. 
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Understanding how checkpoint mechanisms are working on non-transformed cells, and 
comparing them with tumour cells, can help us understand the alterations that tumour cells 
have acquired in order to bypass these regulations. This can aid in the discovery of new 
molecules relevant to deal with each S phase in tumour cells with a higher basal replication 
stress, and to develop new anti-tumoral therapies. Although further experimentation is 
needed, from this thesis we can conclude that Emi1, RAD51, and OZF are potential targets for 
cancer therapy, the inhibition of which could enhance the effect of chemotherapy directed to 
induce replication stress. 
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Based on the exposed results, the general conclusions of this thesis are: 
1. The lack of activation of APC/C
Cdh1
 in S phase in HCT116 cells allows DNA replication 
resumption after a prolonged HU treatment by new origin activation, even though 
genomic instability is acquired in the process. 
2. After an acute HU treatment, there is replisome disengagement from nascent DNA and 
functional helicase-polymerases uncoupling, but CMG complex maintains its integrity and 
can be reused for replication fork restart in hTERT-RPE cells. 
3. RAD51 is essential for efficient fork restart and progression after both acute and mild 
replication stress in hTERT-RPE cells. Furthermore, RAD51 is essential for replication fork 
progression under unperturbed conditions in HCT116 cells, which present a higher basal 
replication stress. 
4. OZF, which co-immunoprecipitates with CMG complex in basal conditions, is necessary 
for replication fork progression during a mild replication stress in hTERT-RPE cells and is 
important for replication fork progression under unperturbed conditions in HCT116 cells. 
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Based on the previously defined objectives and exposed results, the specific conclusions of this 
thesis are: 
I. Conclusions from the study of the contribution of APC/C
Cdh1
 activation after a 
prolonged HU-induced replication stress to preserve genomic integrity. 
1.1) Tumour cell lines are predominantly deficient in APC/C
Cdh1
 activation in S phase and 
are able to resume replication in response to a prolonged HU treatment. 
1.2) New origin firing contributes to replication recovery in HCT116 cells after a 
prolonged HU treatment. 
1.3) HCT116 cells acquire genomic instability after a prolonged HU treatment. 
1.4) Emi1 depletion-induced APC/C
Cdh1
 activation compromises replication resumption 
and genomic instability acquisition in HCT116 cells. 
II. Conclusions from the analysis of the HU-induced changes at replication fork levels in 
non-transformed human cells. 
 
2.1) CMG helicase maintains its integrity and association with chromatin after an acute 
replication stress in hTERT-RPE cells. 
2.2) CMG helicase is disengaged from nascent DNA after an acute replication stress, 
indifferently of CDK activity in hTERT-RPE cells. 
2.3) FBH1 depletion reduces the amount of single-stranded nascent DNA, but does not 
impair replication fork restart in hTERT-RPE cells. 
2.4) Replisome disengagement from nascent DNA correlates with large amounts of 
single-stranded parental DNA and RPA accumulation. 
2.5) Nascent DNA is not degraded by Mre11 after an acute replication stress in hTERT-
RPE cells. 
2.6) Replication resumption occurs without long stretches of single-stranded parental 
DNA in hTERT-RPE cells. 
 
 
 
CONCLUSIONS 
 
191 
 
III. Conclusions from the characterization of the role of specific proteins, RAD51 and OZF, 
at replication forks in response to HU-induced replication stress. The conclusions of 
RAD51 role are obtained from chapter 3 in the results section, while the conclusions about 
OZF are obtained from chapter 4 in the results section. 
3.1) RAD51 depletion or inhibition does not affect the number of restarted forks but 
impairs fork progression after an acute replication stress in hTERT-RPE cells. 
3.2) RAD51 depletion or inhibition does not cause fork degradation after an acute 
replication stress in hTERT-RPE cells. 
3.3) RAD51 depletion does not impair replication recovery, although increases genomic 
instability, after an acute replication stress in hTERT-RPE cells. 
3.4) RAD51 inhibition does not affect fork progression under unperturbed conditions in 
hTERT-RPE. 
3.5) RAD51 is necessary for an efficient fork restart and progression after an acute 
replication stress in hTERT-RPE cells. 
3.6) RAD51 inhibition affects mitotic entry, having more effect after an acute replication 
stress in hTERT-RPE cells. In this last case, an increase in genomic instability is also 
obtained. 
3.7) RAD51 inhibition affects fork progression under mild or bearable replication stress 
in hTERT-RPE cells and also during unperturbed conditions in HCT116 cells. 
3.8) OZF interacts with components of CMG complex, although it is not essential for 
replication in hTERT-RPE cells under unperturbed conditions. 
3.9) OZF depletion reduces fork progression rate under mild replication stress conditions 
in hTERT-RPE cells, although it is not essential for checkpoint activation.  
3.10) OZF depletion reduces fork progression in HCT116 cells under unperturbed 
conditions. 
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1. CELL CULTURE 
1.1. CELL LINES AND CULTURE CONDITIONS 
The cellular models and culture conditions used in this thesis are specified below: 
Table 3. Cell lines used in this thesis. 
Cell line Cell type Medium Origin 
hTERT-RPE 
Human retinal pigment epithelial 
cells, immortalized with hTERT 
DMEM: F12 (1:1) supplemented 
with 7% FBS (foetal-bovine serum, 
Biological Industries) 
ATCC 
HCT116 
Human colorectal 
adenocarcinoma cells 
DMEM: F12 (1:1) supplemented 
with 7% FBS 
Dr. 
Capellà, 
ICO 
A431 
Human epithelial cells from 
epidermoid carcinoma 
DMEM supplemented with 10% 
FBS 
ATCC 
DLD-1 
Human colorectal 
adenocarcinoma cells 
DMEM: F12 (1:1) supplemented 
with 7% FBS 
ATCC 
HeLa 
Human epithelial cells derived 
from a cervix cancer 
DMEM supplemented with 10% 
FBS 
ATCC 
HPAF-II 
Human pancreatic ductal 
adenocarcinoma cells 
DMEM supplemented with 10% 
FBS 
ATCC 
HT29 
Human epithelial cells from 
pancreatic ductal 
adenocarcinoma  
DMEM supplemented with 10% 
FBS 
ATCC 
MCF7 
Human epithelial cells derived 
from breast cancer metastasis in 
the pleural effusion 
DMEM supplemented with 10% 
FBS 
London 
(S. 
Guaita) 
SW1990 
Human epithelial cells derived 
from pancreatic ductal 
adenocarcinoma metastasis in 
the spleen 
DMEM supplemented with 10% 
FBS 
ATCC 
U2OS Human osteosarcoma cells 
DMEM supplemented with 10% 
FBS 
ATCC 
HEK293T 
Human embryonic kidney cells, 
immortalized with SV-40 
DMEM supplemented with 10% 
FBS 
ATCC 
 
All culture media (Biological Industries, ref. 01-055-1A for DMEM and ref.01-095-1A for F12) 
were supplemented with 1% of non-essential amino acids (Biological Industries, ref.01-340-
1B), 2mM L-Glutamine (Sigma-Aldrich, ref.49419), 1mM pyruvic acid (Sigma-Aldrich, 
ref.P5280), 50U/mL penicillin and 50µg/mL streptomycin (both from Biological Industries, 
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ref.03-031-1B). All supplements were filtered with a 2µm membrane before being added to 
the media in order to maintain sterility.  
Cell lines were maintained at 37°C in incubators (Thermo Scientific, HERACell 150i) with 
humidified atmosphere of 5% CO2, which were periodically treated with biocide- and anti-
mycoplasma-containing products. Manipulation of cells was always performed under sterile 
conditions inside a vertical laminar flow hood (Mars Safety Class 2) with previously sterilized 
material. 
1.2. MAINTENANCE OF CULTURED CELLS 
When cells were at around 80% of confluency, they were subcultured to prevent medium 
exhaustion or, in the case of normal cells, growth arrest due to contact inhibition.  To do so, 
the medium from the flasks was removed and discarded and the cells were washed with PBS 
(phosphate-buffered saline) to remove any traces of serum. Cells were enzymatically 
dissociated by adding 0.05% trypsin (Biological Industries, ref.15400-054) for a few minutes 
and, once detached, fresh medium was added to inactivate the trypsin (at least twice the 
trypsin volume). The cell-medium mixture was homogenised by pipetting several times and a 
portion of cells was transferred into a new flask, where fresh culture medium was added. 
PBS 
131mM NaCl 
1.54mM KH2PO4 
5.06mM Na2HPO4 
 
1.3. CRYOPRESERVATION 
Cell lines are a valuable resource and thus, it is important to have a long-term storage system 
for them. When needed, cells at a low passages were cryopreserved in liquid nitrogen in 
complete medium with 10% dimethyl sulfoxide (DMSO; Sigma, ref.D2650), a cryoprotective 
agent that reduces the risk of ice crystal formation. Three cryotubes of cell suspension was 
prepared from each 150cm
2
 flasks. Cells were enzymatically dissociated with trypsin (as 
explained before) and once detached, they were collected in a 15mL sterile tube and were 
centrifuged at 650g for 5 minutes at 4°C. Then, the supernatant was removed, and pellets 
were resuspended in 2.7mL of supplemented culture medium. Finally, cell suspension was 
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mixed with DMSO and the cryotubes were rapidly mixed and placed in dry ice. The vials were 
stored in a liquid nitrogen storage container. 
On regular basis, a new vial of low passage cells was taken from the liquid nitrogen container 
and thawed in supplemented cultured medium. The cells were thawed slowly by pipetting 
small volumes of cultured medium into the cryotube, resuspending as many cells as possible 
and returning the solution to the 15mL tube to dilute the DMSO. The process was repeated 
until all cells from the cryotube were in suspension. The tube was centrifuged at 650g for 5 
minutes at 4°C and the supernatant was removed. The pellet was resuspended with 13mL of 
fresh medium and the cells were transferred into a 75cm
2
 flask and were incubated overnight 
in incubators. After that, medium was replaced and, if necessary, cells were subcultured. 
1.4. AGENTS USED 
Table 4. Agents used in this thesis. 
Agent Reference Function Working concentration 
Thymidine Sigma, T1895 Deoxynucleoside 
1.5mM in hTERT-RPE 
2.5mM in HCT116 
if not specified otherwise 
Hydroxyurea 
(HU) 
Sigma, H8627 
Ribonucleotide reductase 
inhibitor 
10mM to stall replication 
forks 
1mM or 0.1mM to slow 
replication forks 
Nocodazole Sigma, M1404 
Inhibitor of microtubule 
polymerization 
250ng/mL in tumour cells 
500ng/mL in hTERT-RPE 
MG132 
SelleckChem, 
S2619 
Proteasome inhibitor 20µM 
BrdU Sigma, B5002 Thymidine analogue 
10µM in asynchronously 
growing cells 
20µM in synchronized cells 
CldU Sigma, C6891 Thymidine analogue 25µM 
IdU Sigma, I7125 Thymidine analogue 
250µM 
 
EdU 
Invitrogen, 
A10044 
Thymidine analogue 50µM 
Roscovitine Sigma, R7772 CDK inhibitor 25µM 
B02 Sigma, SML0364 Rad51 inhibitor 25µM 
Mirin Sigma, M9948 Mre11 inhibitor 50µM 
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1.5. THYMIDINE SYNCHRONIZATION 
Cell synchronization is used in order to obtain a population enriched on a specific cell cycle 
phase. In this thesis, cell synchronization was performed with a single thymidine block to 
obtain a population enriched in S-phase. As mentioned before, thymidine is a 
deoxynucleoside, and an excess of it can be used to inhibit DNA synthesis, thereby arresting 
cells either at the G1/S transition, or in S phase. This arrest can be easily reverted by removing 
the thymidine from the media, allowing the cells to re-enter into S phase. It should be noticed 
that this reversible S-phase arrest may promote replication stress, as it promotes fork stalling. 
This synchronization method can be used to synchronize any cell line in S phase. To this end, 
cells were seeded at 60% of confluency and then thymidine was added to the media. Cells 
were incubated with thymidine for 20-24 hours, and finally released into fresh media for 2 
hours, time at which more than 80% of the cells are in S phase. 
1.6. DNA TRANSFECTION METHODS 
1.6.1. CALCIUM PHOSPHATE 
For transient transfection of HA-tagged proteins, HEK293T cells were transfected using calcium 
phosphate. Calcium phosphate facilitates the binding of the co-precipitate of condensed DNA 
to the cell surface, therefore DNA is able to enter into the cell by endocytosis. 
Cells were seeded in a 10cm
2
 plate and, at the time of transfection, they were at around 50% 
of confluency. Some hours (6 hours approximately) before transfection, the medium was 
replaced.  
For a 10cm
2
 plate, two tubes were prepared with the following solutions: 
A. 0,5mL of HBS2X 
B. 0,5mL of a mixture of ultrapure water with 10µg of DNA and 250mM CaCl2. 
The solution B was added on top of solution A slowly (drop-wise) and stirred with a vortex. It 
was incubated during 10 minutes at room temperature (RT) and it was vortexed twice during 
that period. The mix was poured around the plate, while stirring gently. Fresh medium was 
added after 8-16 hours of transfection and cells were collected after 48 hours post-
transfection. 
MATERIALS AND METHODS 
 
199 
 
HBS 2X pH7 solution 
50mM HEPES 
10mM KCl 
280mM NaCl 
12mM Dextrosa 
1.5mM Na2HPO4 
 
1.7. SIRNA TRANSFECTION 
Transient siRNA transfections were performed using HiPerFect Transfection Reagent (Qiagen, 
ref.301705) or Lipofectamine® RNAiMax (Invitrogen, ref.13778), according to manufactures 
guidelines. 
1.7.1. HIPERFECT TRANSFECTION 
For HiPerFect-mediated transfections, reverse-transfection protocol was used and thus, cell 
seeding and transfection were carried out on the same day. The number of cells used in each 
case was calculated according to manufacturer’s guidelines. siRNA oligos were transfected at 
50nM final concentration. In the case of hTERT-RPE cells, 140.000 cells were plated in a 35cm
2 
plate for each transfection. The proper volume of siRNA was added to a sterile tube, and then 
the mix of HiPerFect and OptiMEM (Gibco, ref.31985-070) was prepared (indicated in Table 5). 
The mix was added to the siRNA and it was incubated for 15-30 minutes. Finally, the cells in 
suspension were added to the tube with the transfection reagents, carefully mixed and 
seeded. Filter tips and clean gloves were used in all cases.  
Table 5. Volums used in HiPerFect Transfection in a 6-well plate. 
Culture 
format 
Equivalent volume 
of 20µM of siRNA 
stock 
Volume of 
HiPerFect 
Volume of 
OptiMEM 
Volum of cells (in a 
concentration of 
77777cells/mL) 
6-well plate 
(35cm
2 
plate) 
5µL 15µL 200µL 1.8mL 
To prevent possible off-target effects, oligo sets containing 4 different sequences 
(ONTARGETplus SMARTpools; Dharmacon) were used in all cases, except in the case of OZF, 
where a mix of 3 different sequences was used. The siRNA concentration that resulted in an 
efficient decrease in target protein levels was analysed for each of them before experiments 
were conducted. The following siRNA oligos (Dharmacon) were transfected with HiPerFect 
reagent in hTERT-RPE cell line: 
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Table 6. siRNA sequences used in this thesis in HiPerFect transfection. 
Target protein Reference Sequences 
Non-target (NT) D-001810-10-20 
5’-UGGUUUACAUGUCGACUAA-3’ 
5’-UGGUUUACAUGUUGUGUGA-3’ 
5’-UGGUUUACAUGUUUUCUGA-3’ 
5’-UGGUUUACAUGUUUUCCUA-3’ 
FBH1 L-017404-00-0005 
5’-CCUCAACGCUGGUCAAGUA -3’ 
5’-AGGGAAGGGUGGAUUCAUA-3’ 
5’-GUGCCUAUUUGGUGUAAGA-3’ 
5’-AAACAAAACCUCGUCAUUA-3’ 
Rad51 L-003530-00-0005 
5’-UAUCAUCGCCCAUGCAUCA-3’ 
5’-CUAAUCAGGUGGUAGCUCA-3’ 
5’-GCAGUGAUGUCCUGGAUAA-3’ 
5’-CCAACGAUGUGAAGAAAUU-3’ 
OZF 
J-019625-05-002 5’-GCGAGAAGCUUUUCGAAUG-3’ 
J-019625-06-002 5’-GCAAAUCCAACCUUACUGA-3’ 
J-019625-07-002 5’-GCGAACAUCACUUAUUGUA-3’ 
 
1.7.2. LIPOFECTAMINE® RNAIMAX TRANSFECTION 
For Lipofectamine® RNAiMAX-mediated transfections, forward-transfection protocol was used 
and thus, cells were seeded to be 60-80% confluent at the time of the transfection. The 
Lipofectamine® RNAiMAX reagent was diluted in OptiMEM medium. In parallel, siRNA was also 
diluted in OptiMEM (the volumes used in 6-well plate was indicated in Table 7). Then, diluted 
siRNA was added to the diluted Lipofectamine® RNAiMAX reagent (1:1 ratio), and the mix was 
incubated at RT for 5 minutes. Finally, the siRNA-lipid complex was added to the cells. 
Experiments were performed after 1-2 days of transfection.  
Table 7. Volumes used in Lipofectamine® RNAiMax Transfection in a 6-well plate. 
Culture format 
Equivalent volume of 
20µM of siRNA stock 
Volume of 
OptiMEM 
Volume of 
Lipofectamine® 
RNAiMAX 
Volume of 
OptiMEM 
6-well plate 
(35cm
2 
plate) 
5µL 195µL 6µL 194µL 
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The following siRNA oligos (Dharmacon) were transfected with Lipofectamine®  RNAiMAX 
reagent in HCT116 cell line: 
Table 8. siRNA sequences used in this thesis in Lipofectamine®  RNAiMAX transfection. 
Target protein Reference Sequences 
Non-target 
(NT) 
D-001810-10-20 
5’-UGGUUUACAUGUCGACUAA-3’ 
5’-UGGUUUACAUGUUGUGUGA-3’ 
5’-UGGUUUACAUGUUUUCUGA-3’ 
5’-UGGUUUACAUGUUUUCCUA-3’ 
Emi1 L-012434-00-0005 
5’-CAACAGACACUUAAUAGUA-3’ 
5’-CGAAGUGUCUCUGUAAUUA-3’ 
5’-UGUAUUGGGUCACCGAUUG-3’ 
5’-GAAUUUCGGUGACAGUCUA-3’ 
OZF 
J-019625-05-002 5’-GCGAGAAGCUUUUCGAAUG-3’ 
J-019625-06-002 5’-GCAAAUCCAACCUUACUGA-3’ 
J-019625-07-002 5’-GCGAACAUCACUUAUUGUA-3’ 
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2. CELL PROLIFERATION AND SURVIVAL ASSAYS 
2.1. COLONY FORMATION ASSAY 
Colony formation assay is based on crystal violet-mediated proteins and DNA staining of 
attached cells to evaluate the cell viability after the treatment at long-term conditions. 
For colony formation assays, cells were seeded in 12-well plates and treated during the 
indicated times with HU or left untreated. Cells were then extensively washed with PBS and 
then released into fresh medium without HU. After some hours of release, cells were diluted 
(200 cells in each well) in 6-well plates. Seven days later, cells were fixed and stained with 1% 
crystal violet in 70% ethanol during 5 minutes at RT and the number of colonies was counted.    
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3. ELECTROPHORESIS AND WESTERN BLOT (WB) 
3.1. PREPARATION OF SAMPLES 
Three different type of samples have been used to perform electrophoresis and WB analysis 
during this thesis: whole cell lysates, chromatin enriched fractions and iPOND extracts. The 
preparation of each of them was performed as explained below. 
3.1.1. WHOLE CELL LYSATES 
For whole cell lysates, cells were washed with PBS and then lysed by adding a SDS (sodium 
dodecyl sulphate)-containing lysis buffer. Cells were collected by scraping.   
The high amount of anionic detergent denaturalizes all the proteins, and the addition of 
protease and phosphatase inhibitors is not required in this case. Nevertheless, SDS 
precipitates at low temperature and thus, samples had to be collected at RT.  
After adding the lysis buffer, lysates were viscous due to DNA denaturing. To fluidify the 
samples and degrade the DNA, they were heated at 97°C for 15 minutes and finally stored at -
20°C. 
Lysis buffer (pH 6,8) 
67mM Tris 
2% SDS 
 
3.1.2. CHROMATIN ENRICHED FRACTIONS 
Chromatin extraction was performed following a modified version of the protocol described 
on (Méndez and Stillman, 2000)
621
. Samples must be kept on ice and sterile material has to be 
used all the time. 
First, cells were harvested by scraping on ice with ice-cold PBS, and then centrifuged at 660g 
for 5 minutes at 4°C. Supernatant was discarded and pellets could be stored at -80°C during 
several weeks. 
Next, cells were lysed by adding buffer A (8 times the volume of the pellet), supplemented 
with freshly added protease and phosphatase inhibitors and Triton X-100. The optimal 
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concentration of Triton X-100 and the incubation time on ice must be set up for each cell line 
(from 0.1% to 0.5% of Triton X-100, and from 10 to 20 minutes of incubation). To do so, the 
degree of lysis and purified nuclei could be observed under microscopy. In the case of hTERT-
RPE, lysis was performed with 0.1% Triton X-100-containing buffer A during 20 minutes on ice. 
In HEK293T cells, lysis was performed in 0.1% Triton X-100-containing buffer A during 10 
minutes on ice. After that, cells were centrifuged at 600g for 5 minutes at 4°C. 
Supernatants (S1 fraction), corresponding to the cytoplasmic fraction of the cells, were 
collected in a new tube and stored at -20°C. Pellets, corresponding to nuclei, were washed 
with buffer A (8 times the volume of the pellet) supplemented with protease and phosphatase 
inhibitors but without Triton X-100, and then centrifuged at 600g for 5 minutes at 4°C. 
Supernatants were discarded and pellets (nuclei) were resuspended and incubated during 10 
minutes on ice with buffer B (8 times the volume of the pellet, a critical point) supplemented 
with protease and phosphatase inhibitors. After incubation, cells were centrifuged at 1700g 
for 5 minutes at 4°C. 
Supernatants (S2 fraction), corresponding to the nuclear soluble fractions, were collected in 
new tubes and stored at -20°C. Pellets, corresponding to chromatin-associated and nuclear 
matrix-bound proteins, were washed with buffer B (8 times the volume of the pellet) 
supplemented with inhibitors until they became transparent (more than two washes are not 
required). Supernatants were discarded each time by centrifugation at 600g for 5 minutes at 
4°C. 
Finally, pellets were resuspended in lysis buffer (3 times the volume of the pellet), which is the 
same one used in whole cell lysates. Since samples contained SDS, they were heated at 97°C 
for 15 minutes and finally stored at -20°C.  
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Buffer A 
10mM HEPES, pH 7.4 
10mM KCl  
1.5mM MgCl2  
0.34M sucrose  
10% glycerol  
1mM DTT  
Protease inhibitors: 21μM leupeptine, 154nM aprotinine, 1mM PMSF  
Phosphatase inhibitors: 1mM NaF, 0.1mM sodium orthovanadate 
 
 
Buffer B 
3mM EDTA 
0.2mM EGTA 
1mM DTT 
Protease inhibitors: 21μM leupeptine, 154nM aprotinine, 1mM PMSF  
Phosphatase inhibitors: 1mM NaF, 0.1mM sodium orthovanadate 
 
3.2. PROTEIN QUANTIFICATION 
Protein quantification was performed using two different colorimetric assays: 1) Bradford 
assay
622
, which is based in Coomassie Blue G-250 dye binding, and 2) the Lowry assay
623
, based 
on copper-protein chelation.  
3.2.1. BRADFORD METHOD 
The Bradford method relies on the binding of the dye Coomassie Blue G250 to the proteins. 
The binding of the dye to a protein causes a shift in the absorbance maximum of the dye from 
465 to 595nm. The increase of absorption at 595nm is monitored to determine protein 
concentration. 
This assay has certain limitations, as it cannot be used to quantify protein when the sample 
contains certain substances such as EDTA or detergents such as Triton X-100 or SDS, because 
they interfere with the estimation of protein concentration.  
This assay was performed when RIPA buffer was used. Bovine serum albumin (BSA) was used 
to obtain the calibration curve.  
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Firstly, diluted Bradford solution was prepared by diluting Protein Assay Dye Reagent 
Concentrate (Bio-Rad, ref.500-006) with distilled water in proportion 1:4. Then, standards and 
samples were prepared by following the table below (Table 9). Replicates of each standard 
and sample were prepared twice. 
Table 9. Volumes required to prepare standards and samples in 96-well plates. 
 
µg of BSA  
(stock 1µg/µL) 
µL of sample µL of lysis buffer µL of water  
Standards 
0 - 1 39 
1 - 1 38 
2 - 1 37 
4 - 1 35 
8 - 1 31 
16 - 1 29 
Samples - 1 - 39 
After that, 160µL of diluted Bradford solution was added to the wells and mixed well by 
pipetting up and down several times. The mix was incubated for 10 minutes at RT. Finally, the 
absorbance of each well was measured with a multimode plate reader (Spark®, TECAN) at 
595nm and 450nm, and the ratio 595nm/450nm was used to estimate the protein 
concentration, since it has been demonstrated that this ratio is  linearly correlated with 
protein concentration
624
. 
With the absorbance values of the standards, a simple lineal regression was performed. With 
the absorbance values of the samples, the average of replicates was calculated, it was 
interpolated, and the concentration of each sample was determined. 
3.2.2. LOWRY METHOD 
The Lowry method was developed approximately 60 years ago. The Lowry reaction is based on 
the amplification of the Biuret reaction, in which the peptide bonds of proteins react with 
copper under alkaline conditions to produce Cu
+
, and a subsequent reaction with the Folin-
phenol reagent, consisting in the oxidation of the aromatic residues of the protein by the 
reagent. In the Folin-Ciocalteau reaction, the phosphomolybdotungstate present in the 
reagent is reduced to heteropolymolybdenum blue, which absorbs light at 750nm. 
This assay was used for protein quantification in samples lysed with buffers-containing more 
than 1% SDS. BSA was used to obtain the calibration curve.   
MATERIALS AND METHODS 
 
207 
 
First, Solution A was prepared as a reaction mixture of the reagents 1, 2 and 3, following the 
proportions 48:1:1. Secondly, Solution B was prepared by diluting Folin-Ciocalteau’s Phenol 
reagent (Merck, ref.1.09001) in distilled water in proportion 1:1. 
Then, the standards and the samples were prepared by following the table below (Table 10). 
Replicates of each standard and sample were prepared twice. 
Table 10. Volumes required to prepare standards and samples in 96-well plates. 
 
µg of BSA  
(stock 1µg/µL) 
µL of sample µL of lysis buffer µL of water  
Standards 
0 - 2 8 
0.5 - 2 7.5 
1 - 2 7 
2 - 2 6 
4 - 2 4 
8 - 2 0 
Samples - 2 - 8 
After that, 180µL of Solution A was added to the wells and mixed well by pipetting. The mix 
was incubated for 10 minutes at RT. 
Then, 20µL of Solution B was added and mixed well by pipetting. It was incubated 30 minutes 
at RT and the absorbance is measured at 750nm in multimode plate reader (Spark®, TECAN). 
With the absorbance values of the standards, a simple lineal regression was performed. With 
the absorbance values of the samples, the average of replicates was calculated, it was 
interpolated, and the concentration of each sample was determined. 
Solution A 
Solution 1: 2% of Na2CO3 in 0.1M NaOH 
Solution 2: 0.5% CuSO4
 
Solution 3: 1% sodium potassium tartrate 
  
Solution B 
Folin-Ciocalteau’s Phenol reagent 
Distilled water
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3.3. SAMPLE PREPARATION 
Samples were prepared to load between 15-50µg of protein in each well. The volumes of the 
different samples were normalized between them by adding lysis buffer. Finally, loading buffer 
(Laemmli buffer
625
) was added at 1x final concentration and samples were boiled for 5 minutes 
at 97°C.  The presence of DTT reduces any disulphide bridges present that hold together the 
protein tertiary structure. On the other hand, SDS is an anionic detergent which binds strongly 
and denatures the protein. 
Laemmli Buffer  
(loading buffer) 
67mM Tris-HCl, pH 6.8 
10% glycerol 
2% SDS 
10mM DTT 
0.01% Bromophenol blue 
 
3.4. ELECTROPHORESIS AND WB 
Electrophoresis combined with WB is a semi-quantitative method used to detect and quantify 
the relative abundance of proteins of interest on a certain sample. The first step consists in 
separating the proteins by SDS-PAGE electrophoresis. The SDS present on the samples, on the 
gel and on the buffers, denatures the proteins and adds negative charges on them, so they can 
migrate towards the positive pole, while they are separated according to their molecular 
weight. Separated proteins are then transferred to nitrocellulose membranes, where they are 
detected by incubation with primary and secondary antibodies. The primary antibodies 
recognize the protein of interest via the variable region (Fab), and they are recognized by 
secondary antibodies conjugated to HRP (horseradish peroxidase) enzyme on their constant 
region (Fc). Finally, these secondary antibodies are detected by the addition of peroxidase 
substrate ECL (enhanced chemiluminescent substrate), which reacts with the HRP enzyme 
present on the secondary antibody, giving a chemiluminescent substrate. 
* The electrophoresis and WB experiments were performed at least three times in each case. 
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3.4.1. SDS-PAGE ELECTROPHORESIS 
The SDS-polyacrylamide gels can be prepared with different amounts of acrylamide, which 
provides different size of pores. For high molecular weight proteins, a lower amount of 
polyacrylamide was required to form larger pores. For low molecular weight proteins, a higher 
amount of polyacrylamide was used to form smaller pores. Gels have two different sections, 
the stacking and the resolving. While the former allows the alignment of the different samples 
loaded in the gels due to its larger pores, the latter is the one properly separating the proteins. 
The system Mini-PROTEAN® of Bio-Rad was used in all our experiments. 
Table 11. Volumes required to prepare stacking and resolving gels. 
 Resolving gel 
Stacking gel 
 6% 10% 12% 
Solution 1 (mL) 5 5 5 - 
Solution 2 (mL) 2 3.4 4 0.36 
Solution 3 (mL) - - - 1.5 
Ultrapure water (mL) 3 1.6 1 1.2 
TEMED (µL) 14 14 14 7.5 
1,5APS 13% (µL) 50 50 50 30 
 
Gel solutions 
Solution 1: 0.75M Tris-HCl pH 8.8, 0.2% SDS 
Solution 2: 30% Acrylamide, 0.8% Bis-acrylamide
 
Solution 3: 0.25M Tris-HCl pH 6.8, 0.2% SDS 
The mix of resolving gels were prepared, adding the polymerizing agents last (Table 11). First, 
the mix of resolving gel was poured between the glasses of the structure built up to create the 
gels, and 1mL of ultrapure water was added slowly on top of the resolving mix, without 
disrupting it. Once polymerized, the ultrapure water was removed by decantation. 
The mix of stacking gels was prepared (Table 11). It was poured on top of the resolving gel and 
immediately a gel comb was insert in order to create the loading wells. Once the stacking gel 
was polymerized, the glasses containing the gel were transferred from the building structure 
to the electrophoresis bucket. The running buffer was added until the gel was completely 
sunk, and the comb was removed.  
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Electrolyte buffer 
25mM Tris 
192mM Glycine 
0.1% SDS 
In one of the loading wells, 2.5µL of protein standard (Precision All Blue Standards 
(ref.1610373) or Low (ref.1610304) or High Range Unstained Standards (ref.1610303), all from 
Bio-Rad) was loaded. The previously prepared samples were then loaded in the rest of wells 
with a Hamilton syringe. 
The electrophoresis bucket was plugged to the power source and set at 100V to run the gels 
(Figure 77). When samples reached the bottom of the bucket (it can be determined by the 
intense blue band of bromophenol that Laemmli buffer contained), the power source was 
unplugged, and the next step was performed. 
 
Figure 77. Diagram of SDS-PAGE. 
3.4.2. TRANSFERENCE OF PROTEINS TO NITROCELLULOSE MEMBRANES 
Once proteins had been properly separated according to their molecular weight, they had to 
be transferred into a nitrocellulose membrane to be able to incubate them with specific 
antibodies, avoiding the interference of diffusion and denaturing reagents.  
The membranes needed to be hydrated by sinking them in transfer buffer. All the sponges, 
filter papers, membranes and gels were equilibrated in transfer buffer. The sandwich was 
assembled with the necessary parts stacked for the transference, as indicated in Figure 78. No 
MATERIALS AND METHODS 
 
211 
 
air bubbles could remain between the membrane and the gel. Two sponges and filter papers 
were used to build up pressure inside the sandwich.  
 
Figure 78. Diagram of protein transference to a nitrocellulose membrane 
 
The sandwich was transferred to a transference bucked filled with transfer buffer. The bucket 
was plugged to a power source at 4°C and the desired voltage was set. During this thesis, the 
transference was performed during 2 hours at 70V. After this time, the membrane was dried 
in order to fixate the proteins. For proteins with a molecular weight higher that 120KDa, the 
transference was performed using a 2x transference buffer, which contains twice the SDS and 
electrolyte concentration. 
Transfer buffer 
25mM Tris 
192mM Glycine 
0.02% SDS 
20% Ethanol 
 
Transfer buffer 
2x 
50mM Tris 
384mM Glycine 
0.04% SDS 
20% Ethanol 
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3.4.3. PONCEAU S STAINING 
The Ponceau S is a sodium salt of a diazo dye of a light red colour, that can be used to rapidly 
and reversibly stain and detect protein bands on nitrocellulose membranes. Its staining 
allowed the determination of the efficiency of the previous steps of the WB and it could be 
used as a loading control. 
The membrane was incubated in Ponceau S solution for 1 minute. After that, it was destained 
with several washes with distilled water to diminish background colour. The standard protein 
was marked with a pencil. Finally, the membrane was washed until it was completely 
destained.   
Ponceau Protein Stain Solution 
0.1% Ponceau reagent (Sigma, P3504)  
5% Acid acetic 
 
3.4.4. BLOCKING 
Membranes must be blocked to avoid the antibodies to be non-specifically attached to the 
membranes. Since the membrane has the ability to bind to proteins, it is necessary to saturate 
it before incubating the antibodies. Blocking of membranes was performed using 3% milk-
containing Tris-Buffered Saline-Tween20 (TBS-T) for total proteins, or 3% BSA-containing TBST-
T. The membranes were incubated with those blocking buffers for 1 hour while shaking at RT. 
TBS-T 
20mM Tris 
150mM NaCl 
0.05% Tween20 
 
3.4.5. INCUBATION WITH PRIMARY AND SECONDARY ANTIBODIES 
Blocked membranes were incubated overnight at 4°C with primary antibodies against the 
proteins of interest, diluted in 3% BSA-containing blocking solution. The incubation was static 
in a humidity chamber. The dilution used for each primary antibody was specified below 
(Table 12). 
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After that, membranes were washed three times with TBS-T (for 7 minutes each wash), and 
then incubated during 1h at RT with secondary antibodies against the primary ones, diluted in 
5% milk-containing TBS-T in a static manner. The dilution used for each secondary antibody 
was specified below (Table 13). Then, the membranes were washed twice with TBS-T and once 
with TBS (7 minutes each).  
TBS 
20mM Tris 
150mM NaCl 
 
3.4.6. DEVELOPING 
Finally, the membranes were developed by adding an ECL solution (EZ-ECL; Biological 
Industries, ref.20-500-120) that reacts with the HRP enzyme present on the secondary 
antibody, giving a chemiluminescent reaction. When the substrate of peroxidase (luminol) was 
added, it resulted in an excited state, and when it returned to stable conditions, it emitted 
light, which was captioned by the exposition of the membrane to a film (AGFA Cunik 60, 
Fujifilm) or a camera (ChemiDoc™, BioRad). The membranes were exposed different times to 
obtain a good visualization of the proteins. 
3.4.7. ANTIBODIES 
Table 12.Primary antibodies with the commercial provider, reference and dilution 
used in this thesis for WB. 
Primary antibodies Reference Source Dilution 
Cdc45 (H-303) Santa Cruz; sc-55569 Rabbit 1/200 
CDK4 (H-303) Santa Cruz; sc-709 Rabbit 1/500 
Cyclin A2 (H-432) Santa Cruz; sc-751 Rabbit 1/500 
Cyclin B1 (GNS1) Santa Cruz; sc-245 Mouse 1/200 
Emi1 Invitrogen; 37-6600 Mouse 1/100 
GAP120 Santa Cruz; sc-63 Mouse 1/200 
H3 Abcam; ab1791 Rabbit 1/2000 
HA Sigma; H6908 Rabbit 1/1000 
Lamin B1 (M-20) Santa Cruz; sc-6217 Goat 1/500 
MCM2 (H-126) Santa Cruz; sc-10771 Rabbit 1/200 
MCM3 Homemade (by Dr. Juan Méndez) Rabbit 1/1000 
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MCM6 (C-20) Santa Cruz; sc-9843 Goat 1/200 
OZF Sigma, HPA003358 Rabbit 1/3000 
P-Chk1 (S296) Cell signalling; #2349 Rabbit 1/1000 
Psf3 (GINS3) Bethyl Laboratories; A304-124A Rabbit 1/2000 
Rad51 (H-92) Santa Cruz; sc-8349 Rabbit 1/200 
RPA32 Cell signalling; #2208 Rat 1/1000 
 
Table 13. Secondary antibodies with the commercial provider, reference and dilution 
used in this thesis for WB. 
Secondary antibodies Reference 
Dilution for 
whole cell 
lysates 
Dilution for chromatin-
enriched fractions and 
 iPOND extracts 
Anti-Rabbit IgG (H+L) HRP 
Conjugate 
BioRad, 
1706515 
1/3000 1/2000 
Anti-Mouse IgG (H+L) HRP 
Conjugate 
BioRad, 
1706516 
1/3000 1/2000 
Anti-Rat IgG (whole 
molecule) Peroxidase 
conjugate 
Sigma, 
A9037 
1/3000 1/2000 
Anti-Goat IgG (whole 
molecule)-Peroxidase  
Sigma, 
A5420 
1/10000 1/5000 
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4. IPOND: ISOLATION OF PROTEINS ON NASCENT DNA 
iPOND
550,551
 is a powerful technique to analyse the proteins bound directly or indirectly to the 
nascent DNA. The method is based on the isolation of proteins complexes crosslinked to EdU 
thymidine analogue-containing nascent DNA, which allows the conjugation of biotin through a 
click reaction and the purification of proteins crosslinked by high affinity interaction between 
biotin and streptavidin. Proteins obtained by iPOND can then be analysed by electrophoresis 
and WB (iPOND+WB) or by the identification/quantification by mass spectrometry 
(iPOND+MS). In this thesis only the analysis by WB was performed, and to do so one 100cm
2
 
plate per condition was used. The biotinylation and sonication of the samples were always 
validated before performing the modified version of iPOND
128
. 
4.1. PREPARATION OF SAMPLES 
The iPOND procedure begins by incubating cells with EdU (referenced in Table 2) for a short 
period of time (15 minutes) to label the replication forks, and then some dishes were treated 
while others were left untreated (Pulse control condition). Cells were fixed in 1% PFA-
containing PBS for 10 minutes at RT. After crosslinking, PFA was quenched with 0.125mM 
glycine (pH 7) for 5 minutes at RT. Then, cells were washed twice with PBS and finally 
harvested in ice-cold PBS, supplemented with protease inhibitor cocktail (PIC, Roche 
14424700), by scrapping. Cells’ pellets were obtained by centrifugation at 1000g for 10 
minutes at 4°C and finally stored at -80°C (during a couple of weeks). 
4.1.1. PROCESSING: BIOTINYLATION AND SONICATION OF SAMPLES 
Cells’ pellets were lysed by incubation of 500µL of lysis buffer (ChIP-IT® Express Shearing Kit, 
Active Motive 53032), supplemented with 0.05% PCI-containing PBS and 0.5mM PMSF, during 
30 minutes on ice. 
Lysates were passed 10 times through a 21-gauge needle, and then nuclei were pelleted by 
centrifugation at 2400g for 10 minutes at 4°C. Pellets were washed with PCI-containing PBS 
and centrifuged again at 2400g for 10 minutes at 4°C. 
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In order to conjugate biotin with the EdU incorporated into nascent DNA, click reaction was 
performed. This reaction is based on the presence of an alkyne functional group in EdU that 
allows cooper-catalysed cycloaddition to a biotin azide to yield a stable covalent linkage. To 
this end, cells’ nuclei were incubated during 30 minutes at RT with 500µL of click reaction 
solution.  
Click reaction solution 
100mM Tris-HCl, pH 8 
2mM CuSo4 
0.2mM biotin azide (Invitrogen B10184) 
100mM ascorbic acid 
*Reagents must be added to ultrapure water in this order 
After click reaction, nuclei were pelleted by centrifugation, washed again as previously with 
PIC-containing PBS and then pelleted again by centrifugation at 2400g for 10 minutes at 4°C. 
Finally, pellets were resuspended in 600µL of shearing buffer (Active Motif, ref.101231) 
supplemented with 0.05% PCI-containing PBS, sonicated in a water sonicator (Bioruptor, 
Diagenode) for 15 minutes at high intensity (30s on/30s off pulses), and centrifuged at 15000g 
for 20 minutes at 4°C. After that, supernatants were collected and divided it in: 
- Input: 30µL of sample, and 30µL of lysis buffer was added. Input was boiled for 15 
minutes (in case of proteins of high molecular weight, samples were boiled during 30 
minutes). Input was finally quantified by Lowry assay (section 3.2.2). 
- DNA purification and validation of sonication: 30µL of sample 
- Dot-blot: 10µL of sample 
- iPOND extract: 530µL of sample 
The samples were stored at -20°C.  
* Samples must be kept on ice if not specified otherwise. 
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4.2. DNA PURIFICATION AND VALIDATION OF SONICATION 
For DNA purification, 30µL of processed cell extracts (5%) were mixed and incubated overnight 
at 65°C with 170µL of ultrapure water, 10µL of 5M NaCl and 1µL of RNAse (Active Motif, 
ref.101249; 10µg/µL) to reverse the crosslink. 
After that, 1µL of Proteinase K (Ambion, AM2546; 20µg/µL) was added, and samples were 
incubated at 55°C during more than 4 hours. Then, 1µL of Glicogen (20µg/µL, no essential), 
2.2µL of sodium acetate 3M pH 5.2 and 267µL of cold 100% ethanol were added into the 
sample and mixed. The mix was finally incubated overnight at -20°C. 
After incubation, the samples were centrifuged at maximum speed during 30 minutes at 4°C. 
The pellet was washed once with cold 70% ethanol, and centrifuged at maximum speed during 
10 minutes at 4°C. The pellet was left at 37°C to dry it, and finally it was incubated with 20µL 
of ultrapure water (previously tempered at 55°C) during 20 minutes at 55°C to elute DNA. 
The obtained DNA was quantified using a nanodrop (ThermoFisher Scientific). After that, 10ng 
of DNA was send to Functional Genomics Facility of IDIBAPS to analyse with Bioanalyzer 2100 
the fragments of DNA obtained. On the other hand, the sample left was loaded into a Red Safe 
(INtRON, ref. 21141)-containing 1.5% agarose gel. Finally, DNA fragments were visualized 
using Infinity system of gel documentation (Vilber). Fragments of 100-300bp were properly 
considered to perform iPOND technique. 
4.3. DOT-BLOT 
The biotinylation of the samples was analysed by dot-blot. To this end, 1µL of processed cell 
extract was spotted onto a nylon membrane (Hybond-N+, Amersham) in triplicate. As a 
standard, a serially diluted 5’-biotinylated oligonucleotide (5’-
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGG-3’) was used, and also was spotted in triplicate 
on the membrane. After that, membranes were air-dried at room-temperature for 15 minutes, 
and then DNA was crosslinked to the membrane by UV light using a GS Gene Linker UV 
Chamber (program C-L, 125mJ). After crosslinking, membranes were rehydrated with TBS-T, 
blocked with 5mg/mL salmon sperm DNA- (Sigma) containing TBS-T for 1 hour at room-
temperature, and washed several times with TBS-T before incubation with primary antibody. A 
primary antibody against Avidin, which was already conjugated to HRP enzyme, was used in 
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this case. Membranes were incubated during 15 minutes at room-temperature with the 
primary antibody (1/1000), washed several times with TBS-T and finally developed using ECL.  
4.4. IPOND 
The modified version of iPOND
128
 was performed as follows. For each condition, 500µL of 
beads were used. Streptavidin-conjugated Dynabeads M-280 (Invitrogen) were washed three 
times with cold 1x ChIP buffer and then blocked during 1 hour at ROOM-TEMPERATURE with 10 
mg/mL salmon sperm DNA- (Sigma-Aldrich) containing PBS. Then blocking solution was 
removed and beads were resuspended in 4.5mL of cold 1x ChIP dilution buffer with 10 mg/mL 
salmon sperm DNA. Processed cell extracts (aprox. 500µL) were then incubated with 
previously blocked Dynabeads (1:10) for 30 minutes at RT. Finally, beads were washed twice 
with low salt buffer and twice with high salt buffer (between washes, 5 minutes in rotation at 
RT), and then resuspended in 200µL of Laemmli buffer 2X for WB analysis. Finally, samples 
were boiled during 30 minutes at 97°C. Samples must be kept on ice before the addition of 
Laemmli buffer if not specified otherwise. 
 
1x ChIP 
buffer 
1% Triton X-100  
2mM EDTA, pH 8  
150mM NaCl  
20mM Tris-HCl, pH 8  
20mM beta-glycerol phosphate 
2mM Na3VO4  
 
Low salt 
buffer 
1% Triton X-100  
High salt 
buffer 
1% Triton X-100 
2mM EDTA, pH 8  2mM EDTA, pH 8  
150mM NaCl  500mM NaCl 
20mM Tris-HCl, pH 8   20mM Tris-HCl, pH 8  
 
 
 
 
 
MATERIALS AND METHODS 
 
219 
 
5. IMMUNOPRECIPITATION 
In this thesis, the interaction between different proteins was analysed by 
immunoprecipitation, which is a small-scale affinity purification of antigens using specific 
antibodies that are immobilized on agarose resine. 
5.1. IMMUNOPRECIPITATION OF HA-OZF 
In this case, a pre-immobilized antibody approach was used, since anti-HA antibody was bound 
to agarose and was used to immobilize the protein HA- tagged OZF. This immunoprecipitation 
was used to check if OZF protein interacts with other replisome proteins.   
The HEK293T transfected cells with HA-OZF were collected by scrapping with ice-cold PBS on 
ice. Cells were centrifugated at 600g during 5 minutes at 4°C and pellets. 
To perform the immunoprecipitation, firstly nuclei were obtained from the samples (already 
explained in section 3.1.2). Cells were lysed by the addition of buffer A (8 times the volume of 
the pellet), supplemented with freshly added protease and phosphatase inhibitors and 0.1 % 
Triton X-100 in HEK293T cells, during 10 minutes on ice. After that, cells were centrifuged at 
600g for 5 minutes at 4°C. Pellets were washed with buffer A (8 times the volume of the 
pellet), supplemented with freshly added protease and phosphatase inhibitors and without 
Triton X-100.  Cells were centrifuged at 600g for 5 minutes at 4°C, the supernatant was 
discarded, and pellet corresponded to nuclei was kept. 
Secondly, nuclei were lysed by resuspending the pellets by the addition of buffer RIPA250 (5 
times the volume of the pellet), supplemented with DNAse (8 units/100µL), and nuclei were 
incubated during 45 minutes at 4°C in rotation. Nuclei were centrifugated at 14100g during 10 
minutes at 4°C to eliminate non-soluble fractions. Supernatants were collected (soluble 
fraction), and pellets were discarded. The soluble fraction of nuclei was quantified by Bradford 
assay (see in section 3.2.1). 
Finally, immunoprecipitation was performed. Firstly, 20µg of protein was separated as INPUT, 
and stored at -20°C. Then, 50µL per sample of Monoclonal Anti-HA-Agarose antibody (clone 
HA-7, Sigma, A20956) was washed with PBS five times, and finally RIPA250 buffer was added 
to the initial volume taken. After that, the beads were incubated with 1000-1500µg of protein 
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obtained from soluble nuclei fraction (the volumes were normalized between them by adding 
RIPA250 buffer) during 3 hours at 4°C in rotation. After incubation, samples were centrifuged 
at 10000g for 30 seconds. Pellets were the bound fraction, while supernatant was kept as not 
bound fraction. Bound fraction was washed three times with 1mL of RIPA250. To perform the 
immunodetection, loading buffer 4x was added to the beads. The bound and not bound 
fractions were stored at -20°C since electrophoresis was performed. Samples must be kept on 
ice before the addition of Laemmli buffer if not specified otherwise 
5.2. IMMUNOPRECIPITATION OF MCM3 
For MCM3 immunoprecipitation, a protocol from Dr. Juan Méndez’s laboratory was used. 
Briefly, a free antibody approach was used: the free and unbound antibody was allowed to 
form immune complexes in the cell lysate and the complexes were then retrieved to the 
beads.  In this case antibodies against MCM3 was used to purify the complexes bound to those 
proteins and analyse them after HU treatment. This technique was performed in hTERT-RPE 
cells, and the volumes indicated are for a 150cm
2
 plate. 
Firstly, chromatin solubilization was performed from samples collected as in section 3.1.2.  For 
nuclei obtaining, cells were lysed by the addition of 400µL of buffer A, supplemented with 
freshly added protease and phosphatase inhibitors and 0.1% Triton X-100, and incubated for 
20 minutes. After that, cells were centrifuged at 600g for 5 minutes at 4°C. Supernatants (S1 
fraction), corresponding to the cytoplasmic fraction of cells, were collected in a new tube and 
stored at -20°C. Pellets, corresponding to nuclei, were washed with 400µL of buffer A 
supplemented with protease and phosphatase inhibitors but without Triton X-100, and then 
centrifuged at 600g for 5 minutes at 4°C. Supernatants were discarded and, to obtain soluble 
chromatin, pellet (nuclei) were incubated with 1mM CaCl2 – containing buffer A (400 µL) and 
0.2U of micrococcal nuclease (Sigma, N3755) was added. It was incubated 2 minutes at 37°C 
and the reaction was stopped by adding 1mM EGTA to the mix. The nuclei were collected by 
centrifugation as above. Finally, the pellet was resuspended and incubated during 30 minutes 
on ice with 400µL of buffer B supplemented with protease and phosphatase inhibitors, with 
occasional mild vortexing. After incubation, samples were centrifuged at 1700g for 5 minutes 
at 4°C. Pellet (P2 fraction) was enriched in insoluble chromatin and nuclear matrix proteins. 
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Supernatant (S2 fraction) corresponded to solubilized chromatin and this was used for 
immunoprecipitation. 
Finally, MCM3 immunoprecipitation was performed. First, 20µL of solubilized chromatin were 
separated as INPUT, 20µL of loading buffer 4X was added to it and it was stored at -20°C. 
Then, half the volume of the sample (approximately 180µL) was incubated with 4µL of anti-
MCM3 (homemade, from Dr. Méndez; Rabbit) and the other half (approximately 180µL) was 
incubated with 40µL of anti-IgG (Rabbit, Sigma, I8140) during 1 hour at 4°C in rotation.   
Meanwhile, the Pierce® Protein A Agarose beads (ThermoScientific, 20333) were washed: 
40µL of beads per condition was used, and washed with PBS five times, and finally buffer B 
was added to the initial volume taken.  
After adding 40µL of beads per condition, samples were incubated for 1 hour at 4°C in 
rotation. Finally, samples were centrifuged at 10000g for 30 seconds. Pellets were the bound 
fraction, while supernatant was kept as not bound fraction. Bound fraction was washed twice 
with wash buffer 1. To perform the immunodetection, loading buffer 4x was added to the 
beads. The bound and not bound fractions were stored at -20°C since electrophoresis was 
performed. 
Wash buffer 1 
50mM Tris-HCl, pH 7.4 
150mM NaCl 
1mM EDTA 
1% Triton X-100  
 
Wash buffer 2 
50mM Tris-HCl, pH 7.4 
250mM NaCl 
1mM EDTA 
1% Triton X-100  
* Samples must be kept on ice before the addition of Laemmli buffer if not specified otherwise. 
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6. FLOW CYTOMETRY 
Flow cytometry was used to analyse different cell features, such as DNA content, as well as to 
determine the number of cells in S- phase or in mitosis, by a combined analysis of DNA 
content, BrdU and MPM2. For this analysis, cells were incubated with BrdU-containing 
medium before treating them as indicated. Then cells were harvested by trypsinization and 
centrifuged at 660g for 5 minutes at 4°C. After that, cell pellets were washed with ice-cold PBS 
and centrifuged as before. Finally, cells were resuspended in ice-cold PBS, diluted 1:10 in cold-
ethanol 70% and stored at -20°C during at least 2 hours to fix them. Samples can be stored at -
20°C for several months. 
After fixation, cells were washed with PBS-T, and then centrifuged at 660g for 5 minutes at 
4°C. Then DNA was denatured by incubation with 0.1% Triton X-100-containing 2M HCl-PBS 
solution for 15 minutes at RT. HCl was then neutralized by washing twice with borate buffer 
(0.1M Na2B4O7·10H2O, being the pH adjusted to 8.5 by the addition of 0.1M boric acid 
solution), which was removed each time by centrifugation at 660g for 5 minutes at 4°C. After 
neutralization, cell pellets were rinsed with PBS-T and centrifuged as above. Then the blocking 
step was performed by incubation of cells with 3% BSA-containing PBS-T for 1 hour at RT. After 
blocking, cells were centrifugated as above and cell pellet was incubated with primary 
antibodies anti-BrdU (Abcam, ab6326; Rat; 1/250) and anti-MPM2 (Millipore, #05-368; Mouse; 
1/250) diluted in blocking solution for 1 hour at RT in rotation. After that, cells were 
centrifugated as above. Finally, cell pellets were washed with PBS-T and incubated with 
secondary antibodies Alexa488-conjugated anti-rat (Invitrogen, A21208; 1/400) and Alexa647-
conjugated anti-mouse (Invitrogen,A31571; 1/500) diluted in PBT-T for 45 minutes at RT in 
dark, washed again with PBT-T and finally resuspended in 1% propidium iodide-containing 
PBS, supplemented with 1mg/mL RNAse (Sigma, ref.R4875). Cells were incubated with this 
solution during 30 minutes at 37ºC before flow cytometry analysis with BD FACSCalibur 
(Cytometry and Cell Sorting Core Facility, IDIBAPS). The analysis of the data was performed 
with FlowJo software. 
PBS 
145mM NaCl 
PBS-T 
145mM NaCl 
6mM Na2HPO4 6mM Na2HPO4 
2.5mM NaH2PO4 2.5mM NaH2PO4 
 
 0.05% Tween20 
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7. IMMUNOFLUORESCENCE 
As flow cytometry, immunofluorescence is a useful technique to analyse several cell features. 
It uses the specificity of primary antibodies to their antigen, to detect them with secondary 
antibodies conjugated to fluorescent molecules than can be visualized by fluorescent 
microscopy. 
For flow cytometry analysis, cells are maintained in suspension. By contrast, cells are attached 
to coverslips for immunofluorescence techniques and mounted onto slides with mowiol after 
the immunofluorescence. 
Images were acquired using Leica TCS-SL or Zeiss LSM880 confocal microscopies (Confocal 
Microscopy Unit Core Facility, UB), and analysed using Fiji (Image J) software.  
* Coverslips can be kept for several months at 4°C into dark chambers. 
7.1. 53BP1/CYCD1, 53BP1/ƔH2AX AND 53PB1 IMMUNOFLUORESCENCE 
Previously grown attached in coverslips and treated, cells were rinsed with PBS and fixed with 
2% PFA-containing PBS for 20 minutes at RT. After several PBS washes, cells were 
permeabilized with 0.2% Triton X-100-containing PBS for 10 minutes at RT and washed with 
PBS for 5 minutes. Then the cells were incubated with blocking solution (3% FBS- and 0.1% 
Triton X-100-containing PBS) for 1 hour at RT. After blocking, cells were incubated with the 
indicated primary antibodies anti-53BP1 (Abcam, ab36823; Rabbit; 1/500), anti-YH2AX 
(Millipore, #05-636; Mouse; 1/3000) or anti-CycD1 (DCS-6, sc-20044; 1/100) diluted in blocking 
solution for 45 minutes at 37°C. After 15 minutes washing in blocking solution at RT in 
agitation, cells were incubated with Alexa488-, Alexa555-, or Alexa647-conjugated secondary 
antibodies (Invitrogen, 1/500) diluted in blocking solution for 20 minutes at 37°C. Then, cells 
were washed again with blocking solution at RT and DNA was counterstained with DAPI 
(Sigma-Aldrich, ref.D9564). Finally, coverslips were mounted onto slides with mowiol-
containing media (Sigma-Aldrich, ref.81381). Cells counterstained with DAPI were used to 
analyse the presence of micronuclei, where indicated. 
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For EdU staining, the click reaction was performed previously to immunofluorescence.  To this 
end, cells were incubated during 30 minutes at RT with 500µL of click reaction solution.  
Click reaction solution 
100mM Tris-HCl, pH 8 
2mM CuSo4 
1uM Alexa488- azide (Invitrogen, A10266) 
100mM ascorbic acid 
*Reagents must be added to ultrapure water in this order 
7.2. SSDNA ANALYSIS BY BRDU IMMUNOFLUORESCENCE UNDER NATIVE CONDITIONS 
To analyse the accumulation of ssDNA in the nascent or parental DNA, a BrdU 
immunofluorescence was performed under native conditions. For nascent ssDNA detection, 
the BrdU incorporation in replication forks was done just for 10 minutes to label nascent DNA 
recently synthesized in cells previously attached to coverslips. For parental ssDNA detection, 
the BrdU incorporation was done for 48 hours and then released overnight in 10µM thymidine 
before HU treatment. After HU treatment, cells were rinsed with PBS, permeabilized with 0.5% 
Triton X-100-containing PBS for 10 minutes at RT and fixed with 3% PFA/2% sucrose-
containing PBS solution for 10 minutes at RT. After several PBS washes, cells were incubated 
with blocking solution with 3% BSA/0.05% Tween 20-containing PBS during 1 hour at RT. Cells 
were incubated with the anti-BrdU (Becton Dickinson; 347580; Mouse; 1/50) antibody diluted 
in blocking solution for 1 hour at 37°C. After 15 minutes washing in blocking solution at RT in 
agitation, cells were incubated with Alexa488-conjugated anti-mouse secondary antibody 
(Invitrogen, A21202; 1/500) diluted in blocking solution for 20 minutes at 37°C. Then, cells 
were washed again with blocking solution at RT and DNA was counterstained with 1% 
propidium iodide-containing PBS supplemented with 0.1mg/mL RNAse (Sigma, ref. R4875) 
during 15 minutes at 37°C or with DAPI (Sigma-Aldrich, ref. D9564). Finally, coverslips were 
mounted onto slides with mowiol (Sigma-Aldrich, ref.81381).  
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8. QUANTITATIVE IMAGE-BASED CYTOMETRY (QIBC) 
QIBC experiments were performed by Amaia Ercilla PhD at the Centre for Chromosome 
Stability (University of Copenhaguen) as described in (Toledo et al., 2013) 
239
. Briefly, cells 
were seeded in 96-well plates, treated as indicated and collected for immunofluorescence. 
Cells were incubated with 0.5% Triton X-100-containing PBS for 1 minute at 4°C to pre-extract 
the soluble proteins. After that, cells were fixed in 4% PFA-containing PBS for 10 minutes at 
RT. After fixation, cells were incubated with anti-BrdU (Becton Dickinson, 347580; Mouse; 
1/50) or/and anti-RPA (homemade; Rabbit; 1/1000) primary antibodies for 1 hour at RT. 
Finally, cells were incubated with Alexa Fluor Plus secondary antibodies for 1 hour at RT. 
Images were acquired by a motorized Olympus IX-81 wide-field microscope and analysed with 
the ScanR Acquisition software. 
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9. DNA FIBER ANALYSIS 
DNA fiber assay
626
 is a powerful technique to analyse replication dynamics
543
. DNA fibers are 
labelled with two different thymidine analogues (CldU and IdU), which are visualized by 
incubation with different anti-BrdU antibodies that present different specificity for each of 
them. The incubation of cells with the different analogues, before and after 10mM HU 
treatment (which stalls replication forks and replication did not continue), allowed us to 
determine the number of stalled forks (labelled only with the first analogue), restarted forks 
(labelled with both analogues) and new origin firing events (labelled only with the second 
analogue) in each case. The incubation with both analogues, before and during 1mM HU 
treatment, allowed us to determine the replication speed during a perturbing condition that 
slows replication.  
100000 cells were seeded on a 6-well plate (two wells per condition, one labelled and the 
other unlabelled). After pulse-labelling cells with CldU and IdU and treating as indicated (in the 
labelled well), cells were washed with cold PBS, harvested by trypsinization mixing labelled 
and unlabelled cells (in a 1:1 ratio), centrifuged at 660g for 5 minutes at 4°C and resuspended 
in 200µL of ice-cold PBS.  
After that, DNA spreading was performed. To this end, 4µL of the cell suspension were spotted 
onto glass slides and cells were lysed with 8µL of spreading buffer directly on the cell drop and 
mixed carefully with the pipet tip. Slides were incubated for 2 minutes at RT (in flat position), 
and then were tilted at a 15° angle, allowing the drop to flow along the slide slowly. The 
stream of DNA was air-dried briefly during 10 minutes and then fixed with a freshly prepared 
mix of methanol:acetic acid (3:1) during 10 minutes. Once fixed, slides could be stored in a 
fridge for one month.  
After fixation, the slides were washed three times with PBS. Then, they were washed once 
with denaturation buffer (2.5M HCl in ultrapure water) and incubated in denaturation buffer 
for 80 minutes at RT. After this time, HCl was removed from the slides by washing four times 
with PBS (incubating slides 5 minutes in the last wash).  
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After that, slides were washed once with blocking buffer (1% BSA- and 0.1% Tween20-
containing PBS solution), and then were incubated with blocking solution on parafilm in dark 
and humid container during 30 minutes at RT.  
Once blocked, slides were incubated with anti-BrdU primary antibody for CldU (Abcam, 
ab6326; Rat; 1/250) diluted in blocking solution for 75 minutes at RT. After that, slides were 
washed once with 0.1% Tween20-containing PBS and twice with PBS.  
Then, slides were fixed with 4% PFA-containing PBS for 10 minutes at RT, washed again three 
times with PBS and incubated with secondary antibody Alexa555-conjugated anti-rat 
(Invitrogen, A21434; 1/500) diluted in blocking buffer for 60 minutes at RT. From this point on, 
slides were protected from light. 
After incubation, slides were washed three times with PBS and incubated overnight with anti-
BrdU primary antibody for IdU (Becton Dickinson, 347580; Mouse; 1/200) diluted in blocking 
solution at 4°C. After that, slides were washed once with 0.1% Tween20-containing PBS and 
twice with PBS and incubated with secondary antibody Alexa488-conjugated anti-mouse 
(Invitrogen, A21202; 1/500) diluted in blocking buffer for 60 minutes at RT. Then, slides were 
washed five times with PBS and mounted with Mowiol-containing media. 
During the next 48 hours, images were acquired using Leica TCS-SL or Zeiss LSM880 confocal 
microscopies (Confocal Microscopy Unit Core Facility, UB). The analysis of images was 
performed using Fiji (Image J) software.  
Spreading buffer 
200mM Tris-HCl, pH 7.4 
50mM EDTA 
0.5% SDS 
* All material and reagents used for DNA fiber assay were previously sterilized.  
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10.  STATISTICAL ANALYSIS 
Statistical analysis was always performed using GraphPad Prism T software (version 6.1). 
Paired or unpaired t-test analyses were performed as indicated. Mann-Whitney test was 
performed in IdU or CldU track length analysis, where values do not follow a Gaussian 
distribution. Values marked with asterisks are significantly different: *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001. “n.s.” was used to indicate absence of statistical significance. 
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